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ABSTRACT 
Biosynthetic Studies on Tenellin and 
Aminoisobutyrate Metabolism in Streptomyces sp. 
M . Caragh Moore, B.Sc. 
This thesis is divided into two parts. Part 1 covers the biosynthesis of the fungal 
metabolite tenellin, and Part 2 the metabolism of P-aminoisobutyrate in Streptomyces sp. 
Tenellin is a yellow pigment of the fungus Beamaria bassiana. It is of mixed biosynthetic 
origin, being derived from a polyketide moiety and the amino acid L-phenylalanine. The 
timing of the C-methylations of the polyketide chain is discussed in Chapter 2, which 
describes attempts to incorporate deuterium labelled partially assembled putative 
intermediates into the polyketide. The biosynthesis of the pyridone ring of teneUin 
requires the condensation of the polyketide moiety with a rearranged phenylpropanoid 
unit derived from phenylalanine. The natui-e of this inttiguing inti-amolecular 
rearrangement is discussed in Chapters 3 and 4. A phenylalanine derived tetramic acid, 
proposed as an intermediate in the biosynthesis, has been synthesised, and used in 
biosynthetic investigations. The results of these investigations and the subsequent 
identification of tyrosine as a closer precursor to teneUin argue against its intermediacy. 
The failure of [2-"C^H^^N]-phenylalanine to become incorporated intact suggests a 
transamination process for phenylalanine / tyrosine prior to incorporation. PreUminary 
investigations suggest /?ara-hydroxy phenyllactate may be the substrate for the 
rearranging enzyme and a more direct precursor to tenellin. 
P-Aminoisobutyrate, the end product of reductive thymine cataboUsm, contributes to both 
the propionate and butyrate pools in Streptomyces sp. The pathway of incorporation into 
the isobutyrate / butyrate pool has been investigated, and confirmed to be the reverse of 
that known to occur in L-valine metabohsm. A mutant strain of Streptomyces avemitilis, 
unable to produce isobutyrate, was used due to low level incoiporations into the 
branched-chain fatty acids. This work was carried out in collaboration with Dr. Hamish 
McArthur, Pfizer Central Research Division, Groton, USA, and Dr. Kevin Reynolds, 
Department of Pharmaceutical Science, University of Maryland. 
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1. Introduction 
1.1 Primary and Secondary Metabolism 
Study of die vital metabolic processes of living things has revealed the detail of the 
complex web of cycles of enzyme catalysed reactions. Beginning with the substrates of 
photosynthesis, CO2 and H2O, many diverse classes of essential molecules are built up 
and used to construct the primary metabolites. Of central importance is the co-enzyme 
adenosine triphosphate, (ATP) which is the cell's energy source, working in co-
operation with particular enzymes in the reactions they catalyse. This web of biochemical 
reactions refen-ed to as primary metabolism produces metaboUtes including amino acids, 
sugars, nucleotides, acetyl-coenzyme A, mevalonic acid, all of which are essential for 
metabolism in all cells.' Secondary metaboUtes can be distinguished from their primary 
counterparts in tiiat they are not essential for the primary functions of life, and are not 
found in all life forms, having a restricted distribution characteristic of individual strains 
or species. They are formed as products of speciaUsed pathways originating from the 
metabohtes of primary metabolism. Although they are not essential for life they have 
important and useful functions for the survival and fitness of the organism including 
acting as competitive weapons (antibiotics), sexual hormones and differentiation effectors 
between and within cells.^ 
Throughout history mankind has exploited crude plant extracts for medicines, purfumes, 
stimulants, narcotics, hallucinogens and poisons. Many secondary metabohtes 
(otherwise known as natural products) have been isolated and characterised from natural 
sources for use in medicinal chemistry, such as the penicillin and tetracycline antibiotics, 
morphine and ephedrine. Sometimes these compounds appear to serve no useful purpose 
in the producing organism, but have been of great benefit in the service of man, 
motivating chemists from the early nineteenth centuiy to seek to purify and characterise 
these natural products. Attempted total syntheses of tiiese products followed, often 
bringing with them breakthoughs in understanding the 'rules' of organic chemistry. It 
was their studies on the total synthesis of vitamin B j , , and an examination of its thermal 
and photochemical reactions, that led Woodward and Hoffman to enunciate the principals 
of conservation of orbital theory in 1969.^  Although traditionally primary metaboUsm has 
been the realm of biochemists, and secondary metabolism that of organic chemists, it is 
an interdisciplinary approach which is now enabhng exciting advances in understanding 
the biosynthesis and enzymology of many of these complex metabolites, the polyketides 
and the polypeptides in particular."* 
Biosynthesis and accumulation of most secondary metabolites is limited to distinct 
developmental stages of the producer organism. Microbial cultures pass from a phase of 
rapid cell growth (trophophase) to a phase of ceU speciaUzation (idiophase), and it is in 
the latter stage that the enzymes of secondary metaboUtes are expressed.' Thus these 
metabolites rely on the catabolic products of primary metabolism for their biosynthesis. 
Secondary metabolites, though diverse in structure, can be classified into groups on the 
basis of the units from which they are constructed. In fact, many metabolites have only 
one basic building block which is used to create the whole structure. The group of 
interest discussed here are the polyketide metabolites, which are assembled in a similar 
fashion to the fatty acids (a group of primary polyketide metabolites) by linear 
combination of acetate units, witii reduction of the keto groups to various degrees. 
1.2 Techniques in Biosynthesis 
1.2.1 The use of isotopically labelled studies 
Extensive information has been obtained about primary and secondary metaboUsm by use 
of feeding experiments utiUsing isotopicaUy labelled precursors. This involves 
administration of a likely precursor to the organism and analysis of the metaboUte 
produced to detect incorporation. 
Two general types of feeding experiment have been used: 
• Radioactively labelled precursors with long half lives, e.g. '''C and and ^^ P which 
can be sensitively assayed by scintiUation counting. 
• Stable isotopic labelling, '^C, '^N, '^0, or "H and detection by NMR or MS studies. 
NMR studies provide information about regiochemistry of incorporation and have 
proved of greatest importance.^ 
The advantage of using radioactively labelled substrates is that a very low level of activity 
can be recorded. However metaboUc products must be rigorously purified to eliminate 
errors from contamination. Site specific information requires chemical degradation of the 
metaboUtes with painstaking purification of the degradation products. High Performance 
Liquid Chromatography may also be used with scintUlation counting to separate and 
detect the radioactive products. 
Although methods of analysis using stable isotopes are much less sensitive than those 
used to assay radioactivity, they are non-desttoictive and reveal more information about 
the regiochemistry of incorporation of the precursor into the metaboUte. Nuclear magnetic 
resonance is the preferred method of analysis, but mass spectroscopy often combined 
with GC or HPLC is sometimes chosen as much smaUer amounts may be analysed. The 
number of isotopes may be assessed, but detection is not site specific. '^ C NMR with 
proton decoupling is most commonly used to follow die fate of carbon atoms. The 
natural abundance of carbon-13 is 1.1%, allowing detection of reasonably smaU 
incorporations above natural abundance. Studies with double labelled precursors such as 
[ 1,2-'^CJ-acetate have enabled very detailed analyses of bonds broken and retained 
during biosynthetic processes.^  ^H NMR has also been widely used with relatively 
inexpensively prepared deuterium labelled precursors and has similar chemical shift 
values to proton NMR. "H NMR however, has associated problems: low sensitivity (due 
to low magnetogyric ratio), poor dispersion of chemical shifts, and broad signals due to 
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the H nuclear quadruple (1=1). Despite this, its low natural abundance (0.015% of H) 
allows incorporations to be measured at very low levels. In tills context ^H-NMR is 
effectively sixty times more sensitive than '^ C NMR when apphed to biosyntiietic 
incorporation studies.* Less frequentiy used is ^H NMR, due to tiie radioactivity of 
tritium. However the nuclear properties of tritium (highest known magnetogyric ratio and 
nuclear spin of ^ ) combined witii its neghgible natural abundance make it die most 
sensitive isotope for NMR analysis.' '^ O NMR studies have also been successfully used, 
despite the difficulty of aquiring good quality '^ O NMR spectra. The signals are very 
broad due to the quadrupolar nucleus which relaxes very badly. However, tiie attraction 
again is the low natural abundance of oxygen-17 (0.04%), allowing small enrichments to 
be observed.'" '^N NMR may be useful, although its use as a label in a-amino acids 
does not always give reliable results because of rapid transamination. 
Isotopes may also be detected indirectiy, usually by monitoring their interaction with an 
adjacent '^ C atom by '^ C NMR. This approach has been frequentiy used with 
deuterium." Each deuterium atom shifts the adjacent resonance of the attached carbon-
13, 0.3 - 0.6 ppm to higher frequency. This is known as an a-shift. However, as the 
signal to noise ratio of caibon-13 atoms attached to deuterium atoms is reduced due to 
poor relaxation, signal multiphcity and loss of n.O.e, it can be difficult to obtain reliable 
levels of enrichment. Joint proton and deuterium decoupUng may be used to reduce the 
signal to a singlet thus increasing the sensitivity. (3-Shifts (which are smaller, 0.04 ppm 
to lower field) are also additive and observable, and do not have die disadvantages 
associated with a-shifts. They also provide information on tiie incorporation of intact 
units, '^C-C-D.'^ The fate of oxygen-18 may similarly be followed by monitoring the 
induced chemical shift of an adjacent carbon-13, a technique which was used for example 
to establish the origin of oxygen atoms in die polyether antibiotic monensin'^ (discussed 
in Chapter 5). Similarly nitrogen-15 incorporation may be monitored by die observed 
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coupUng to an adjacent carbon-13, and was a valuable aid in elucidating the structure of 
the fungal metaboUte tenelUn.''' 
Studies using stable isotopes, however, are not without disadvantages. The labeUed 
precursor is only a smaU fraction of the total pool of unlabeUed precursor, and therefore 
wiU only become incorporated into a fraction of the molecules of the metaboUte 
produced. Furthermore the administered precursor is not always able to penetrate the site 
of biosynthesis, or may be degraded en route. Because of these obstacles it is necessary 
to administer higher concentrations of the precursor, and there is a danger of the normal 
metaboUsm being perturbed. Fungi in particular are prone to lose or change their 
metabolic capabUities under such conditions.'^ 
1.2.2 Enzymes, inhibitors and mutants 
A complementary approach to the administration of isotopically labeUed intermediates on 
a putative biosynthetic pathway is to seek to isolate intermediates directiy from the 
organisms. Mutation of the wild type organism (induced by UV or chemically, or by 
genetic engineering) results in organisms, which if deficient in an enzyme on the pathway 
may accumulate biosynthetic intermediates, but are unable to synthesize the natural 
metaboUc product. These inteirnediates may be isolated and analysed. Supplementation 
with the subsequent intermediate on the pathway should restore die production of the 
natural products. AppUed to polyketide biosynthesis such techniques have enabled the 
identification of post assembly modifications (e.g. hydroxylations'*, methylations"), as 
weU as identifying the biosyntiietic origin of the precursors, particularly die starter 
units.'* Polyketide chain elongation intermediates have even been isolated from mutant 
strains of the mycinamycin producing organism Micromotwspora griseorubida sp.'^  
Production and isolation of mutants deficient in a specific enzyme activity can be a 
laborious process. An alternative approach has been to block potential enzymes on die 
pathway by use of inhibitors."" An extension of this technique involves die 
administration of isotopicaUy labeUed putative intermediates after die 'block'.-' Specific 
inhibitors have also been used in paraUel with feeding studies to impede degradation of 
die putative intermediate prior to its utilization on die pathway of interest."' 
1.3 Biosynthesis of the Polyketide Metabolites 
The polyketides are a large and very diverse group of metabolites, extending from 
primary into secondary metaboUsm. Their wide distribution makes tiiek study a 
fascinating domain, involving techniques from a range of disciplines. Stuctures range 
from the very simple aromatics such as the fungal metaboUte orselhnic acid (1.1) 
discussed below, to the massive marine metaboUte maitotoxin (1.2), the largest non-
polymeric secondary metabohte known. Incredibly, only 8.1 mgs of maitotoxin was 
used in the structure elucidation!" 
CO2H 
NaOoSO 
(1.2) HO OH OH 
Figure 1-1 Orsellinic acid and Maitotoxin 
The secondary metabolites known as the polyketides are assembled in a manner closely 
related to that of the primary metaboUtes, tiie fatty acids. These long hydrocarbon chain 
fatty acids are usuaUy derived from a linear combination of acetate units, altiiough like the 
polyketide metaboUtes propionate may also be incorporated. Fatty acids are activated in 
the cytosol of the ceU by reaction with coenzyme-A and ATP yielding fatty acyl-CoA, as 
shown below for acetyl-CoA (1.3). 
O OH 
Figure 1-2 Acetyl coenzyme-A 
For the condensation of the acetate units, acetyl-CoA is first activated by carboxylation to 
malonyl-CoA and then ti'ansesterified onto an acyl cairier protein (ACP) attached to a 
fatty acid synthase (FAS). Acyl carrier protein, like CoA, contains a phosphopantetheine 
group to which acyl groups are esterified. 
O 
biotin 
n HCO2 ][ HACP j 
^ ^ CO2H CO2H 
acetyl-CoA f ^ malonyl-CoA malonyl-ACP 
ATP ADP + Pi 
+ HSCoA 
SACP 
Figure 1-3 Activation of acetate units for fatty acid biosynthesis 
Malonyl-CoA is transesterified onto the fatty acid synthase (FAS) condensing enzyme 
ready for condensation with the starter unit, usually acetyl-CoA, also held on a free thiol 
residue of the condensing enzyme. Condensations of the gi-owing fatty acid chain are 
driven by loss of CO2, to form P-ketoacyl-ACP. In Type I I FASs a specific P-ketoacyl 
synthase (condensing enzyme EI) usually mediates this first condensation with acetyl-
CoA directly, which may account for the observed incorporation of a number of 
alternative starter units.^'* After each chain extension the acyl carrier protein transports the 
P-ketoacyl around a series of enzymes which catalyse the reduction of each P-keto group 
by N A D P H to a saturated methylene group. The extended chain is then transferred to the 
keto-synthase thiol, releasing the acyl canier protein to accept another malonyl-CoA, and 
to serve as the substrate for the next condensation. This cycle continues until the 
complete fatty acid has been synthesised, which is then released from the enzyme 
complex." 
starter unit 
SACP 
HSCoA 
O O 
SACP 
OH 
SACP 
NADPH 
(3-keto-synthase 
P-keto-reductase 
dehydratase 
enoyl reductase 
^ — ^ N A D P 
O ' OH 
SACP 
Figure 1-4 The reactions of fatty acid biosynthesis 
The stereochemical course of the transformations of fatty acid biosynthesis have been 
established by Sedgwick and Comforth^^ using chiral methyl methodology, and all 
activities apart from the final reducing enzyme, enoyl reductase appear to operate with the 
same stereochemistry in different organisms. Retention of configuration for the 
carboxylation step is followed by inversion of configuration during condensing malonyl-
ACP with acetyl-ACP. The P-ketoacyl reductase mediates a si-face reduction^^ and 
P-ketoacyl-ACP dehydratase executes the i-^/i-elimination of water.-* 
Fatty acid synthases (FAS), are composed of at least six enzymatic activities, making 
them among the most sophisticated of known enzymes. Fungal and animal synthases are 
multifunctional enzymes (M^ > 200,000) consisting of single or clusters of 
multifunctional polypeptides, contiguous stretches of which ai'e folded into autonomous 
domains of polypeptide subunits each having a specific catalytic activity. These are 
known as Type I synthases. For mammalian FASs two almost identical multifunctional 
peptides dimerize in vivo and it is suggested that such an arrangement orientates the thiol 
residues of the condensing enzymes so that fu l l activity can be expressed. Fungal and 
yeast FASs often have complex molecular architecture requiring the association of a 
number of multifunctional subunits.^^ Bacterial and plant synthases differ from these in 
that they are readily dissociable into their component enzymes, and ACP, and are known 
as Type I I synthases.^" Each enzyme is monofunctional and may be active in isolation 
from the other enzymes. In either case it is the acyl carrier protein which sequentially 
escorts the intermediate thioesters to the catalytic sites of the FAS. In Type I FASs this 
acyl carrier protein is covalently linked to a serine residue on the synthase. Some bacteria 
(especially the Actinomycetes) possess Type I I FASs similar to the yeast and fungal 
systems.^' This is significant as the complex polyketides also produced by these 
organisms require complex multifunctional polyketide synthases. 
Some fatty acids incoiporate unusual starter units, instead of acetyl-CoA, resulting in 
fatty acids with structural variation at the terminal end. Starter units include isobutyryl-
CoA, 2-methylbutyryl-CoA, 3-methylbutyryl-CoA (the catabolic products of the amino 
acids L-valine, L-isoleucine and L-leucine). Other unusual staiter units are propionyl-
CoA, cyclohexylcarboxyl-CoA, and even fluoroacetyl-CoA." 
CO2H 
Figure 1-5 Iso-palmitate derived from starter unit isobutyryl-CoA 
Although non-acetate starter units are relatively common, altematives to acetate within the 
chain are rare. However, in a similar manner to bacterial polyketide synthases certain 
fatty acid synthases incorporate propionate units, activated first as methylmalonyl-CoA. 
Further diversity may also be introduced into the hydrocarbon chain, by desaturases 
(resulting in unsaturated fatty acids), methylations with S-adenosyl methionine, or by 
incomplete reduction of the polyketide. 
1.3.1 Fungal polyketide biosynthesis 
In a similar manner to the classical fatty acid biosynthesis the polyketides are assembled 
f rom the condensation of acetyl-CoA and malonyl-CoA units.^" 
O 
0 ' 4 , 0 H 
SACP condensing enzyme 
o o 
SR 
CO2 HSR 
Figure 1-6 Polyketide biosynthesis 
However unlike fatty acid biosynthesis the polyketide is not completely reduced to 
generate a ful ly saturated carbon chain. Each polyketide synthase (PKS) is programmed 
to effect a different degree of reduction leading to a range of partially reduced chains. 
These then fold and cyclise or cascade via intramolecular condensations and substitutions 
to generate a specific metabolite. 
The majority of polyketide metabolites so far identified are products of the fungi, the 
fungi imperfecti being paiticularly prolific producers. The phenolic polyketides are a 
ubiquitous class, which arise from intramolecular condensations of extended, inherently 
unstable, unreduced polyketide chains. It has been suggested that a poly-(3-keto 
intermediate is stabilised on the synthase, possibly by metal ion chelation (as shown in 
Figure 1-7).^ ^ Orsellinic acid (1.1) produced by both plants and fungi is assembled from 
four acetate units. Cyclisation, via aldol condensation, of the P-keto intermediate 
followed by dehydration and two enoUsations gives the structure shown below. 
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malonyl-CoA 
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H r n j l ^ ^ ^ 
CH3 
SACP 
HO ^ CH3 
orsellinic acid (1.1) 
Figure 1-7 Biosynthesis of orsellinic acid 
6-Methylsalicylic acid (1.4), (from Penicilliim patulum) requires an NADPH-dependent 
p-keto reductase as pait of the PKS, due to the absence of a hydi'oxyl group at carbon-4. 
Dehydration of the partially reduced P-keto inteirnediate is followed by cychsation and 
aromatisation. An enzyme extract from Penicillium patulum has been purified which in 
the presence of NADPH converts acetyl-CoA and malonyl-CoA into 6-methylsalicyUc 
acid. This enzyme was shown to be a single multifunctional protein similar to the Type 1 
fatty acid synthases." The reduction step appears to occur at the triacetic acid level, 
implying a processive mechanism of polyketide assembly. 
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COSR 
(1.4) 
6-methylsalicylic acid 
Figure 1-8 Biosynthesis of 6-methylsalicylic acid 
Many polyketide metabolites of fungi and plants possess extra methyl groups attached to 
the acetogenic carbon skeleton. These ai'e usually donated from L-methionine activated as 
S-adenosyl L-methionine (SAM) (1.5) by nucleophilic substitution (8^2) of the S-methyl 
group. O and N-Methylations are also well known as a feature of polyketide 
biosynthesis, usually occuring as post-assembly modifications. The timing of 
C-methylations is not well established. Presumably C-methylations occui- prior to 
reduction of the poly-P-keto chain via nucleophilic attack of the methylene, or possibly at 
the alkene level, following the dehydration step. This impUes a C-methylation enzyme 
operating closely with the polyketide synthase enzyme, i f the mechanism of polyketide 
assembly is a processive one.^ ^ The timing of the C-methylations in tenellin biosynthesis 
is the subject of Chapter 2 of this thesis. 
OH OH 
^ O H ^^^^^^^0^^^^ 
SR 
Figure 1-9 C-Methylation of a fungal polyketide by SAM 
Exti'a methyl groups at the beginning of the polyketide chain may also originate from the 
incorporation of unusual starter units, as is observed in iso- and anteiso-fatty acid 
biosynthesis. Propionate is used as a starter unit in the biosynthesis of the 
anthroquinones, austi-ocoiticinic acid (1.6) and (-i-)-austrocorticin (1.7), produced by the 
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Australian toadstool Cortinarius dermocybe,^'* but there are no known examples in fungi, 
of incorporation of propionate at any other position in the polyketide chain. 
OMe O 
MeO 
OMe O 
CO2H 
MeO 
austrocorticinic acid (1.6) (+) austrocorticin (1.7) 
Figure 1-10 Fungal metabolites using propionate starter units 
Intriguingly, two biosynthetic pathways appear to be operating during the biosynthesis of 
the aurovertins (1.8). Pi-opionate has been shown to become incorporated as the starter 
unit, but acetate and methionine may also become incorporated at this site." 
OMe 
aurovertin B R = H 
aurovertin D R = OH 
O 
(1.8) 
Figure 1-11 Aurovertins B and D 
Although the majority of fungal polyketides appear to be aromatic, a number of fungal 
metabolites have been isolated which have a reduced polyketide framework. Convincing 
evidence for a processive mechanism of assembly operating in fungal polyketide 
assembly has come f rom a number of studies involving the successful uicorporation of 
partially assembled fragments into certain metaboUtes. Isotopically labelled 
N-acetylcysteamine thioesters of partially assembled reduced intermediates have been 
successfully incorported into dehydrocurvularin (1.9), in a mutant strain of Altemaria 
cinerariae. Such thioesters appear to be able to intercept the polyketide synthase, and are 
then fiuther chain extended. As dual '^C labels were used, and intact incorporation 
observed, degradation of these intermediates prior to incorporation may be discounted.^* 
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Alternaria dehydrocurvularin (1.9) 
cinerariae 
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Figure 1-12 Intact incorporation of putative intermediates into dehydrocurvularin 
Polyketide metabolites of mixed biosynthetic origin are not uncommon in plants and 
fungi . Tenellin (1.10), a fungal polyketide metabolite, which is the subject of Part 1 of 
this thesis, is one such metabolite, biosynthesised from a polyketide moiety and the 
amino acid phenylalanine or tyrosine. 
CH3 CH3 
tenellin (1.10) 
Figure 1-13 Tenellin 
Other related polyketide metabolites, such as the tetramic acids, are discussed in Chapter 
3. The polyketide moiety is presumably biosynthesised independently, then condensed 
with the amino acid moiety. This is also assumed to be the pathway of biosynthesis for 
the group of terpene-polyketide metabolites, such as grifolin (1.11), which have pendent 
isoprenoid groups, generally attached to polyketide-derived phenol ring. 
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g r i f o l i n ( l . l l ) 
Figure 1-14 Grifolin derived from famesyl pyrophosphate and orcinol 
However for the flavanoid metabolites originating from phenylalanine, the amino acid 
moiety is incorporated into the polyketide itself as the starter unit, after conversion via 
trans cinnamic acid to 4-coumaiic acid (1.12). Interestingly, the first three condensations 
with malonyl-CoA are controlled by chalcone synthase (or resveratiol synthase) at the 
CoA level. These synthases are unique amongst polyketide synthase enzymes for this 
reason, that they are devoid of an ACP. 
HO 
"^Nr^"^^"^ SCoA 
- - ^ ^ (1.12) 
chalcone 
synthase r 
3 X malonyl-CoA 
flavanoids 
O OH 
Figure 1-15 Biosynthesis of the flavanoids 
1.3.2 Bacterial polyketide biosynthesis 
In comparison to the fungi, bacteria do not produce a great variety of polyketide 
metabolites, except the actinomycetes. In paiticular the subclass Streptomyces (soil 
bacteria) are able to produce polyketides ranging from simple acetogenic ai"omatic 
compounds to complex macrolide structures. As many of these compounds are 
antibiotics they have attracted much attention. Bacterial polyketides, are generally 
15 
structurally more complex than the fungal metaboUtes due to the utilisation of propionate 
units, and occasionally butyi-ate units, in addition to acetate units during biosynthesis. 
Incorporation of propionate and butyrate results in pendent methyl and ethyl groups 
respectively attached to the polyketide backbone. This is in contrast to the orgin of 
pendant methyl gioups in fungal polyketides, which arise from C-methylations 
contributed by S-adenosyl methionine to the polyketide chain. 
In an analogous process to fatty acid biosynthesis acetate, propionate, and butyrate units 
are activated by acetyl-CoA carboxylases to give malonyl-CoA, propionyl-CoA, and 
butyiyl-CoA respectively. The synthase enzymes ai-e programmed to select each substrate 
in the correct order, and on reduction the methyl and ethyl branches adopt either the D or 
L configuration as the chain is progressively buUt up. 
The polyketide synthase enzymes also contain a whole complement of reducing activities 
which can selectively reduce or retain the P-keto functionality as the chain is assembled. 
As a consequence the whole range of functional groups CH,, C=C, C-OH, C=0 , may be 
displayed in the resulting polyketide. 
The malonyl-CoA precursors to the acetate, propionate and butyrate precursors from 
which the polyketide chain is assembled are derived from the cataboUsm of various 
primary metabolites. Amino acids, fatty acids and the products of the citric acid cycle are 
known to contribute carbon atoms to the propionate and butyrate pools. Once cells enter 
the stationary stage of cell growth, primaiy metaboUtes ai^ e broken down to these 
essential precursors, and secondary metabolism can begin. Part 2 (Chapter 5) of this 
thesis investigates one such link between primary metabolism and the malonyl-CoA 
precursors of polyketide biosynthesis using the Streptomyces polyketides monensin A 
(1.13) and aveirnectin (1.14) as case studies. 
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monensin (1.13) 
OCH3 
avermectin A l b (1.14) 
OCH3 
Figure 1-16 Monensin A and avermectin Alb 
The evidence strongly supports a processive mechanism of polyketide biosynthesis for 
these higher order polyketides. In particular the macrohdes erythromycin A and tylosin 
have been studied due to thek commercial significance as antibiotics. 
I t has already been dicussed that fragments of mycinoUde IV have been identified in 
mutant strains of the mycinamycin producing Micromonospora griseorubida.^^ Similar 
fragments have been identified in mutant strains of Streptomyces fradiae which secretes 
the tylosin aglycone tylactone (1.15) ." Furthermore isotopically labelled 
N-acetylthioesters of partially assembled tylactone were successfully recognised and 
converted into the aglycone in the same mutant strain.^* Dual carbon-13 labelled 
intermediates have also been incorporated into erythromycin A (1.16)^' and nargenicin A 
(1.17),^*" as their thioesters. The use of a deuterium label in diketide (1.18) demonstrated 
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that oxidation to the P-keto thioester was not occuring prior to incorportion into 
erythromycin."" Similar studies on these metabohtes and others continue to emerge."^ 
OH 
.NHAC 
Streptomyces 
fradiae GS14 
^^^^  "*0H 
NHAc 
tylactone 
(1.15) 
.NHAC 
Saccharopolyspora 
erythraea 
NHAc 
' " 1 ° " ( U 8 ) 
OH OH 
erythromycm 
OMe 
NHAc 
Nocardia 
argentinenesis 
OH ^ 
f H 
i [ Jt H 
H 
NHAc 
H 
(1.17) 
Figure 1-17 Incorporation of partially assembled intermediates into reduced bacterial polyketides 
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Despite the structural diversity of bacterial polyketides identified, striking stereochemical 
homologies may be observed between them, particularly between the macrohde 
antibiotics. In 1965 Celmer"*^ outlined a configurational model which summarised the 
absolute stereochemistiy of all the known 12 and 14-membered macrolides. This model 
may be extended to include the 16-membered macrolides with only one asymmetric 
centre (C-14) showing an inconsistency. The polyethers and the ansamycins also show 
considerable stereochemical homologies,'*'* and indeed correlations between the three 
classes are also found.'*' 
1.4 Genetic Studies on Polyketide Synthases 
Important advances in our understanding of the polyketide synthases have been made 
using chemical and biochemical approaches. However a key problem is understanding 
the origin of programming. How do the PKSs control the construction of such diverse 
and elaborate metabolites? It is genetic techniques that have for the last ten years led the 
exceptional advances in umavelling this mystery. Cloning and sequencing of a variety of 
PKSs, have established that these PKSs resemble both the Type 1 and Type 2 fatty acid 
synthases. 
1.4.1 Fungal polyketide synthases 
Although the multifunctional. Type 1 PKS for 6-methylsaUcylic acid biosynthesis from 
Penicilliim patulum was the fu-st functional PKS protein isolated, the genetics of fungal 
polyketide synthases have not yet been widely explored. The gene coding for this PKS 
has since been cloned and sequenced.''* Subsequently PKS genes from various 
filamentous fungi have been sequenced, and all show a Type 1 structure. Most lack the 
three reductive functions, and a thioesterase, and code for aromatic polyketides such as 
norsolorinic acid (1.19), an intermediate of aflatoxin biosynthesis in Aspergillus 
parasiticus.'^^ The mevinolin (1.20) PKS from Aspergillus terreus has also been 
sequenced and is of particulai" interest as it is reduced, and also requires a 
methyltransferase domain for the C-6 methylation."* 
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OH O OH O 
norsolorinic acid (1.19) mevinolin (1.20) 
Figure 1-18 Norsolorinic acid and mevinolin 
1.4.2 Bacterial polyketide synthases 
Most of the genetic work with both the Type I and Type I I polyketide synthases has 
concerned the Streptomycetes and their near relatives among the Actinomycetes. 
Important generalisations emerged from early attempts to isolate genes; that all of the 
biosynthetic genes needed to make a particular antibiotic f rom primary metabohtes occur 
together in a single cluster, and that the genes for self resistance are also to be found 
there. An early demonstration of this was the cloning of the entire cluster of genes {act 
genes) responsible for the biosynthesis of the benzoisochromanequinone actinorhodin 
(1.21) f rom Streptomyces coelicolor A3(2). This has led to the development of two main 
routes to the isolation of complete sets of genes for other polyketides. Furthermore 
cloned D N A cairying the gene cluster for the polyketide synthases were found to be 
sufficiendy alike to be used as probes to isolate other polyketide synthases."' However it 
gradually became apparent that not all of the genes isolated actually encoded the PKS 
sought. For example when genes isolated from the monensin producer Streptomyces 
cinnamonenesis were disrupted, monensin production was undisturbed.^" It is now clear 
that the act probes are only useful for isolating aromatic polyketide synthases, but the 
complex reduced polyketides do not show sufficient homologies. 
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OH O CO2H 
actinorhodin (1.21) 
Figure 1-19 Actinorhodin 
As for the bacterial fatty acid synthases. Type II PKSs, encoded for by adjacent genes on 
the chromosome are found for bacterial aromatic polyketides, each open reading frame 
(ORF) encoding an individual protein with one enzymatic activity and for a discrete acyl 
carrier protein. The expressed proteins presumably cluster togther into a complex. Thus 
for the actinorhodin PKS there are six genes, the minimal PKS genes {act 1 composed of 
ketosynthase, chain length factor, acyl canier protein), together with ketoreductase {act 
ni), aromatase {act VII), and cyclase {act IV).'' 
actl 
actii r ^ flcrvn acriv 
KR KS CLF ACP ARC CYC 
minimal PKS 
Figure 1-20 Arrangement of actinorhodin genes 
The programming mechanism for complex or reduced bacterial macrohdes is quite 
different f rom that for the aromatic polyketides. Each ORF encodes a single 
multifunctional protein with activities for the reduction or partial reduction of the P-keto 
acyl group to the appropriate degi'ee, and with the required stereochemistry i.e. a Type I 
PKS. Several of these ORFs are involved in the complete synthesis of the metaboUte. 
Erythromycin (1.16) is the most thoroughly investigated ahphatic polyketide at the 
genetic level ." The polyketide synthase, responsible for the sequential condensation and 
reduction cycles of propionyl Co-A with six units of methylmalonyl Co-A provides the 
first enzyme free intermediate, 6-deoxyerythionolide B, which is further tailored to the 
active antibiotics erythromycin A-D. The evidence for a processive mechanism of 
assembly was presented above. Following the pioneering work of Hopwood and 
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coworkers (who located and sequenced the genes responsible for the actinorhodin 
P K S ) , " the region in the vicinity of the gene encoding erythromycin resistance was 
sequenced reveahng three large open readng frames (eryAI, eiyAII, and eryAIIF), coding 
for giant multifunctional proteins (DEBSl , DEBS2, and DEBS3), the eythromycin 
PKS.^" Sequence homology with the equivalent domains in fatty acid synthases, allowed 
the catalytic centres {domains) to be assigned. There are in fact two modules per protein 
{cassette), each of which is able to perform a condensation step followed by appropriate 
reduction steps. Clearly then these are multifunctional Type I PKSs. The cassettes 
co-operate to form a modular assembly line in which the intermediates remain enzyme 
bound via thioester links. This modular airangement is also seen in other PKSs, such as 
rapamycin, tylosin, avemectin, but the number of modules per cassette, and their order 
along the chromosome, can vaiy. The rapamycin PKS includes the largest PKS known 
(RAP 3) containing six modules!^' The modular arrangement of the erythromycin genes, 
and their corresponding activities are shown below. 
eryAIlI 
module 1 module 3 module 5 
module 2 
module 4 module 6 
KS A'l' KR ACP KS A l KK ACP I t N T A T ACP KS AT KR ACP KS AT KR A kCV KS Al' UH kK KK ACP 
1 
HO in 
HOIl i -
A T = acyltransferase 
A C P = acylcairier protein 
K S = ^keto-ACP synthase 
K R = P-keto-ACP reductase 
D H = dehydrogenase 
E R = enoyl reductase 
T E = thioesterase 
6-deoxyerythronoUde-B 
Figure 1-21 Modular arrangement of the erythromycin genes 
Evidence for the correlation between the structure of the growing polyketide chain and 
the sequential activity of the domains in the module came from gene disruption 
experiments (Katz et alf^). Disruption of the P-keto reductase (KR) of module 5 led to 
an erythromycin analogue (1.22) with an unreduced keto functionahty in the expected 
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position. I f the enoyl reductase (ER) in module 4 is disrupted, analogue (1.23) is 
produced." 
Figure 1-22 Novel erythromycin analogues from gene disruption experiments 
All three DEBS proteins have been overexpressed and purified to homogeneity, 
indicating that the DEBS multifunctional proteins like the animal FAS, are 
homodimeric.^^ There are two models suggested, one based on the linear head to tail 
model of the animal FAS." The evidence (proteolysis studies^") however, seems to point 
to the alternative dimeric double helical structure with close interchain cooperation 
between KS, ACP and AT domains, a presumed requirement of the condensation steps. 
The DH, ER and KR form loops which protrude outwaids from the central core. This 
new model also adequately explains the data relating to FASs, and may be a more 
accurate model. 
The erythi'omycin PKS has been genetically engineered in many ways. The gene 
disruption stategy of Katz has been mentioned. Since the development by Hopwood and 
Khosla^' of the expression plasmid pRM5, allowing engineered contructs to be 
expressed in Streptomyces coelicolor, domains have been relocated along the gene, 
resulting in the isolation of novel compounds. The first example of such was the 
repositioning of the thioesterase (thought to catalyse lactonisation of the polyketide) from 
the terminus of DEBS3 to the terminus of DEBSl^^. Erythromycin production was 
blocked after module 2 and lactone (1.24) was isolated. A purified DEBSl-TE contruct 
protein has also been used to show unambiguously that, despite the opposite 
stereochemistries of the methyl groups in the product lactone, only the S isomer of 
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methyl malonate is the substi-ate for the enzyme." Attempts to elucidate the molecular 
basis for Celmer's model have shown that condensation of (2S)-methylmalonyl-CoA in 
module 2 proceeds with decaiboxylative inversion without cleavage of the C-H bond 
adjacent to the methyl group whereas in module 1 the chain extension process involves 
loss of the hydrogen attached to C-2 of the methylmalonyl-CoA precursor. The 
production of the D-methyl center in module 2 the asymmetric center of the (2S)-
methylmalonyl-CoA estabUshes that condensation takes place with inversion of 
configuration. The loss of hydrogen to produce the L-methyl center generated in module 
1 implies that an additional obligatory epimerization step takes place in that module. The 
nature and timing of the epimerization remain to be estabUshed.^ " 
Even more ambitiously, a complete loading module has also been transplanted from the 
avermectin PKS into a DEBSl-TE contruct.*^ The impressive result was the production 
of two novel lactones with starter acyl units characteristic of the avermectins (1.25, 
1.26). 
OH OH OH 
< ^ 0 ^ 0 "Nv>**'^ o'^ o /^\^^"^o^o 
(1.24) (1.25) (1.26) 
Figure 1-23 Novel lactones from genetic engineering of the erythromycin PKS 
The construction of hybrids for both aromatic and reduced polyketides continues to be a 
challenging field, which has enticing potential for the production of novel antibiotics, and 
other active compounds.*^ 
The gene cluster for the biosynthesis of rapamycin (1.27) has been sequenced,*^ and is 
worth noting as the structure of this polyketide incoiporates a pipecolate unit, probably 
derived from the amino acid lysine. The thioesterase is replaced by a specialised 
monomeric multidomain protein (pipecolate incorporating enzyme) beheved to catalyse 
formation of the ester and amide bonds to pipecoUc acid.** It is probable that other 
reduced polyketides of mixed biosynthetic origin, such as the tetramic acids, and indeed 
tenellin have similar biosynthetic machinery. 
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OMe = 
MeO 
rapamycin 
(1.27) 
Figure 1-24 Rapamycin derived from a polyketide and a pipecolate unit 
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PART 1 
B I O S Y N T H E T I C STUDIES 
ON T E N E L L I N 
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2. The Timing of C-Methyltransferases in Tenellin 
Biosynthesis: An unresolved problem. 
2.1 Introduction and Background 
2.1.1 The biosynthesis of tenellin 
Tenellin (2.1) is a yellow metabolite of the insect pathogenic fungus Beauvaria bassiana. 
It was first isolated and purified along with a related metabolite, bassianin (2.2), and a 
dibenzoquinone pigment oosporein (2.3) in 1967.' 
tenellin (2.1) 
bassianin (2.2) 
Figure 2-1 Structures of tenellin and bassianin 
Oosporein (a red pigment) was shown to be of polyketide origin, being enriched by 
carbon-14 labelled acetate and malonate, as well as by orsellinic acid and orcinol.^ 
CO2H 
CH3 c^^HO 
orsellinic acid orcinol 
O OH OH O 
HO 0 0 OH 
oosporein (2.3) 
Figure 2-2 Biosynthesis of oosporein 
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TeneUin and bassianin were shown to derive from the amino acid phenylalanine and a 
polyketide moiety. The polyketide chains are partially reduced and are elaborated by 
pendent methyl groups derived from L-methionine. 
The biosyntheses and structures were elucidated by feeding '^N- and '^C- doubly 
labelled compounds and analysis of the metabolite with '^ C NMR spectroscopy (Vining 
et at., 1974).^ The 'H and '^C-NMR spectra and fragmentation ions from the mass 
spectrum have since been fully assigned."* Carbon atoms in and adjoining the hydroxamic 
group were identified by '^N-'^C couphng obsei-ved in teneUin emiched with '^N from 
potassium nitrate-'^N. This illustrates the usefulness of feeding experiments, not merely 
as a tool for unravelling the biosynthesis, but as an aid to structural analysis. 
The polyketide moiety of tenellin was labelled as expected from intact incorporation of 
singly and doubly labelled '^ C-acetates, and L-['^CH3]-methionine enriched die mediyl 
groups, presumably after activation to S-adenosyl-L-methionine (SAM). The timing of 
such C-methylations in fungal polyketide biosynthesis remains unknown at present. 
Tenellin is an ideal metabolite in which to explore this issue. The nitrogen of the 
pyridone ring of tenellin was proposed to derive from the intact incorporation of L-
phenylalanine as enrichments from '^N-phenylalanine were comparable to those from 
'^C-labelled phenylalanines. The labelling patterns from DL-[1-'^C]- and DL-[2-'^C]-
phenylalanines indicated an intiiguing reairangement of the propanoid component 
occuring, involving migration of the original carboxyl caiton of L-phenylalanine to 
become C4 of the pyridone ring.^ This was shown to be intramolecular in a definitive 
feeding experiment with [l,3-"C2]-phenylalanine, in which the labelled carbons came 
together and became C-4 and C-5 in the pyridone ring of tenellin (Figure 2-3). The '^C-
NMR clearly showed two satellite peaks due to spin-spin coupUng symmetrically located 
about the C-4 and C-5 singlet peaks.* The mechanism and proposed intermediates of tiiis 
intriguing rearrangement are the subject of Chapters 3 and 4 of this thesis. 
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OH O 
"O 
I 
OH 
NH3* 
L-phenylalanine 
I 4 
,CH3 ^CHa 
B. bassiana 
tenellin 
NH3* 
acetate L-methionine 
Figure 2-3 Origin of the skeletal carbon atoms in tenellin 
The absolute configuiation of tenellin was estabUshed by Cox by oxidative degradation 
of crude tenellin releasing the 2-methylbutyi-ic acid fragment. Complexation with 
Parker's chiral solvating agent ( I R , 2R)-(-)-l,2-diphenylethane-l,2-diamine^ followed 
by ' H N M R analysis, and comparison against complexes with (RS)-2-methylbutyric acid 
and (S)-(+)-2-methylbutyric acid resulted in the (R)-assignment of the chiral centre. 
Interestingly this is consistent with the configurations found for the 2-pyridones 
funiculosin and ilicicolin-H, although fungal polyketide synthases generally possess the 
(S)-configuration at such methylated centres.^  
2.1.2 Timing of the C-methylations in fungal polyketide assembly 
A number of investigations have addressed the issue of the timing and mode of the C-
methylation process during fungal polyketide biosynthesis. An early investigation into 
citrinin (2 .4) biosynthesis estabUshed that methylation inhibitors, such as ethionine, 
suppressed the formation of any aromatic intermediates. This is consistent with direct 
methylation of the poly-^-ketone.^ 
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5x 
SCoA PKS O O 
V Y 
o o 
SENZ 
3x CH3 / \ Blocked by ethionine 
HO2C 
OH 
citrinin (2.4) 
Figure 2-4 Ethionine inhibition of citrinin biosynthesis 
It has been shown by Lederer et a/.'" that transfer of the CH3'' from the sulphonium ion 
of methionine to a weakly nucleophilic double bond, results in the loss of one of the 
three original hydrogen atoms as a result of rearrangement to the most stable intermediate 
carbocation. In contrast all hydrogens are retained if the €113"^  attacks a strongly 
nucleophilic double bond such as an enolate. 
NH3* 
OH OH 
Figure 2-5 Methylation of enolate by S-adenosyl-L-methionine 
Poignantly, a number of investigations with ['^C'Hj-me^/z^'/J-L-methionine have 
established that all the deuteriums are retained in the resultant methylated polyketides." 
An investigation with teneUin gave similai" results. AH thi-ee deuterium atoms 
from['^C^H3-me//23'/]-L-methionine were incorporated intact into the pendent methyl 
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groups of tenellin.* On the basis of a similar investigation, it had been suggested by 
Wyss and Tamm'^ that methylation may occur before reduction of a poly-p-keto chain 
during the biosynthesis of die reduced fungal polyketides, the cytochalasins (2.5) 
0 0 0 0 o o 
cytochalasin A 
Figure 2-6 Proposed mechanism of cychalasin assembly, involving early methylation 
However, as discussed in Chapter 1, there is mounting evidence (i.e. die incoiporation 
of intact, reduced intermediates) for a processive mechanism of assembly for the reduced 
fungal polyketides, as well as for die reduced bacterial polyketides. This involves a 
reduction cycle following each chain extension, rather than the formation of a complete 
P-keto chain prior to reduction. The above results with [^^C'H^-methyl]-L-meth\onine 
suggest that, for a processive mechanism, the methyl groups must be incorporated into 
the polyketide chain diuing the assembly process at the (3-keto stage, rather than after the 
polyketide chain is assembled and reduced. The P-keto acyl group formed by chain 
extension with malonyl-CoA could readily be attacked by die electrophilic metiiyl group 
of S-adenosyl methionine, followed by die usual cycle of P-keto reduction. Thus a 
processive mechanism would implicate the involvement of a C-methyl transferase 
enzyme operating closely with, or possibly expressed as a part of, a Type I polyketide 
synthase enzyme (PKS). 
A biosyndietic investigation on die fungal polyketide cubensic acid (Figure 2-7) 
(produced by Xylaria cubensis) which has eight pendent methyl groups, demonstrated 
that each of those is derived from SAM.'^ It is also interesting to note that die structure of 
cubensic acid can be divided into five biosynthetic regions, (thi'ee different modules, two 
of which are repeated) each requiring a series of enzymatic activities to achieve die 
correct functionality along die backbone. These structural units are obsei-ved in odier 
reduced fungal polyketides.''* It was Uierefore suggested that a processive modular 
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mechanism of assembly, similar to the Type I PKS modular assembly of bacterial 
macroUdes (discussed in Chapter 1) could be operative in reduced fungal polyketide 
biosynthesis. For cubensic acid each module could code for a multifunctional protein 
including a methyl transferase activity. 
OH 
cubensic acid 
OH 
Module 3 
CO2H 
A 
Module 1 Module 2 Module 3 
Module 1: KS, MT, KR, DH, ER, KS, MT, KR, DH, ER. 
Module 2: KS, MT, KR, DH, KS, MT, KR. 
Module 3: KS, MT, KR, DH, KS, KR. 
Module 2 
KS = P-ketoacylsynthase 
MT = methyltransferases 
KR = P-ketoreductase 
DH = dehydratase 
ER = enoylreductase 
Figure 2-7 Modular assembly of cubensic acid 
Similar speculations can be made conceming the mechanism of polyketide assembly in 
tenellin biosynthesis. A modular PKS is plausible, and structui-al similarities can be 
highlighted with other fungal pyridones e.g. bassianin (2.2) and funiculosin (2.6). It is 
noteworthy however that the R-configuration for the 2-methylbutyrate unit of tenellin is 
not a general feature of fungal PKSs.* 
HOH-
funiculosin (2.6) 
Figure 2-8 Structure of funiculosin 
2.1.3 Incorporation studies with partially assembled fungal polyketides 
There have been a number of successful experiments reported in which isotopically 
labelled, partially assembled polyketide intemiediates have been incorporated into 
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polyketides, lending strong support for a processive mechanism of assembly. As already 
stated, Vederas et al. have reported successful incoiporations of such intermediates into 
dehydrocui-vularin (2.10), a macrolide phytotoxin fi'om Alternaria cineriae. Early studies 
with wild-type A. cineranae resulted in complete degradation to acetate prior to 
incorporation. However an unprecedented level of intact incorporation of the di- (2.7) 
and tetra- ketides (2.9) (>12% of incorporated precursor) was achieved with a UV 
mutant deficient in the ability to grow on fatty acids, high glucose replacement media and 
and the addition of P-oxidation inhibitors.'' Subsequent investigations widi a range of 
potential p-oxidation inhibitors, using high glucose replacement medium, and carefully 
controlled multiple pulse feeding enabled low level intact incorporation of the diketide 
into the wild-type organism. Attempts to incorporate die triketide (2.8) were 
unsuccessful, and it was suggested that the polyketide synthase may only pemiit loading 
of external precursors at certain chain lengths or oxidation states. However, impressive 
incorporations of the intact tetraketide (70% of incoiporated precursor) were achieved 
using the P-oxidation inhibitor 3-tetiadecylthiopropanoic acid. It is noteworthy that some 
(ca. 7%) intact incoiporation of the teti^ aketide was observed under the same experimental 
conditions even without die use of p-oxidation inhibitors.'* In die successful studies, die 
observed absolute incoiporation of the precursor used was 1-2%. 
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A C H N 
NHAc OH O 
dehydi-ocui^vulaiin 
(2.10) 
AcHN 
Figure 2-9 Incorporation of NAC-thioesters into dehydrocurvularin 
However it is widely accepted that the failure of such incorporation experiments far 
exceeds the number of successful reports. When incorporations are observed they are 
generally very low, due to difficulties in cell transport across membranes and the need to 
intercept the polyketide synthase. Futhermore these experiments can be plagued by 
P-oxidation of the precursors prior to incorporation. However Staunton et al. reported a 
successful series of experiments on aspyrone (2.17), a fungal polyketide produced by 
Aspergillus melleus. Not only were the reduced di- (2.12), tri- (2.14), and tetra-ketides 
(2.16) incorporated,^^ but this study reported the fu-st incorporation of mid-chain-
extension cycle intermediates (2.11), (2.13) and (2.15).'^ This allowed the investigation 
of the stereochemistiy of the hydroxyacyl intermediates, and the stereochemistry of the 
dehydi-ation of thediketide (2.12). The success of these experiments was due in part to 
the choice of deuterium as a veiy sensitive label, allowing the detection of low level 
enrichments, ^H having a natural abundance of only 0.015%. 
As all inteiTnediates remain covalendy bound to the enzyme system until the completed 
chain is released, intercepting the polyketide synthase (PKS) and introducing partially 
assembled fragments is difficult. For this reason N-acylcysteamine thioesters of the 
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putative inteiTnediates were administered to cultures. It is proposed that this residue can 
mimic the thiol terminus of the pantetheine group present in coenzyme-A and in the ACP 
of the PKS system/' Such thioester precursors undergo ttansesterification onto the 
enzyme more readily than oxygen-esters, which reduces the opportunity for the 
catabolism of the precursors prior to incorporation. The majority of the successful 
feeding experiments with advanced precursors to polyketides have used N-
acylcysteamine thioesters.^ " 
ACPS 
6 (2.12) 
O OH (2.13) 
ACPS 
product of PKS 
post-assembly 
modification 
aspyrone 
PKS-bound 
intermediates, 
identified by 
/*• incorporation 
of deuterium 
labelled 
NAC-esters. 
Figure 2-10 Intermediates in aspyrone biosynthesis 
A processive mechanism of polyketide assembly is presumably occuring in tenellin 
biosynthesis. This would require a methyltransferase activity integral with the polyketide 
synthase. No incorporations of partially assembled intermediates into fungal polyketides, 
which require a C-methylation step by S-adenosylmethionine have been reported to date. 
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However i f fragments such as 2-methylbutyi-ate (2.18) and (E)-2,4-dimethyl-2-
hexenoate (2.19) can be shown to become incorporated intact into tenellin, this would 
demonstrate that they were early intermediates is the assembly process, confirming a 
processive model for methylation. 
O * 
SR 
(2.18) 
KS = P-ketoacylsynthase 
MT = methyltransferase 
KR = P-ketoreductase 
DH = dehydratase 
ER = enoylreductase. 
* = deuterium labelled inteimediates fed to B. bassiana 
Figure 2-11 Proposed intermediates in tenellin biosynthesis 
It was anticipated that appropriate intermediates would be administered as N-
acylcysteamine thioesters to promote their incorporation onto the ACP thiol group of the 
PKS, ready to be caiiied through subsequent chain extension steps. [l-^^C-Methyl]-!-
methylbutyrate had previously been prepai^ ed, and fed to B. bassiana both as its sodium 
salt and as its N-propionylcysteamine thioester.* However no incorporation into tenellin 
was observed in these expeiiments. The sensitivity of such experiments is very low. 
Cai-bon-13 has a natural abundance 1.1% relative to carbon-12. To accurately detect 
enrichment (a 20% increase in peak height) greater than 0.32 % incorporation of the 
labelled precursor into the metabolite is required. Given the inherent insensitivity of this 
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experiment a negative result does not necessarily negate the intermediacy of 
2-methylbutyrate. However, as demonstrated by the Staunton group, the sensitivity is 
substantially increased using deuterium labelled studies. With the low natural abundance 
of deuterium (0.015%), only 0.003% incoiporation is requked to obsei-ve a 20% 
increase in peak height in the resultant "H NMR. Accordingly N-propionylcysteamine 
thioesters of [2-/?ie%/-^H3]-2-methylbutyi-ate and [2-me%/--H3]-(E)-2,4-dimethyl-2-
hexenoate have been prepared and administered to production cultures of Beauvaria 
bassiana. The results of these experiments are discussed below. 
SR 
CDs 
2-methylbutyrate 
B. bassiana 
tenellm 
CDs 
(E)-2,4-dimethyl-2-hexenoate 
Figure 2-12 Proposed feeding experiments to B. bassiana 
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2.2 Synthesis of Proposed Intermediates 
2.2.1 Synthesis of sodium [2-mef^>'/-^H3]-2-methylbutyrate 
Sodium [2-wer/2y/-^H3]-2-methylbutyrate was synthesised by alkylation of diethyl 
2-ethylmalonate (2.20) with [•H3]-methyliodide. Base mediated ester hydrolysis 
followed by acidic work-up afforded [2-wer/?>'/-^H3]-2-methyl-2-ethylmalonic acid 
(2.22). Decarboxylation of this was accomplished by heating in a carius tube at 180°C 
yeilding [2-mer/23'/-^H3]-2-methylbutyric acid. The acid was separated from involatile 
impurities by lyophilisation, followed by neutraUsation to generated an aqueous solution 
of the salt sodium [2-/7jer/2>'/-^H3]-2-methylbutyrate (2.23). Involatile impurities and 
water were removed by further lysophilisation. Piior to preparation of the N-propionyl 
cysteamine thioester the acid salt was reacidified, extracted into diethyl ether, and the 
solvent removed in vacuo, yielding [2-we/'/2}'/-^H3]-2-methylbutyric acid. 
O (2.20) 
2H 
ONa 
H 
(2.23) 
1, u 
51% 
I V , V 
82% 
(i) NaH, THF, 0°C, (ii)eH3l, THF, reflux 2hr, 
(iii) KOH(aq), reflux 24hi-, HCl(aq), (iv) H2O, 180°C, 3hr, HCl(aq), 
(v) pH 8 with NaOH(aq). 
Figure 2-13 Synthesis of [2-me//;3'/--H3]-2-methyIbutyrate 
Cysteamine dihydrochloiide (2.25) was neuti-aUsed and acylated with propionyl chloride 
(2.24) to give N, N'-dipropionyl cystamine (2.26). Reduction with sodium amalgam in 
dry methanol afforded N-propionyl cystamine (2.27), which was coupled with 
[2-methyl-^ll^]-2-methylhutyhc acid using 1,3-dicyclohexylcarbodiimide and 
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4-dimethylaniinopyridine in ether. After puiification over sUica the N-propionyl 
cysteamine thioester (2.29) was could be stored under nitrogen at 4°C. 
CI 
(2.24) + 
H2N, 
S - S ' 
54% 
,NH2 
(2.25) 
(i) 0°C, pH > 8.2, (ii) NaHg amalgam, MeOH. 
Figure 2-14 Synthesis of NJST'-dipropionylcystamine 
S - S ' 
47% 
(2.26) O 
n 
SH 
0 (2.27) 
Q-Na* L _ 
2u- -^ o^  93% C^Ha (2.23) 
OH 
C^ Ha (2.28) 
86% i i HS' 
(2.27) 
C^ Ha 
I 
O (2.29) 
(i) HCl(aq), H2O, (ii) DCC, DMAP, ether, 20°C, 12hr. 
Figure 2-15 Synthesis of N-propionylcystamine-[2-OTe//!_y/-^H3]-2-methyIbutyrate 
2.2.2 Synthesis of (E)-[2-/Me/^3'/-^H3]-2,4-diinethyI-2-hexenoic acid 
Meldrum's acid (2.30) was selected as an appropriate malonate for acylation with 
propionyl chloride (2.24). Heating under reflux in ethanol resulted afforded the ester 
ethyl 3-oxo-pentanoate (2.31). This was alkylated with ["HjJ-methyl iodide using 
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sodium ethoxide in ethanol, yielding ethyl [2-w7er/2}'/-^H3]-3-oxo-2-methylpentanoate 
(2.32), which was purified by distillation. 
^ ' (2.24) O (2.30) 
1,11 
72% 
111,1V 
OEt 
'C-H3 
(i) pyridine, DCM, 20°C, 16hr, (ii) ethanol reflux, 5hr, (2-32) 
(iii) NaOEt, ethanol, 13°C, (iv) C-H3I, ethanol, reflux, 24hr. 
Figure 2-16 Synthesis of [2-me//i}'/-^H3]-elhyl 3-oxo-2-methylpentanoate 
(E)-[2-Me//2>'/-'H3]-2,4-dimethyl-2-hexenoic acid was prepai^ ed from ethyl [2-methyl-
^H3]-3-oxo-2-methylpentanoate (2.32), according to the procedure described by 
Katzenellenbogen and Utawanit.'' The reduction and dehydi'ation steps in the method 
mirror transformations of the putative biosynthetic pathway, and it was envisaged that 
intermediates (2.33) and (2.34) could potentially be used in feeding experiments. 
Ethylation of the dianion of ethyl [2-mg/'/2>'/-^H3]-3-oxo-2-methylpentanoate (2.32) with 
ethyl bromide, followed by distillation afforded the P-ketoester (2.33). Subsequent 
reduction with sodium borohydiide gave the P-hydroxyester, ethyl [2-OTer/2>'/-'H3]-2,4-
dimethyl-3-hydroxyhexanoate (2.34) Purification of this mixtui-e of diasteriomers 
required both silica and alumina chromatography. The (3-hydroxyester was dehydrated 
using lithium diisopropylamide with diethoxyaluminium chloride to give ethyl (E)-[2-
mer/2j/-^H3]-2,4-dimethyl-2-hexenoate (2.35). Hydrolysis under basic conditions, 
followed by acidic work up, afforded the desii'ed carboxylic acid (2.36) which was used 
directly for thioester preparation. Intermediates (2.33) and (2.34) were complex mixtures 
of diastereoisomers and were not fully characterised. 
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OEt i,ii,m 
C^Ha (2.32) 
70% OEt 
c2h3 (2.33) 
61% IV 
C^ Ha (2.35) 
H OH Q 
v,vi 
44% OEt 
C^ Ha (2.34) 
OH 
C^ Ha (2.36) 
(i) NaH, THF, 0°C, (ii) BuLi, hexane, 0°C, (iii) EtBr, THF, 20°C, 30min, 
(iv) NaBH4, ethanol, 0°C, 30min, (v) Al(0Et)3, AICI3, THF, 20°C, 30min, 
(vi) LDA, THF, 65 °C, Ihr, (vii) NaOH, methanol, reflux, 5hr. 
Figure 2-17 Synthesis of (E)-[2-OTe;/}y/-^H3]-2,4-dimethyl-2-hexenoic acid 
[2-C^H3-Mer/2j/]-N-propionyl cysteamine-(E)-2,4-dimethyl-2-hexenoate (2.37) was 
prepared by coupling N-propionyl cystamine (2.26) with {E)-[2-methyl-^Hj]-2A-
dimethyl-2-hexenoic acid (2.36) using 1,3-dicyclohexylcarbodiimide and 4-
dimethylaminopyridine in dry ether. This could be stored under nitrogen at 4°C, after 
purification over sihca. 
HS' 
C^Ha (2.36) 
-I-
H 
I 
63% 
(2.27) 
C^ Ha (2.37) O 
(i) DCC, DMAP, ether, 20°C, 12hr. 
Figure 2-18 Synthesis of [2-C^H3-/?jer/;_y/]-N-propionyl cysteamine-(E)-2,4-dimethyl-2-hexenoate 
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The key step in this synthesis is the treatment of the P-hydroxyester (2.38) with 
diethoxyaluminium chloride followed by warming with diisopropylamide to produce the 
corresponding a,(3-unsaturated ester (2.40). The process is completely regiospecific, 
and has high stereospecificity with only the E isomer formed. This was confirmed by an 
n.O.e. study which showed no interaction between the CH-3 and CH3-7. The reaction is 
thought to proceed through a (3-alanoxyenolate intemiediate (2.41), the stereoselectivity 
resulting from the minimization of 1,4-interactions in the boat like transition state. 
HO H 
C02Et Al(0Et)2Cl 
(2.38) 
AI(0Et)2CI 
O i O 
V.11 
H H OEt 
(2.39) . -Base 
enolisation 
OEt 
(2.40) 
favoured (2.41) disfavoured 
E-isomer 
Figure 2-19 Dehydration of ethyl 2,4-dimethyl-3-hydroxyhexanoate 
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2.3 Biosynthetic Investigations 
2.3.1 Growth of Beauvaria bassiana 
Frozen samples of B. bassiana production media were used to inoculate fresh production 
media flasks. Tenellin production was good, with an average of 50mg of tenellin from 
100ml of production medium. The yellow colouration characteristic of tenellin 
production usually appeared on day 4 after innoculation. 
2.3.2 Isolation and analysis of tenellin from Beauvaria bassiana 
TeneUin shows only limited solubility in aprotic solvents such as dichloromethane and 
carbon tetrachloride, and therefore ^H NMR spectra were recorded in 
dimethylsulphoxide (DMSO). This was a disadvantage due to a large solvent signal 
observed at 2.49 ppm, however it did not mask the methyl signals of tenellin, and any 
incorporations into these sites should be directly observable. A natural abundance ^H 
NMR spectrum was obtained. However the signal to noise was too low to obtain 
accurate integrals, but the signals for the methyl, methylene, and methine site of the 
polyketide moiety were clearly observed. The chemical shift values for the "H NMR 
signals coirelate closely to those of the 'H NMR (Figure 2-20). The assignments of the 
' H NMR resonances of tenellin are tabulated below The hydroxyl protons, which 
resonate above 9.0 ppm are not listed. 
chemical shift (ppm) 
aromatic 3', 5' 6.78 
6', 2' 7.28 
pyridone 6 8.18 
aliphatic 8 7.54 
9 7.99 
11 5.98 
12 2.40 (under DMSO) 
13 1.36 
14 0.81 
15 0.97 
16 1.83 
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o 
Q 
Figure 2-20 'H NMR for tenellin, recorded at 400 MHz in DMSO-d6 
in 
CD 
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2.3.3 Growth of Beauvaria bassiana in 6.6% DjO 
Two flasks of production media (50ml) prepared with 6.6% DjO in H2O were 
innoculated with 5ml of 7 day old Beauvaria bassiana production media cultures, and 
incubated for 8 days. The resultant tenellin was isolated, and purified by HPLC as 
discussed below. Clear deuterium enrichments were observed in the aliphatic region 
conesponding to isotope enrichments at CH3-I4 , CH3-I5 , CH2-I3 and CH3-I6 at 0.77 
ppm, 0.92 ppm, 1.23 ppm and 1.79 ppm respectively. The aromatic region was clearly 
emiched ortho to hydroxyl at 6.76 ppm, with a minor enrichment at 7.31 ppm meta to 
the hydi'oxyl. CH3-I5 and CH3-I6 ai'e derived from methionine. In this case the 
deuterium may become incorporated via NADPD reduction of a C,-tetrahydrofolate 
cofactor to N^-methyl-THF, required for methylation of homocysteine to methionine. 
The enrichment at CH3-I4 must derive from a deuterium labelled acetate unit, possibly 
via direct exchange with the medium. It is probable that acetate is in rapid equilibrium 
with malonyl-CoA. However the high enrichment at CH3-I4 (dii-ecdy derived form 
acetate) is not so readily explained, as negligible incoiporation is observed at CH-8 
(derived from malonate). Incorporation of deuterium from the NADPD is as expected at 
C H 2 - I 3 , as a result of reduction of the C-12 to C-13 double bond during polyketide 
biosynthesis. Deuterium enrichment of the aromatic protons ortho and meta to the 
phenolic hydroxy may be rationalised by deuterium exchange with the medium, in the 
shikimic acid precursors to phenylalanine / tyi"osine. 
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Figure 2-21 *H NMR of tenellin grown in 6.6% DjO after purification by HPLC 
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2.3.4 Feeding of N-propionyl cysteamine-[2-iwe//ij/-^H3]-2-
methylbutyrate to Beauvaria bassiana 
N-Propionyl cysteamine-[2-me/'/z>'/-"H3]-2-methylbutyrate was initially pulse fed (in 
ethanol / water, 3 : 4) to a final concentration 6.0 mM to Beauvaria bassiana production 
medium cultures at the beginning of culture growth (trophophase). After isolation of the 
resultant tenellin, ^H NMR analysis did not indicate any incorporation of deuterium. This 
was perhaps not unexpected as tenellin production does not commence until the 
stationary stage of cell growth. The added compound may have been degraded by p-
oxidation prior to teneUin production, and the deuterium-labelled products used in 
primary metabolism. 
When N-propionylcysteamine-[2-mer/?}'/-^H3]-2-methylbutyrate was administered after 
tenellin production was evinced (idiophase), "H NMR analysis of the resultant crude 
tenellin sample showed signals at 0.72 ppm, 0.88 ppm and 1.77 ppm (in approximate 
intensity ratio 5 : 5: 1). These chemical shifts suggested incorporation into C-14, C-15, 
and C-16 of tenellin respectively. A signal at 5.65 ppm was also obseived in one 
experiment which could not be assigned to a signal in tenellin and was presumably an 
impurity peak. Tenellin is notoriously difficult to purify, due to its highly polai* nature. 
The purity of the tenellin isolated by the standard work-up procedure is generally 
adequate for analysis of incorporation expeiiments with carbon-13 labelled precursors. 
In general 'crude' tenellin shows respectably clean '^ C NMR and 'H NMR spectra. 
However due to the sensitive nature of ^H NMR, even minor impurities are readily 
detected. Thus the observed enrichments could not confidently be attributed to 
incorporation into tenellin at this stage. 
Accordingly, an HPLC method was developed for purifying tenellin. Analytical reverse 
phase HPLC (methanol: water, 85 : 15, 0.1% tiifluoroacetic acid) was used to check the 
purity of the tenellin isolated. TaiUng could be minimised and sharp peaks obtained when 
a BDS-protected analytical column was used. The feeding experiments with 
N-propionylcysteamine-[2-wer/z>'/-'H3]-2-methylbutyrate were repeated on a larger scale 
(lOx 50ml production media flasks, to a final concentration 5.0 mM) and 300 mg of 
tenellin was isolated. Again enrichments were observed in the ^H NMR at 0.70 ppm, 
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0.85 pm and 1.77 ppm, but the relative intensity of the signal at 0.85 ppm was now 
much reduced, (approximate intensity ratio 7 : 2: 1) as shown in Figure 2-22. This 
'confirmed that labelling at 0.85 ppm is due at least in part to contamination by labelled 
impurities, probably the precursor [2-/w£//i>'/-^H3]-2-methylbutyrate. 
CD3 CD3 
16 15 
chemical shift / ppm 
Figure 2-22 NMR of tenellin fed with N-propionylcystamine-[2-methyl-^3]-2-methylbutyrate after 
purification by HPLC. 
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The apparent enrichment of CH3-I6 is unexpected, and requires explanation. Although 
only one peak was observable by HPLC, this was broad and it is conceivable that the 
tenellin sample still contained impurities. HPLC puiification was repeated and fractions 
collected before and after the mid-point of the elution peak. Both these fractions gave 
similar "H NMR spectra, suggesting that the deuterium labelling was indeed in tenellin 
rather than a deuterated impurity. The labelling of CH3-I6 requu-es deuterium labelling of 
methionine. I f this is occuring, then the labelling at CH3-I5 should also be enriched via 
the same route, with approximately the same level of enrichment, and this is indeed 
observed. Thus there is no evidence for the dkect incoiporation of deuterium into 
C H 3 - I 5 from [2-mer/?>'/-"H3]-2-methylbutyrate. Both these methionine derived sites are 
also sti-ongly enriched in tenellin when B. bassiana is grown in 6.6% D^O, implying that 
the deuterium is exchanged with the medium, possibly after cataboUsm to succinate (see 
below). Deuterium may then be reincorporated via NADPD into methionine. 
The significant enrichment of CH3-I4 is more readily rationalised. This site derives from 
the methyl group of acetate and isotope incorporation here is likely to be the result of a 
partial degi'adation of the intermediate by (3-oxidation to deuterium labelled acetate. 
Branched chain fatty acids with a methyl gi-oup on an even numbered carbon atom are 
degraded to propionate, the branching appearing as C-3." Propionyl-CoA is converted 
to succinyl-CoA via methylmalonyl-CoA and metaboUsm of succinate results in acetate. 
The labelled [C'H"H2]-acetate could subsequently become incorporated into tenelUn, 
giving rise to C-14 labelling (Figure 2-23). 
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° '^^^^^-^SC0A + ATP + CO2 + H2O 
propionyl-CoA 
O 0 
•000. JL 
> ^ SCoA 
CD3 CD3 
S-methylmalonyl-CoA R-methylmalonyl-CoA 
o 
• 0 0 0 ^ ^ ^ 
SCoA 
HD SCoA 
O 
acetyl-CoA 
Figure 2-23 Catabolism of propionate 
D2 
0 0 0 ^ ^ C ^ , ^ SCoA 
O 
succinyl-CoA 
2.3.5 Feeding of [C^HjJ-acetate to Beauvaria bassiana 
In an attempt to verify the observed labelling of C H 3 - I 4 of tenellin, [C'Hj]-acetate was 
pulse fed to B. bassiana cultures to a final concentration of 7.4 mM. The isolated tenellin 
was purified by HPLC and analysed by ^H NMR analysis. Incorporation was clearly 
seen into the methyl-14 peak at 0.72 ppm, as shown in Figure 2-24. This labelling 
pattern lends support to the above hypothesis that the enrichments observed at 0.72 ppm 
from tenellin fed with (R,S)-[2-/7je//?y--H3]-2-methylbutyrate, were the result of acetate 
incorporation after P-oxidation. Suiprisingly, however, no incorporation of deuterium 
was obsei'ved at CH-8, the hydi'ogen which is also expected to be derived from the 
methyl group of acetate. However as this acetate must frrst be activated to malonyl-CoA 
for condensation with the growing polyketide chain, rapid exchange of the acidic 
deuteriums with the protic media would account for isotope washout. 
Prior to HPLC purification in this experiment an enriched impurity peak at 8.2 ppm was 
observed which had the same intensity as the methyl-14 peak of tenellin. This was also 
observed in the feeding experiment below. It is likely this is due to a minor aromatic 
polyketide produced by the cultuies. 
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chemical shift / ppm 
Figure 2-24 NMR of tendlin fed with [C'Hj]-acetate after purification by HPLC. 
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2 .3 .6 Feeding of N-propionyIcysteamine-[2-/ne//i^/-^H3]-2-
methylbutyrate to senescent cultures of Beauvaria bassiana 
Incorporation experiments in the Leadlay / Staunton group, with paitially assembled 
polyketide intermediates into tetronasin (2.45) produced by Streptomyces 
longisporoflavus, have shown that the N-acetyl cysteamine analogues of precursors are 
less likely to suffer degradation by (3-oxidation processes late in the growth cycle. 
Secondary metabolism is observed to continue, albeit at a reduced rate, but the enzymes 
of fatty acid degradation have become less active. Thus at this stage there is greater 
chance of tiie precursor becoming incorporated intact. However incorporation is less 
readily detected late in the growth cycle, due to the dilution effect by previously 
biosynthesised metabolite. None-the-less, detectable incoi-porations of die tri- (2.43) and 
tetra- ketide (2.44) precursors of tetronasin were observed.^^ 
ACPS 
O 
diketide, 
subject to P-oxidation 
(2.42) 
ACPS 
ACPS ACPS 
O 
triketide 
(2.43) 
O OH 
tetraketide 
(2.44) 
O O 
1 
OH OH 
proposed product of PKS 
(2.45) 
tetronasin 
Figure 2-25 Intact incorporation of tri- and tetraketide intermediates into telronasin 
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When N-propionylcysteamine-[2-wer/ry/-^H3]-2-methylbutyrate was administered to 
senescent cells (pulse fed, to final concentration 5.0 mmolar), the deuterium signal 
observed was weaker, but only one peak was observed in the aliphatic region. This was 
at 0.89 ppm, and could coirespond to emichment of tenellin at C-15. No enrichment of 
C H 3 - I 4 , resulting f rom P-oxidation of the intermediate and incorporation of labelled 
acetate was observable, consistent with the inactivation of the enzymes of fatty acid 
degradation. However after rigorous HPLC purification of the 'crude' tenellin no ^H 
signals were observable. Presumably the enrichment at 0.89 ppm, was again due to 
contamination with [2-/7je//j>'/--H3]-2-methylbutyrate or a related metabolite. 
Again in this experiment, a large impurity peak was observed at 8.2 ppm in the crude 
tenellin. This labelled impurity peak was also observed in the ^H NMR of 'crude' teneUin 
recovered after feeding [C^H3]-acetate, and it was suggested that this is due to labelling 
of an aromatic polyketide produced by B. bassiana. Deuterium labelled acetate derived 
f rom P-oxidation of [2-mer/i}'/-"H3]-2-methylbutyrate is presumably the cause of the 
labelling of this metaboUte. Thus it appears that some fatty acid degradation to acetate did 
occur during this experiment. I f this is the case, then tenelhn production during the latter 
production phase must have been low, as no acetate labelling of tenelhn is observable. It 
is therefore unlikely that we wi l l observe any intact incorporation of [2-methyl-'H^]-2-
methylbutyrate into tenellin at this stage of cell growth. 
2 .3 .7 Feeding of N-propionylcysteainine-[^H3-/ne/^>'/]-(E)-2,4-
dimethylhexenoate to Beauvaria bassiana 
Although it might be presumed that it is increasingly difficult to intercept the PKS with 
increasingly advanced intermediates, these intermediates i f conectly chosen, may be 
more immediately recognisable by the PKS, and conversely less acceptable substrates for 
fatty acid degradation. This was concluded in the tetronasin studies. The deuterium 
labelled diketide precursor was not incorporated intact in contrast to the tri- and 
tetraketide precursors at any stage in the growth cycle.'" For the tenellin studies, the 
putative intermediate tiiketide, N-propionylcysteamine-[^H3-/7je%/]-(E)-2,4-
dimethylhexenoate (2.37) was pulse fed to B. bassiana cultures to a final concentration 
of 3.0 m M . After purification by HPLC, "H NMR of the isolated tenellin did not show 
incorporation of ^H from [^H3-A?je/'/?>'/]-(E)-2,4-dimethylhexenoate. Interestingly there 
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was no observable emichment of tenellin from the catabolic products of ['H^-methyl]-
(E)-2,4-dimethylhexenoate. Perhaps the precursor was unable to cross the cell membrane 
of the fungi, in sufficient amounts to observe incorporation. 
2.4 Discussion 
Attempts to establish a processive mechanism for polyketide assembly in tenellin, 
involving eaiiy reduced, methylated intermediates have been unsuccessful. 
Incorporations, when observed were inconclusive. The weight of evidence supports a 
processive mechanism for the biosynthesis of non-methylated reduced polyketides, and 
the failiu"e to detect incoiporation only highlights the difficulties which plague such 
feeding experiments with advanced precursors. The problems aie multiple: lack of 
solubility and cell permeability of substrates, rapid P-oxidation of substrates that do 
penetrate into the cell, difficulty in intercepting the polyketide synthase. A l l these factors 
result in low incorporation levels, and in this case probably below the detection limits of 
the techniques used. 
However, similar successful expeiiments led the field in understanding the nature of 
polyketide synthases. More recentiy it has been genetic approaches to understanding 
polyketide synthases, that have continued to make important advances. Although the 
majority of this work has concerned bacterial systems, the mevinolin PKS fi-om 
Aspergillus tetreus has been sequenced.^^ Further results from this research wi l l be of 
particular interest as mevinolin is both reduced and has a methionine deiived methyl 
group. 
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3. Investigations into a Putative Tetramic acid Intermediate 
3.1 Introduction and Background 
3 .1 .1 The 2-pyridones 
Tenellin is one of a small group of fungal metabolites which possess a 2-pyridone ring. 
These metabolites belong to a larger group of metabolites, shown to be derived from a 
polyketide and an amino acid moiety. This group also includes the tetramic acids' 
(discussed below), and the cytochalasins (discussed in Chapter 4).^ 
Cultures of Beauvaria bassiana may also produce a yellow pigment differing fi-om tenellin 
only in the possession of an extra trans ethylene group in the side chain. This 2-pyridone 
is known as bassianin (3.1), and is co-produced with tenellin in certain cultures of 
Beauvaria tenella? Perversely, tenellin is produced predominandy by B. bassiana and 
bassianin by B. tenella. 
bassianin (3.1) 
Figure 3-1 The structure of bassianin 
A closely related metaboUte to tenellin is ilicicolin H (3.2) produced by Cylindrocladium 
ilicicocola. This metabolite is also substituted at the 5 position of the pyridone ring with a 
4-hydroxyaryl group. Isotopic labelling studies on this metabolite have established the 
biosynthesis to be analogous to tenellin (Tanabe et a/."). Carbon-13 enriched acetates 
labelled the polyketide moiety in the usual way, and pendent metiiyl groups were enriched 
by ['^CHj]-methionine. Furthermore '^N-phenylalanine was shown to label the nitrogen 
of the pyridone ring. In die '^C-NMR of the sample labelled with nitrogen-15, '^C-'^N 
spin-spin coupling could be detected with an observed coupling constant of 12.5 Hz. 
However, contrary to die claims of Tanabe et al. this observation does not eliminate the 
possibility that phenylalanine is metabolised to phenylpyruvic acid prior to incorporation, 
with nitrogen-15 becoming re-incorporated at a later stage. A more rigorous experiment 
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would have involved the intact incoiporation of double-labelled [2-'^C'^N]-
phenylalanine. This possibihty was investigated for tenelhn biosynthesis and is discussed 
in Chapter 4. Other closely related metabolites in this group are leporin A (3.3) (produced 
by Aspergillus leporis) which has an aryl ring at carbon-5 of the pyridone ring,^ and 
funiculosin (3.4) (from Penicillium funiculosum) bearing an interesting tetrahydroxy 
cyclopentane group at this position.* 
ilicicolin H (3.2) 
leporin A (3.3) 
HOW' 
funiculosin (3.4) 
Figure 3-2 Pyridone metabolites related to tenellin 
The 2-pyridones also include the atpenins (3.5) {Penicillium sp. F0125 )^ 
harzianopyridone (3.6) (Trichodemm harzianimif viridicatin and viridicatol (3.7) 
{Penicillum discolor)^ and the efi'otomycin antibiotics (3.8) {Streptomyces 
goldinensis).^° The polyketide origin of the side chain of harziopyridone was established 
by '^C-labelled acetate feeding experiments, again consistent with tenellin biosynthesis, 
and the metiioxyl carbons were labelled predictably by ['^CH3]-methionine. However the 
origin of the remainder of the pyridone ring is not unambiguously established, altiiough 
there is some evidence to suggest that aspartic acid may be a precursor. 
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H3C0 
HaCO 
atpenin A4 R=C1 R'=H 
(3.5) atpenin A5 R=C1 R'=C1 
atpenin B R=H R'=H 
O (3.6) 
harzianopyridone 
(3.7) 
viridicatin R=H 
viridicatol R=OH 
Figure 3-3 Pyridone metabolites 
The biosynthesis of the pyridone ring of aurodox (3.8) is more enigmatic." As 
anticipated for a bacteiial polyketide the backbone of the structure is derived from the 
linear combination of acetate, propionate and butyrate units. However [2-'^C]-acetate 
failed to become incorporated into position-3 (or position-5) of the pyridone ring, 
suggesting that there is another pathway by which nature may construct such a pyridone. 
Interestingly, Nocardia lactamdurans, which produces efrotomycin, has been shown to 
catabolyze uracil via the reductive pathway. The end product of this pathway, P-alanine, 
appears to be incorporated into the pyridone ring of efrotomycin. [5,6-^H2]-Uracil is 
found to label efrotomycin, and carbon-13 coupling at C4 and C5 of efrotomycin is 
observed after feeding resting cells with [4,5-'^C]-uracil.'" Novel members of the 
efrotomycin family, ganefromycin'^ and L-681,217"' have been isolated that lack the 
pyridone moiety, the polyketide chain terminating with a carboxyUc acid group, 
suggesting attachment of the pyridone moiety may be a late stage modification. 
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R i = 
efrotomycin CH3 
aurodox CH3 
kirromycin H 
heneicomycin CH3 
UK-69,753 CH3 
R2= 
OH 
OH 
OH 
H 
H 
3" O: 
disaccharide 
H 
H (3.8) 
H 
disaccharide 
Figure 3-4 The efrotomycin family 
3 .1 .2 The acyl-tetramic acids 
The tetramic acids (2,4-pyn-oUdinediones) occur in both bacteria and fungi. The majority 
of natural tetramic acids are 3-acyl derivatives, the simplest being tenuazonic acid (3.9), 
first isolated f rom Alternaria tenuis.Isotopic labelling studies have confirmed that the 
biosynthesis of die ring occurs via the cychsation of N-acetoacetyl-L-isoleucine, itself 
derived f rom the condensation of L-isoleucine with a diketide.'* 
CO2H 
(3.9) 
tenuazonic acid 
Figure 3-5 Biosynthesis of tenuazonic acid 
Tetramic acids bearing a 1-oxopentadienyl substiuent at carbon-3 of the ring are classified 
as dienoylteti-amic acids, the fkst to be isolated being streptolydigin (3.10) from 
Streptomyces lydicus. Isotopic labeUing studies indicated tiiat acetate, propionate, D-
glucose, and glutamic acid are all incorporated into streptolydigin. Closely related 
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acyltetramic acids are tirandalydigin (3.11) and the tirandamycins (3.12), also from 
Streptomyces sp. 
streptolydigin R= 
(3.10) 
N - ^ ( ^ ^ ' i l O H 
(3.11) 
CONHMe 
trrandalydigin R= NH 
tirandamycin A R^^H (-3 22) 
tirandamycin B R=OH 
Figure 3-6 Streptolydigin and related tetramic acids 
A number of polyenoyl tetramic acids have been isolated, the first of which, 
erythroskyrine (3.13), was the principal pigment of Penicillium islandicum. It appears to 
be derived from L-valine and acetate, but the origin of tetramic acid ring carbons-2 and 3 
and the N-methyl group have not been secured. 
erythroskynne (3. 
Figure 3-7 Structure of erythroskyrine 
A group of orange / yellow coloured pigments (3.14) have been isolated from the slime 
mold Leocarpus fragilis.^^ These compounds clearly derive from tyrosine and a 
polyketide moiety. 
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R=H/Me 
n=0-4 
Figure 3-8 tyrosine derived tetramic acids 
The marine sponges also produce a range of acyltetramic acids including the orange, 
chlorine-containing auran to sides (3.15) from the Theonella sp.,'* and cylindramide 
(3.16) f rom Halichondria cylindrata.'^ Both show cytotoxic activity, against leukemic 
cells and melanoma cells respectively. 
CI CI 
HO P"/ O 
f ^ ^ O CONH2 
V o 
(3.15) 
aurantoside A R=Me 
aurantoside B R=H 
OH 
(3.16) 
cylindramide 
Figure 3-9 Marine tetramic acids 
3 .1 .3 Vining's hypothesis for the biosynthesis of tenellin 
As discussed in Chapter 1 the biosynthesis of the pyridone ring of teneUin (3.18) 
necessitates an intriguing rearrangement. The pyridone ring is deiived from the terminal 
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acetate of the polyketide chain and a moiety resulting from an intramolecular 
rearrangement of a phenylpropanoid (phenylalanine derived) unit. The intramolecular 
nature of this rearrangement was eleganfly demonstrated by Leete et al., by a feeding 
experiment with DL-[l,3-'^C2]-phenylalanine (3.17). Tenellin was found to be enriched 
in positions 4 and 5 of the ring, with clear '^C-'^C coupling observed. An intermolecular 
migration of tiie carbonyl group would not exhibit this coupling. 
H2N COOH 
, Datura sp. 
COSCoA 
CHO 
(3.17) 
Beauvaria 
bassiana 
[NH3] [O2] 
m 
OH O 
7 ^ tenellin (3.18) 
OH 
COOR 
CH2OH 
tropate 
Figure 3-10 Leete's hypothesis for the biosynthesis of tenelhn 
A similar type of reaixangement had previously been observed in the biosynthesis of 
tropic acid, the acid moiety of tiie Datura alkaloids, scopalamine and hyoscyamine. Leete 
and Vining initially proposed a-formyl phenylacetyl coenzyme A as a plausible 
intermediate in both biosyntheses.^'' 
However Vining's subsequent investigations with L-['^N]-phenylalanine strongly 
indicated that phenylalanine was incorporated with littie or no loss of nitrogen into 
tenellin. The extent of the incorporation of nitrogen-15 was comparable with tiiat obtained 
for carbon-13 labelled phenylalanines. Vining also investigated tiie possibility tiiat 
tyrosine might be a more dii-ect precursor to tenellin. L-[U-"C]-Tyrosine was shown to 
have a sharply reduced incorporation (1.6%) compared to L-[p-"'C]-phenylalanine 
(8.4%), suggesting that although tenellin possesses a para-hydroxy group, phenylalanine 
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is the more dkect precursor. Their hypothesis required a pa/ a-hydroxylation step after the 
polyketide-phenylpropanoid condensation step and had circumstantial support in that such 
hydroxylations readily occur in fungi. These results and the widespread occuiTence of the 
tetramic acids in fungi, led Vining to propose the alternative process for the observed 
reaiTangement. Phenylalanine initially undergoes a condensation with the ful ly assembled 
polyketide (3.19) resulting in an intermediate tetramic acid (3.20). Rearomatization of the 
methylenequinoid (3.21) formed by para-hydroxylation, promotes ring expansion to the 
pyridone ring of tenellin.^' 
OH O 
Figure 3-11 Vining's hypothesis for the biosynthesis of tenellin 
Vining's hypothesis is attractive as acyl tetramic acids are ubiquitous in the fungi, and 
numerous biosynthetic investigations have confiiTned their derivation from the 
condensation of amino acids with the terminal residue of a polyketide moiety.' The 
mechanism proposed could also account for the biosynthesis of ilicicohn H , which has 
similarly been shown to aiise f rom phenylalanine and a polyketide chain. However the 
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related pyridones, funiculosin and leporin A, lack a para-phenol group. Clearly ring 
expansion cannot be the result of rearomatisation of an intermediate methylenequinoid in 
these cases. An alternative mechanism may involve the generation of a free radical at the 
C-5 methylene carbon. For tenellin, bassianin, ilicicoUn and leporin A , this would be a 
relatively stable benzyl radical. This could involve a cytochrome P-450 enzyme, which 
mediate some rearrangement reactions as well as hydroxylations, oxidations, 
desaturations and bond cleavage reactions. 
3 .1 .4 Rearrangment reactions of cytochrome-P-450 enzymes 
Cytochrome P-450 enzymes catalyse the oxidations of many diverse groups of 
compounds. Some P-450s wi l l only oxidise a specific group of substrates, but otiiers 
(e.g. the inducible P-450s utilised in xenobiotic oxidation) appear to have broad range 
activity. Within a single organism there may be more tiian thirty genes coding for these 
enzymes.^^ Enzymes of this type possess a heme prosthetic group, and an axially bound 
cysteine residue.^^ 
SEnz 
HO2C 
N ; N 
C02H 
Figure 3-12 Structure of the heme prosthetic group in cytochrome F-450 enzymes 
The following stoichiometry is characteristic of monooxygenases. 
N A D ( P ) H + 0^ +RE^ NAD(P) ' + H^O + ROH 
The mechanism may be thought of as two stages: oxygen activation and substrate 
oxidation. 
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Fe™ *• Fe"^ RH — ^ ^ - ^ Fe" RH — ^ ~ * Fe"-Oo RH 
Fe™ ROH 
le", H ^ 
FeOOH RH 
(FcjOHf^ R'^ (FeO)'*^ RH 
Figure 3-13 Mechanism of cytochrome P-450 action 
The substrate is bound neai- tiie site of oxygen binding, and die cycle proceeds with 
reduction of iron (III) followed by oxygen binding. The following three steps are 
putative, deduced from model work and inference. The (FeO)^* radical then abstracts 
hydrogen f rom the substrate, to generate a substrate radical, followed by quenching of tiie 
substrate radical by an hydioxyl radical from tiie ii-on complex. This process has been 
termed oxygen rebound, and is characteristic of P-450 mechanisms. 
The product does not always appear as a simple alcohol, as reaixangement of intermediate 
radicals may also occur.^'* Moreover unusual reactions such as dehydrogenation, ring 
expansion,^' N-hydroxylation, exchange of protons with solvent may occur, all 
dependent on tiie substrate presented to tiie enzyme. Hakamatsuka et al. have 
demonstrated that many reactions in the biosynthesis of natural products can be 
reasonably explained by P-450 reactions associated with migration or bond cleavage.^^ 
For example the rearrangement of flavanone to isoflavone which involves a 1,2 aryl 
migration^^ has been unequivocally shown to involve a cytochi-ome P-450 enzyme, and a 
radical mechnism has been proposed (Figure 3-14). 
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flavanone O 
isoflavone ^ 
Figure 3-14 Proposed mechanism for the P-450 catalysed rearrangement of flavanone to isoflavone 
The precise details of the mechanism of this rearrangement are still the subject of some 
debate and modified mechanisms have been suggested by Crombie and Whiting which 
also take account of the stabilising effect of the para-hydroxyl of the aryl migrating 
group.^^ However intermediate (3.22) was identified in a cell free study and became 
labelled with oxygen-18 (-30%) when the reaction was conducted under '^ O,."^ 
In an extension of this hypothesis Cox^" proposed a plausible cytochrome P-450 
mediated radical mechanism for tenellin biosynthesis proceeding via a tetramic acid 
intermediate shown below. However this mechanism is not without difficulties as 
investigations with phenylalanine labelled with deuterium at the a-position did not result 
in the labelling of teneUin with deuterium at cafbon-5 of the pyiidone ring. This is 
discussed in Chapter 4. 
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F e ^ O H 
Fe-OH 
FeiOH N 
O H O 
H 3 ^ N - ^ O 
Figure 3-15 Possible P-450 catalysed mechanism for rearrangement of putative tetramic acid intermediate 
in tenellin biosynthesis 
Recently it has been suggested that the biogenenesis of the unique ring-D-aromatic 
phytosteroids (3.23) from Nicandra physaloides involves a ling expansion of a five 
membered ring-D via a cytochrome P-450 generated radical on the methyl group.^' 
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O H ' O 
Figure 3-16 Proposed ring expansion in biosynthesis of the phytosteroids 
A key objective of this present study was to investigate the intermediacy of Vining's 
putative tetramic acid (3.20) in tenelUn biosynthesis. Accordingly it was synthesised 
bearing isotopic labels, for feeding experiments to Beauvaria bassiana. It was anticipated 
that the synthetic material could also be used as a reference for HPLC and LCMS analysis 
of the cultures to try to identify its presence in the broth. 
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3.2 Synthesis of Vining's Proposed Intermediate 
3.2.1 Synthetic routes to acyltetramic acids 
The majority of the naturally occuring tetramic acids that have been isolated exhibit 
biological activity, and the syntheses of such compounds has attracted a gieat deal of 
interest. Witliin this group of natural products there are members which are potent 
antibiotics and antiviral agents, members which exhibit antiulcerative properties, 
cytotoxicity, mycotoxicity, inhibition of tumours, fungicidal action, as well as those that 
are responsible for the pigmentation of certain molds and sponges.^ " 
3-Acyltetramic acids are acidic having pK^ values in the range 3.0-3.5." Analysis using 
proton NMR indicates that these systems are completely enolized, and that they exist in 
several tautomeric forms. The tautomeric behaviour can be explained in terms of two 
pairs of rapidly interconverting internal tautomers. 
H-
N 
H a 
H - O 
FAST 
SLOW 
FAST 
N 
H 
Figure 3-17 Tautomeric behaviour of 3-acyl tetramic acids 
Within each pair interconveition is rapid, aiising from proton transfer along the 
intramolecular hydrogen bond. Interconversion between the pairs (external tautomers) is 
slow and can be detected on the NMR time scale, and the population ratio calculated. The 
observed chemical shifts and coupling constants represent the weighted population 
averages of the corresponding internal tautomers.^ "* The enolic forms b and d 
predominate, as shown by the predominance of the lower frequency carbon-6 enolic 
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carbon resonance. The exo-eno\ d is the main tautomeiic form as the higher frequency C-
2 hydrogen bonded carbonyl signal predominates. 
The polarity of acyl tetramic acids renders them veiy difficult to purifiy. For this reason it 
is expedient to constioict the 2,4-dioxopyiTolidine ring at a late stage in the synthesis. A 
convergent synthetic strategy is also attractive as it restricts the number of synthetic steps 
necessary with the isotopically labelled precursors, and reduces loss of overall yield. 
Clearly it is also desirable to be able to construct enantiomerically pure tetramic acids, 
which can be achieved be using the naturally occuring amino acids in the construction of 
the ring. 
Many stategies have been applied to the synthesis of tetramic acids, and that most widely 
adopted for the construction of the tetramic acid ring of 3-acyltetramic acids is Lacey's 
modified Dieckmann cyclisation.^- The initial method involved the condensation of an a-
aminoester with diketene ((CHjCO),) to give the N-acetoacetyl-a-aminoester (3.23), 
which on treatment with sodium ethoxide was cyclized to 3-acyltetramic acid (3.24).^ ^ 
R 
N H , - ^ C 0 , E t _ ^ C O . E t A o n 
OH 
R N O " N O 
" (3.23) " (3.24) 
(i) Diketene, (ii) NaOMe 
Figure 3-18 Lacey's modified Dieckmann cyclisation 
The advantage of this method is its flexibiUty, enabling preparation of 3-acyltetramic acids 
with a diversity of substituents, although a potential drawback is that the use of basic 
conditions may lead to racemisation of vunerable stereogenic centers. The more complex 
the sidechain, the more problematical it is to construct the P-keto amide intermediate, and 
decomposition of substrates often results in capricious yeilds. Boeckman^^ circumvented 
this problem by the synthesis of a tetramic acid nucleus with the 3-acyl group 
funtionalised with a phosphonate group for further elaboration with aldehydes. Ring 
opening of 2,2-dimethyl-6-(diethylphosphonomethyl)-l,3-dioxin-4-one (3.25) with ethyl 
glycinate, followed by Dieckman cyclisation of the phophonoacetoacetyl-a-amino ester 
(3.26) gave lise to the sodium salt of the tetramic acid. 
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C02Et 
(3.25) (3.26) 
(i) NHjCHjCOjEt, PyH^Tos", (u) NaOMe. 
Figure 3-19 Boeckman's tetramic acid synthesis 
This tetramic acid phoshonate reagent (3.27) was used by both DeShong and Boeckman^' 
in their syntheses of tu-andamycin (3.28). Wadsworth-Emmons olefination of the tetramic 
acid with aldehydes requires protection of the ring nitrogen, and the 2,4-dimethoxybenzyl 
group was selected by Schlessinger et al. for its ease of removal under acid conditions in 
their total synthesis of tifandamycin.^* 
(3.28) o'-
Figure 3-20 Tirandamycin 
An alternative to chain extension of phosphonoacetyl teh-amic acid derivatives for the 
synthesis of 3-(poly)enoyltetramic acids (3.31) has been developed by Jones. 
2,2,6-Trimethyl-l,3-dioxen-4-one (acetone-diketene adduct) was converted via the 
alkylchloride to the 6-phosphonomethyl derivative (3.25). Wadsworth-Emmons 
olefination with saturated and unsaturated aldehydes gave the (poly)ene dioxinones (3.29) 
which could be reacted with the methyl ester of amino acids to give the P-ketoamides 
(3.30), and cyclised to tetramic acids under Dieckmann cyclisation conditions. 
o 9 9 °" 
^^s^k^Al^o MeN " MeN r 
(3.29) .^ ^ (3.30) (331) 
(i) R'CH(NMeH)(C02Me), ptps, toluene (ii) K'OBu, 'BuOH. 
Figure 3-21 Jones' methodology using polyene dioxones 
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The advantage of this strategy is that it is a mild method which generates the highly polar 
and acidic heterocycle in the final step. This sequence has been used in the landmark 
synthesis of the macrocyclic enoyltetramic acid, ikarugamycin (3.32)."° 
Figure 3-22 Ikaiiigamycin 
Despite the problems associated with the base induced cyclisation, the Lacey-Dieckmann 
method has been the principal method for the preparation of chiral tetramic acids. This is 
because it lends itself so well to the use of chiral amino acids to introduce the asymmetry. 
Lacey-Dieckman cyclisations have been carefully evaluated to establish the degree of 
racemisation under vaiious conditions. Studies have shown that racemisation does occur 
to a degree dependent on base concentration and reaction time."*' Incredibly, however, (3-
cyclopiasonic acid (3.33) has been prepared m optically pure form, through exposure of 
the P-keto amide intermediate to methoxide in refluxing benzene for ten hours!'*' 
Figure 3-23 P-Cyclopiasonic acid 
Enantio-selective Lacey-Dieckmann cyclisations are usually accomplished under mild 
conditions; potassium tert-butoxide in tert-butanol at room temperature for minimal 
reaction times. Such conditions were used in the total synthesis of fuligorubin A (3.34) 
by Ley,"*^  and that of ikarugamycin (3.32) by Boeckman and Paquette."" 
77 
MeN 
CO2H 
Figure 3-24 Fuligorubin 
The optical rotation of the synthetic material was virtually identical to that of the natural 
samples. It was argued that the steiic bulk of the base may be a significant factor as the 
stereogenic center is more hindered in comparison to the active methylene group. 
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3.2.2 Synthesis of the proposed tetramic acid in tenellin biosynthesis 
The synthetic strategy for the constiaiction of the putative acyl tetramic acid inteirnediate in 
tenellin biosynthesis was based on the methodology of Jones, and first attempted by 
Cox.^° The disconnections are shown below. 
P \ - O E t 
Figure 3-25 Synthetic strategy for the construction of the putative tetramic acid intermediate in tenellin 
biosynthesis 
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3.2.3 Synthesis of (E)-2,4-dimethylhex-2-enal 
NH2 
(3.35) 6 (3.36) ^ (3.37) 
1 
11 
H 
(3.39) 
(3.38) 
(i) BuLi, -78°C, (ii) -78°C to 0°C, (iii) (C02H)2, H2O, 25°C. 
Figure 3-26 Synthesis of (E)-2,4-dimethylhex-2-enal 
(E)-2,4-Dimethylhex-2-enal (3.39) was prepared following literature methods reported in 
the synthesis of racemic tenellin by WiUiams and Sit'*'* using the directed aldol 
condensation first described by Wittig.'*^ Propionaldehyde (3.36) was condensed with 
tert-butylamine (3.35) at 0°C to give (1,1-dimethyl-N-propylidene) ethylamine (3.37), 
and left to stand over potassium hydroxide pellets, enabhng the separation of the aqueous 
layer. It was necessary to distil the product three times over potassium hydroxide pellets 
to obtain it free from teit-butylamine and water."** Decomposition of the product stored 
under nitrogen at 0°C occured within a few weeks, and therefore it was always redistilled 
prior to use. 
The imine (3.37) was lithiated using butyllithium at -78°C, and condensed with 
2-methylbutyraldehyde (3.38). The lithiated aldimine adduct could be decomposed with 
an aqueous sluiry of oxalic acid to the thermodynamically more stable trans olefin, 
(E)-2,4-dimethylhex-2-enal (3.39). This was relatively stable to storage at -20°C under 
nitrogen if first purified over silica. However further purification was necessai-y piior to 
use. 
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3.2.4 Synthesis of 2,2-dimethyI-6-(E,E-3,5-dimethylhepta-l,3-dienyl)-
l,3-dioxin-4-one. 
o X 0 ^ 0 _ i ^ 9 9 ^ 
(3.40) (3.41) (3-42) 
(3.43) 
(i) LDA, THF, -78°C, CjClg, -SOT, (ii) (EtO)2PHO, K'OBu, DMF, 
(iii) LHMDS, THF. 
Figure 3-27 Synthesis of 2,2-dimethyl-6-(E£-3,5-dimethylhepta-l,3-dienyl)-l,3-dioxin-4-one 
Thermolysis of the acetone diketene adduct (3.40) to (3-acetyl ketene'*^  in the presence of a 
nucleophile such as an alcohol or amine results in the formation of P-keto esters and 
amides. The diethyl phosphonate is a more versatile activated p-keto ester or amide 
equivalent. It was first prepared by Boeckman and Thomas^^ for use in the synthesis of 
tetramic acids, permitting Wadsworth-Emmons olefination under mild conditions. 
A modification of this initial synthesis was followed''^ involving Uthiating freshly distilled 
acetone diketene adduct (3.40) in tetrahydi-ofuran at -78°C, and quenching the yellow 
precipitate thus formed with a solution of hexachloroethane in tetrahydrofuran. To obtain 
high yields it was necessary to transfer the precipitate via Teflon tubing in a dropwise 
manner to the hexachloroethane solution at -50°C. The chlorinated acetone diketene 
adduct (3.41) could be puiified over silica. This was treated with a solution of potassium 
diethylphosphite in dimethylfoirnamide to give the Wadsworth-Emmons reagent (3.42). 
Excess diethyl phosphite was removed by distillation, and the product could be purified 
by flash chromatography and stored at 0°C under nitrogen. 
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Wittig olefination of this phosphonate (3.42) was accomplished by first hthiating the 
phosphonate using hthium hexamethyldisilazide^' in tetrahydrofuran at 0°C. The blood 
red solution was quenched by the addition of 2,4-dimethylhex-2-enal (3.39) to give the 
all-E triene. The product was stable to storage under nitrogen at 0°C after purification 
over silica. This key inteirnediate dioxenone (3.43) could be thermolysed and trapped 
with various protected amino acids to giving P-keto amide intermediates. 
3.2.5 Attempted preparation of acyl tetramic acids using phenylalanine 
methyl ester 
O 3.44 
0 O 
(3.45) 
(i) toluene. A, (iii) KO'Bu, 'BuOH 
Figure 3-28 Attempted preparation of acyl tetramic acids using phenylalanine methyl ester 
When the dioxenone (3.43) was ti'eated with one equivalent of phenylalanine methyl ester 
and heated in refluxing toluene the p-keto amide (3.44) was formed in high yield. After 
purification over silica, Dieckmann cycUsation was attempted using freshly sublimed 
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potassium tert-butoxide in tert-butanol for the relatively short period of ten minutes. 
These mild conditions were selected for the cyclisation step, as the higher temperature 
required for deprotenation by sodium methoxide in methanol resulted in large scale 
decomposition and racemisation. 
In the event the orange oil obtained, after submitting the P-keto ester (3.44) to these 
conditions, was found to be the corresponding acid (3.45), formed by the hydrolysis of 
the methyl ester. There was no evidence that cycUsation to the tetramic acid had occured. 
The results could be rationalised if deprotonation was occuixing at the amide niQ-ogen. 
Delocalisation of the negative charge onto the amide oxygen could be followed by 
cyclisation by nucleophilic displacement of the methyl ester. The heterocycle (3.46) 
would be readily opened by nucleophiUc attack of water during the acidic work-up, 
resulting in the formation of the acid. 
t o o 
Figure 3-29 Rationale for the failed cyclisation step 
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3.2.6 The requirement for a protecting group 
Problems with the cyclisation to generate the acyltetramic acid were reported in the total 
synthesis of malonomycin (3.57), depending on the nature of the acyl substituent. An 
alternative strategy was adopted in this case, involving coupUng of the peptide side chain 
to the pyrolidine-2,4-dione ring after cyclisation.'*^ However, there was precedent for 
such cyclisations preceding smoothly with less complex short chain tecramic acids (both 
in the literature^" and in the work of our reseairh group) without necessitating the 
protection of the nitrogen of the amide. In our case it was evident that protection of the 
nitrogen was necessary. In the reported total syntheses of more complex tetramic acids 
such as tirandamycin and ikarugamycin, N-protection has been generally used. '^ In such 
syntheses the acid labile 2,4-dimethoxybenzyl group is a common choice for protection of 
the amine. Schlessinger" first described the use of this protecting gi'oup in tetramic acid 
syntheses. It has the advantage of being readily removed by either mild oxidative or acidic 
conditions. Brief treatment with neat trifluoroacetic acid at room temperature has proven 
effective for such deprotections.^ ^ 
In the light of the Uteratui'e precedence it seemed prudent to repeat our synthesis with the 
N-protected phenylalanine methyl ester. 
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3.2.7 Synthesis of N-(2,4-diniethoxybenzyI) phenylalanine methyl ester 
O O i i 
(3.47) 
NH3CI 
(3.48a) 
OH i i i ^ i j - ^ ^ ^ ^ s r ^ ^ Y ^ O M e 
^ NH2 
MeO 
(i) K^^CN, MeOH, NH4CI, HjO, (ii) cone" aq HCl, 
(iii) SOCI2, MeOH, (iv) NaBHjCN, MeOH, pH 6. 
(3.49a) 
OMe 
OMe 
OMe 
(3.51a) 
Figure 3-30 Synthesis of N-(2,4-dimethoxybenzyl) phenylalanine methyl ester 
The synthesis of [^H,]-labelled protected amino acid staited from commercially available 
[^H5-aA7/]-(L)-phenylalanine. [1-'T]-Phenylalanine was synthesised by a modified 
Strecker synthesis^^ as it enabled the introduction of a '^ C label at the cai'boxyl group. 
Phenylacetaldehyde (3.47) was treated with ["C]-potassium cyanide and ammonium 
chloride in methanol. The [l-'^C]-2-amino-3-phenylpropionitrile intermediate required 
refluxing in concentrated aqueous hydrochloric acid for two days to complete hydrolysis 
of the nitrile, giving [l-'T]-phenylalanine hydrochloride (3.48a). The amino acid could 
be methylated using an excess of thionyl chloride in methanol,^'' and then ti-eatment with 
sodium bicarbonate solution released the free amine (3.49a), which was used immediately 
as it was prone to polymerisation on standing. 
Conversion of (3.49) to its N-(2,4-dimethoxybenzyl)-derivative (3.51a) was achieved by 
treatment of phenylalanine methyl ester with 2,4-dimethoxybenzaldehyde (3.50) in 
methanol at pH 6 and at ambient temperature. Addition of sodium cyanoborohydride to 
the reaction mixture effected the selective reduction of the imine formed. Impurities of 
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2,4-dimethoxybenzylalcohol were removed by distillation and the residue purified by 
silica gel column chromatography to give the protected amino acid as a colourless viscous 
oil. 
3.2.8 Preparation of acyl tetramic acids using N-(2,4-dimethoxybenzyl) 
phenylalanine methyl ester 
OMe 
- I -
OMe 
(3.51a) t 
(3.43) 
OMe 
OMe 
MeO 
(3.52a) 
(3.54a) 
(i) toluene, ptps, reflux, (ii) KO'Bu, 'BuOH, (iii) CF3COOH. 
Figure 3-31 Preparation of acyl tetramic acids using N-(2,4-dimethoxybenzyl) phenylalanine methyl ester 
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Fkst attempts at the condensation of N-(2,4-dimethoxybenzyl) phenylalanine methyl ester 
(3.51a) with 2,2-dimethyl-6-(E,E-3,5-dimethylhepta-l,3-ciienyl)-l,3-dioxin-4-one (3.43) 
by thermolysis in refluxing toluene were unsuccessful. Unreacted N-(2,4-
dimethoxybenzyl) phenylalanine methyl ester and a mixtui'e of breakdown products of the 
protected ketene could be recovered from the reaction mixture. Although uncatalysed 
thermolysis is the preferred method of reaction of nucleophiles with dioxenones, mild 
acid catalysts such as pyiidinium para-toluene sulphonate (ptps) may be used to assist the 
opening of the acetal as described by Jones et al. for the synthesis of 3-polyenoyltetramic 
acids.^ ^ It was rationalised that as the nucleophilicity of the amine was now reduced, due 
to the bulky protecting group, use of a mild catalyst might assist the reaction to proceed in 
the desired manner. It was encouraging to find that this indeed was the case, and the 
N-protected P-keto amide (3.52a) was a major product of tlie acid catalysed thermolysis. 
Although there was a loss in yield compared with the unprotected phenylalanine methyl 
ester, the recoveiy was perfectly acceptable at approximately 50%, particularly as the final 
two steps were anticipated to be high yielding reactions. 
It was gratifying when the Dieckman cyclisation step using potassium te/t-butoxide in 
te/Y-butanol proceeded smoothly giving the [4-'^C]-N-(2,4-dimethoxybenzyl)-protected 
tetramic acid (3.53a) in excellent yield. 'H and '^ C NMR showed clearly the two slowly 
interconverting external tautomers in ratio of 84 : 16. Ring carbon-5 and the attached 
proton showed a particularly large difference in chemical shift between the tautomers in 
the '^ C and 'H NMR spectra respectively, as is commonly observed for tetramic acids.^ ^ 
Deprotection was readily accompUshed in under five minutes using the standard 
conditions; neat trifluoroacetic acid at room temperature yielding the target tetramic acid 
(3.54a). NMR analysis confimed that the product was sufficiently pure to use in 
subsequent feeding experiments. Again two external tautomers could be seen, this time in 
the ratio 85 : 15. In the case of the labelled tetramic acid, only two labelled peaks 
were observed in a ratio of 85 ; 15 consistent again with the two tautomers of the acid. 
There were no labelled impurities. 
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Figure 3-32 HETCOR NMR of unlabelled tetramic add 
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After completion of the synthesis of the '^ C labelled teti-amic acid (3.54a), the same route 
was exploited to prepare the ["HjJ-derivative (3.54b) for further experiments. In this 
case, with lower cost of deuterium labelled materials, the synthesis was readily amenable 
to providing a gram of final product; ample for feeding experiments to Beauvaria 
bassiana. 
D D 
D D .NH 
OMe 
OMe 
(3.51b) OMe 
OMe 
(3.52b) 
(3.53b) 
D H H (3.54b) 
(i) toluene, ptps, reflux, (ii) K O ' B u , 'BuOH , (iii) CF3COOH. 
Figure 3-33 Route to deuterium labelled tetramic acid (3.54b) 
89 
[^Hj-ai-ylJ-L-Phenylalanine was used to initiate the synthesis. Reaction time for the 
cycUsation was kept to a minimum to limit racemisation of the enantiomerically pure 
centre. A number of attempts were made to establish the enantiomeric purity of the 
product, using chiral HPLC. However the peaks were too broad to be resolved. An 
attempt was made to measure the specific rotation of the deuterated tetramic acid, 
however, optical rotation measurements proved impossible to record due to the deep 
yellow coloui" of the solutions in ethanol. 
3.3 Biosynthetic Investigations 
3.3.1 Feeding of acyl tetramic acids to Beauvaria bassiana 
Initially the '^ C-labeUed putative teti-amic acid precursor 5(RS)-[4-'^C]-3-(E,E-4,6-
dimethylocta-2,4-dienoyl)-5-benzyl-2,4-dioxopyiToUdine (3.54a) was pulse fed to 
Beawaria bassiana cultures to a final concenti-ation 2 mM, immediately after tenellin 
production had commenced. As the labelled compound was insoluble in water it was 
pulse fed in the minimum volume of ethanol.^ ^ The cultures developed an uncharacteristic 
brown colouration, possibly due to the toxicity of ethanol, but a reasonable quantity of 
tenellin was never the less produced and extracted for analysis. '^ C NMR of the crude 
tenellin showed the presence of a considerable amount of the labelled precursor, and no 
observable enrichment of carbon-4 of the pyridone ring of tenellin at 173 ppm. The 
extract was analysed by HPLC, and the large labelled impurity confmned to co-elute with 
the synthetically prepared tetramic acid precursor. Preparative HPLC separated the pure 
tenellin for more accurate analysis, and established that within the sensitivity of the '^ C 
NMR experiment, there was no '^ C enrichment, and that the tetramic acid recovered had 
not been metabolised by the cells. 
Such a result, although disappointing was not suiprising. Firstly it must be considered 
that the size and insolubility of the proposed intermediate poses problems to such feeding 
experiments. In general lai-ge, polai- molecules are notoriously resistant to crossing cell 
membranes, and thus incorporation levels were anticipated to be low from the outset. 
However intact incorporations of a deuterium labelled tetramic acid (3.56) intermediate 
have been observed into the smaller tetramic acid antibiotic, malonomycin I I (3.57)," and 
this cleai'ly provided a nice precedent. 
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Figure 3-34 Incorporation of tetramic acid precursor into malonomycin 
The experiment was repeated with the deuterium labelled precursor, particularly as 
NMR analysis will increase the sensitivity of the experiment due to the low natural 
abundance (0.015%) of deuterium. 
Accordingly 5(S)-[C/H5-Z)e//z};/]-3-(E,E-4,6-dimethylocta-2,4-dienoyl)-5-benzyl-2,4-
dioxopyrrolidine (3.54b) was pulse fed to Beauvaria bassiana cultuies to a final 
concentration 1.5 mM. In one experiment the labelled compound was pulse fed in the 
minimum volume of ethanol, and in a repeat experiment dimethylsulphoxide'* was used 
as the solvent. After HPLC purification and 'H NMR analysis of the resultant teneUin no 
incorporation of the tetramic acid was obsei-vable in either case. 
Other more violent techniques, such as lysing the cells to release the enzymes for the 
supposed pathway, and then attempting a biotransformation of our putative intermediate, 
were considered, but no similar biotransfoiTnations have to our knowledge been 
attempted with B. bassiana. A more elegant experiment would be to load the cultures with 
radioactive '''C-acetate. HPLC analysis combined with '''C-scintillation counting would 
be a very sensitive probe of any labelled teti-amic acid produced. Before attempting such 
an experiment however, other results (discussed below) indicated that the proposed 
tetramic acid was an unlikely intermediate in tenellin biosynthesis, and so experiments 
with this putative intermediate were discontinued. 
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3.3.2 HPLC-analysis of Beauvaria Bassiana cultures 
HPLC with UV detection and LCMS were used in attempts to identify the formation of 
intermediates in the biosynthesis of teneUin. Using LCMS it was possible to speculate on 
the nature of minor metabolites, the more abundant of which could be purified by 
preparative HPLC, and analysed by 'H NMR. Fuithermore now witli the synthetically 
prepared putative acyl tetramic acid (3.54) as a reference compound, a specific search 
could be made in the cultures for this metabohte. Pyridones and tetramic acids are 
notoriously difficult to puiify due to their polar nature. However a technique was 
successfully developed using reverse-phase HPLC with acetonitrile or methanol and 
water as solvents, acidified with 0.1% trifluoroacetic acid. Without the acid the peaks 
were very broad and could not be separated. Tailing' of the peaks was difficult to 
overcome, but could be diminished di-amatically on an analytical scale by use of a 
BDS-protected reverse-phase column. In general excellent separations were accompUshed 
in this way. 
Tenellin was found to elute at 5.9 minutes. A small shoulder, often resolved into a 
separate peak, preceded the main peak at 5.6 minutes. This was subsequently shown to 
be a tautomer of tenelUn, the two tautomers being in approximate ratio 1 : 10. If the 
fi-actions were collected, and resubmitted to HPLC an identical trace was obtained for 
each, again each showing the two peaks in the ratio 1 : 10. Thus it was concluded that 
although tautomerism was a slow process, even allowing separation on the HPLC time 
scale, the tautomers could equilibrate readily over time. Both peaks were confimed to 
have identical mass spectra, with an MH* of 370. Another peak was frequently observed, 
eluting earlier at 3.2 minutes. LCMS confirmed this to have a MH^ of 354. Daughter ion 
spectra were obtained for each of the peaks. The base peak for tenellin and its tautomer 
had m/e 246, which could be assigned to a fragment ion Ci^HgNOj*. Its structure is 
shown in the table below (Figure 3-35). The minor metabolite with MH"^  354 had a 
similar fragmentation pattern but each peak had m/e 16 units less than that for tenelUn. Its 
base peak at 230 could then be assigned to an ion CijHgNO/. Thus we conclude that this 
is the reduced precursor to tenellin, prior to hydi'oxylation at the niti'ogen of the pyridone 
ring, or prior to hydroxylation on the phenyl ring. 
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Peak at M+1 Base Peak Base peak assigned to 
3.2min 354 230 (C.^HgNOJ 
H OH 
5.6niin 370 246(C,2H8N05) 
OH 
5.9min 370 246(C,2H8N05) 
OH 
(3.18) 
- 1 — I — 1 — 1 — I — I — I — I — I — I — I — I — I — I — 1 — 1 — I — 1 — 1 — I — I — I — I — 1 — I — I — I — I — 
3:20 5 :00 6:40 8:20 / min 
Figure 3-35 H F L C of crude tenellin 
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Using preparative HPLC a sample of this minor metabolite was collected in sufficient 
quantity (5.8mg) to obtain a ' H NMR. Although this sample was impure, the spectrum 
'was very similar to that of tenellin. Most informatively a para-substitution pattern of 
coupling was evident in the phenyl region. Thus it was concluded that the structure is the 
pyridone(H) (3.58). This compound is tenellin devoid of the hydroxamic acid OH. 
' • PPM 
- i — I — I — I — I — I — I — I — I — I — I — I — I — I — 
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Figure 3-36 'H NMR of minor metabolite 
HO. 
OH O 
Figure 3-37 Suggested structure of co-metabolite of tenellin in B. bassiana 
94 
The synthetic tetramic acid (3.54) was found to elute later from the H P L C column than 
tenellin, at 8.2 minutes. (M-i-1, 340). The daughter ion spectrum of this component had a 
base peak of m/e 216 corresponding to Cj^HjoOgN as shown on the spectrum below. 
Peak at M+1 Base Peak Base peak assigned to 
8.2min 340 216(C,2H,oN03) 
H 
(3.54) 
3:20 5 : 0 0 6 : 4 0 8:20 
Figure 3-38 HPLC of synthetic tetramic acid and comparison with teneilin 
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Cultures of Beauvaria bassiana were analysed by HPLC for traces of the putative tetramic 
acid intermediate, or any similai" polai" intermediate produced throughout the growth 
cycle. Precursors to teneUin would be expected to be evident earUer in the growth cycle. 
Cultures were sampled on days 1 to 9 after inocculation of fresh production media. The 
myceUa were extracted into acetone in a soxhlet thimble and the acetone extracts 
evaporated and analysed by LCMS. An exhaustive seai^ ch was made for compounds with 
masses corresponding to tenellin, reduced precursors, the proposed tetramic acid, and 
other related hydroxylated tetimiic acids. Daughter ion spectra were obtained on any 
interesting pai-ent ions observed. Apart from the metaboUtes previously isolated no novel 
metabolites were identified and there was no evidence for any of the Vining's proposed 
tetramic acid in the B. bassiana cultures. 
3.3.3 Use of P-450 inhibitors 
An alternative approach to finding plausible intermediates in the biosynthesis of 
secondaiy metaboUtes has employed the use of specific enzymatic inhibitors. As 
cytochrome P-450 enzymes are weU known in numerous organisms, from bacteria to 
mammals, a number of cytochi-ome P-450 inhibitors have been developed. When the 
organism is grown in the presence of the inhibitor it is sometimes possible to isolate a less 
oxidised metaboUte along the biosynthetic pathway by blocking reactions on that pathway 
which involve P-450 enzyme catalysis. In 1986 VanMiddlesworth et al. observed the 
accumulation of trichodiene when inhibitors were administered to the strain producing the 
mycoxin diacetoxyscirpenol.^' Since then the technique has been appUed to the 
elucidation of the biosynthesis of a number of secondary metabolites, including 
aphidicoUn, nigericin, betaenone B, chaetoglobosin A, and altemaric acid (3.61).^° For 
example when the fungus Alternaria solani, which produces altemaiic acid, was 
incubated witii the inhibitor S-3307D (3.60) a new metabolite, proaltemaiic acid (3.59) 
was isolated which is a plausible precui-sor to alternaric acid.^' 
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OH O ^ " O ' 
proaltemaric acid (3.59) 
HO COoH 
O " O 
altemaric acid (3.61) 
S-3307D (3.60) 
Figure 3-39 Plausible biosynthesis of altemaric acid 
It has been shown that Beamwia bassiana is able to metabolize diazepam, warfainn and 
testosterone via oxidative reactions such as hydroxylation and N-demethylation. 
Metabolism of each substrate can be inhibited by the cytochiome P450 inhibitors SKF-
525A and metyrapone, consistent with the involvement of this enzyme system in the 
metabolism of these drugs by B. bassiana. Clearly this indicates that B. bassiana 
possesses a cytochrome P-450 oxidative metaboHzing system.*^ As discussed above, a 
cytochrome P-450 dependent enzyme may be responsible for the observed rearrangement 
in the biosynthesis of tenellin. Also if teti-amic acid (3.20) is indeed the substi-ate for this 
enzyme according to Vining's hypothesis, it may be possible to identify the teti-amic acid 
intermediate, prior to hydroxylation, by incubating the cultures with cytochiome P-450 
inhibitors. 
Accordingly Beauvaria bassiana cultures were incubated with two P-450 inhibitors: 
metapyrone (3.62) and miconazole (3.63), at two concentrations (2 mM and 4 mM). 
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N 
metapyrone (3.62) 
CI 
miconazole (3.63) 
Figure 3^0 Structures of metapyrone and miconazole, P450 inhibitors 
The cultures were incubated for ten days and then the myceUa were extracted with 
acetone. The cultures incubated with miconazole appeared to produce tenelhti normally, 
as indicated by the chai-acteristic yellow colouration after four days of incubation, 
although tenellin production was reduced in the flask with the higher concentration of 
inhibitor. Metapyrone appeared to inhibit tenellin production to a greater extent. The 
cultures remained a creamish colour, indicating that tenellin production was substantially 
arrested. The extracts were analysed by LCMS to search for any tetramic acid (3.20) 
present. For the cultures incubated with miconazole the dominant peak was tenellin with 
m/e 370 (MH''). A slight increase from 1% to 3% in the peak con-esponding to the 
co-produced pyridone (3.58) was evident, relative to the teneUin peak. There was no 
evidence for the production of any teQ-amic acid (3.20). Cultures incubated with 
metapyrone showed low levels of tenellin with negligible amounts of the co-produced 
pyridone (3.58) precursor. It may be assumed that the tenellin detected was primarily 
residual from the innoculum, and produced in the previous sub-culture. Tenellin 
production was clearly suppressed but there is no evidence for the production of any 
tetramic acid or other major metabolites. This suggests that metapyi-one had a general 
toxicity effect. However, a P-450 mechanism may be impUcated at a much earher stage in 
the biosynthesis of tenelUn. This could involve the reairangement of phenylalanine or a 
related metabolite, prior to condensation with the polyketide chain. This is discussed in 
Chapter 4. 
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3.4 Reinvestigation into the Intermediacy of Tyrosine 
3.4.1 Feeding of [3-"C]-tyrosine to Beauvaria bassiana 
In the above investigation no intermediates were detected by LCMS and HPLC analysis 
which contained a phenyl group (from phenylalanine) prior to pa/a-hydroxylation. This 
and the other results discussed in the foUowing chapter led us to reconsider Vining's 
conclusion that tyrosine was not involved in tenelUn biosynthesis. This '''C study with 
tyrosine showed negligible incorporation (1.6%) compared with the high incorporation 
levels (8.4%) observed after "C-phenylalanine was administered to the cultures.^-' The 
experiment was re-investigated with '^ C labelled precursors (l-'^C-labeUed phenylalanine 
and 3-'^C-labelled tyi-osine) and both amino acids were incorporated into teneUin at 
similar levels. This is discussed fuUy in Chapter 4. 
NH3* 
tyrosine 
(4.27) 
HO 
B.bassiana 
tenellin 
B.bassiana 
NH3+ 
phenylalanine 
(4.28) 
Figure 3-41 Tyrosine and phenylalanine are both utihsed in tenellin biosynthesis 
tenellin 
Phenylalanine may well first be pa/a-hydroxylated to tyrosine, by a phenylalanine 
hydroxylase, and tiien used in the biosynthesis of teneUin. It is possible therefore that 
tyrosine condenses with the polyketide chain to form the tetramic acid inteirnediate shown 
below (3.64), which then undergoes the proposed rean-angement to the pyridone ring 
structure of tenellin. 
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Figure 3-42 An alternative putative tetramic acid intermediate 
Synthesis of this modified tetramic acid (3.64) became the new synthetic target, both for a 
reference compound in LCMS analysis, and for biosynthetic investigations such as those 
discussed above. 
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3.4.2 Attempted synthesis of p-hydroxylated tetramic acid intermediate 
The proposed synthetic sti-ategy involved a modification of tliat used in the synthesis of 
Vining's proposed intermediate (3.20), using a protected tyrosine as the stai-ting material. 
An added complication is the requu-ement foi- protection of the phenol hydi-oxyl group. 
MeO 
OMe 
OMe 
(3.69) t 
OMe OMe 
MeO 
^ ^ ^ ^ MeO 
MeO 
(3.43) 
(i) toluene, ptps, reflux, (ii) K O ' B u , ' B u O H , (iii) CF3COOH 
Figure 3-43 Proposed synthesis of p-hydroxylated tetramic acid intermediate 
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The group initiaUy selected for the protection of the phenol was 4-methoxybenzyl. It was 
envisaged that this could be readily removed in the final deprotection step with 
trifluoroacetic acid, along with the N-2,4-dimethoxybenzyl group. 
The methyl ester of tyrosine as its hydrochoride salt (3.66), was readUy prepared using 
thionyl chloride in methanol.^" UnUke the free amine this was stable to storage and could 
be prepared on a large scale. Protection of the amine with 2,4-dimethoxybenzaldehyde 
(3.50) was accomplished (70% yield) in methanol at room temperature witii sodium 
cyanoborohydiide affecting reduction of the imine. Work-up procedures proved to be 
problematic as the basic conditions, generated on tiie addition of water, deprotonated die 
phenolic group. However, quenching with 1 M hydrochloric acid circumvented this 
problem, but added tiie compUcation of hydi'ogen cyanide production during the process. 
Thus the procedure had to be effected with caution with the waste gases bubbled tiirough 
concentrated sodium hydroxide solution to neutraUse the hydrogen cyanide. The 
alternative protection of the phenolic group prior to protection of the amine was 
unsuccessfully attempted. The white ciystalUne hydrochloride product (3.67) was 
protected as the 0-4-methoxybenzyl ether (3.69) by treating with two equivUents of 
potassium carbonate, 4-methoxybenzyl choride (3.68) and tetrabutyl ammonium iodide. 
This protection step was attempted many times in acetone, according to Uterature 
procedures,^^ over a number of days, with warming to reflux, but no reaction occurred. 
Alternative bases and solvents such as diisopropylethylamine in dichloromediane" were 
attempted, but the reagents appeared equaUy unwiUing to react. EventuaUy the reaction 
was accomplished in high yield (92%) using dimethylformamide as the solvent, stirring at 
60°C for three days. Presumable this was due to the increased solubility of the reactants 
in this solvent. The product (3.69), an oU, could be purified over siUca. 
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OMe 
NH3CI 
(3.66) 
OMe 
HO 
OMe 
(3.67) 
OMe 
MeO 
(i) SOCI2, MeOH, reflux, (iv) NaBHjCN, MeOH, 
(iii) K2CO3, (Bu)4NI, DMF, 60°C. 
OMe 
OMe 
(3.69) 
OMe 
Figure 3-44 Synthesis of N-(2,4-dimethoxybenzyl)-0-(4-methoxybenzyl) tyrosine methyl ester 
Attempts at the condensation of the protected tyi-osine (N-2,4-dimethoxybenzyl)-0-(4-
methoxybenzyl) tyrosine methyl ester (3.69) with 2,2-dimethyl-6-(E,E-3,5-
dimethylhepta-l,3-dienyl)-l,3-dioxin-4-one (3.43) by thermolysis in refluxing toluene 
were unsuccessful. Unreacted (3.69) was recovered, along with a mixture of breakdown 
products from the protected ketene. Mild acid catalysis with pyridinium pa/a-toluene 
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sulphonate was attempted. After separation over silica, an ion with m/e 657 
corresponding to the molecular ion for the desired condensation product was detected by 
mass spectroscopy, in one fraction, however negligible product was detectable by NMR. 
Loss of the 4-methoxybenzyl group appeai-ed to occur even under the mildly acidic 
conditions, and a variety of unwanted products were obtained. Phenolic benzyl ethers are 
in general more labile than phenyl protected amines. Attempts were made to catalyse the 
reaction with various Lewis acids: aluminium compounds, and boron trifluoride etherate, 
but without success. An alternative strategy was attempted which aimed first to 
deprotonate the amine of the protected tyrosine with sodium hydride, followed by 
reaction with the protected diketene. Again a mixtui-e of products resulted, with no 
obsei-vable product. As the usual conditions (reflux in toluene with ptps) for condensation 
had been so successful for the phenylalanine derivative, the sensible approach was to 
change the protecting group used, so as to avoid unwanted deprotection under these 
conditions. 
The benzyl group has been widely used in peptide synthesis to protect the phenolic group 
of tyrosine.^^ It is also cleaved by tiifluoroacetic acid, although long reaction times ai-e 
required. A fuither disadvantage is the migration of the benzyl cation to the 3-position of 
the ring, during cleavage, giving unwanted side products. 2,6-Dichlorobenzyl ethers have 
also been used as they give a lower incidence of alkylation at the 3-position of the 
benzene ring, but they ai'e even more stable to trifluoroacetic acid deprotection.** 
Sensitivity of the tetramic acid to long treatment with such a powerful acid was envisaged 
to present a future problem. Side reactions, when deprotecting phenohc benzyl ethers, 
can be minimised if a cation scavenger is included in the reaction mixture. Favourites ai'e 
dimethyl sulphide, thioanisole and pentamethylbenzene.*^ Pentamethylbenzene'" was 
selected as it has the lowest incidence of side reactions and furthermore has been shown 
to increase the rate of deprotection. 
Synthesis of the 0-benzyl protected N-2,4-dimethoxylbenzyl tyrosine methyl ester (3.71) 
was accomplished with potassium caitonate and benzyl bromide (3.70)^' in dimethyl 
formamide over two days at 60°C. Pyridinium /?a/a-toluene sulphonate catalysed 
thermolysis, inrefluxing toluene, of 2,2-dimethyl-6-(E,E-3,5-dimethylhepta-l,3-dienyl)-
l,3-dioxin-4-one (3.43) with the protected tyrosine (N-2,4-dimethoxybenzyl)-0-(benzyl) 
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tyrosine methyl ester (3.71) did indeed result in the desiied condensation product (3.72), 
in reasonable yield (55%). Even more gratifying was the ease at which the Dieckmann 
cylisation using potassium re/r-butoxide in tert-hutanol of this product proceeded 
smoothly, yielding the N- and 0-protected tetramic acid (3.73) (81%). 
The final hurdle was deprotection step. In anticipation of some problems, very small 
amounts were used in deprotection attempts, and the reactions monitored by reverse 
phase HPLC. After ten minutes stirring in neat trifluoroacetic acid containing ten 
equivalents of pentamethyl benzene, the trifluoroacetic acid was removed in vacuo from 
the blight red mixture. The resulting solid was dissolved in dichloromethane and washed 
with water. The majoiity of the pentamethylbenzene could be precipitated out from 
methanol: water, (85: 15), the solvent used for HPLC analysis. The filtrate was analysed 
by HPLC which showed predominandy one product. Isolation of this compound, 
followed by mass spectroscopy identified this as the N-deprotected, 0-protected tetramic 
acid (3.74). Clearly longer reaction times were necessary for deprotection of the phenolic 
benzyl ether. The reaction was monitored over four hours during which time the benzyl 
etiier remained intact! After seven hours the N-deprotected tetramic acid could no longer 
be detected by HPLC, and work-up confirmed, unsurprisingly, tiiat decomposition had 
occured. As deprotections of the. phenohc ether of tyrosine are accomplished within one 
and a half hours this was indeed a disappointing result. As a last resort attempts were 
made to deprotect the tetramic acid using an alternative reagent, trimetiiylsilyl iodide in 
acetonioile. This has been effectively used to deprotect tyrosine benzyl ethers in peptide 
syntheses.^' Yields are high and no formation of 3-benzyl tyrosine is generally observed. 
However with the relatively sensitive tetramic acid many side reactions occuired and no 
product was observable. Alternative protection / deprotection strategies will need to be 
explored for the successful synthesis of the tetramic acid (3.64). For example 
deprotection with ttifluoromethanesulphonic acid is also known to remove benzyl and 
tert-butyl ethers, where reaction times are sometimes shorter than with trifluoroacetic acid 
deprotection." The metiiyl etiier may also be cleaved with trifluorometiianesulphonic 
acid.'' 
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' ^ i s ^ (3.67) 
(i) K2CO3, D M F , 6 0 ° C . (ii) toluene, ptps, reflux, (ill) K O ' B U , ' B U O H , (iv) CF3COOH 
Figure 3-45 Synthesis of 4-benzyloxy tetramic acid intermediate 
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3.5 Discussion 
Vining's proposed tetramic acid intermediate in teneUin biosynthesis (3.20) was 
successfully synthesised in both '^ C labelled (3.54) and deuterium labelled (3.55) forms. 
Both of these compounds were fed to cultures of Beamaria bassiana, but successful 
incorporation was not observed. Subsequent re-evaluation of the role of tyrosine in 
tenellin biosynthesis established that it is a good precursor to tenellin. Therefore Vining's 
tetramic acid (3.20) appears an unlikely intermediate in tenellin biosynthesis. The tyrosine 
derived tetramic acid (3.64) is a plausible intermediate, and its synthesis has been 
attempted. AH but the final deprotection step were achieved. Deprotection of the phenol 
group will require an alternative protection / deprotection sti'ategy to avoid the problems 
discussed above. 
However, LCMS analysis of Beauvaria bassiana cultures did not reveal evidence for the 
phenylalanine derived tetr-amic acid (3.20) or the tyrosine deiived tetramic acid (3.64), at 
any stage in the growth cycle. Additionally, the use of cytochrome P-450 inhibitors did 
not result in the accumulation of such intermediates. It is unUkely that these relatively 
stable putative intermediates should be present in amounts below the detection limits of 
such a technique. Rather, the results suggest that tenellin biosynthesis does not proceed 
via a tetramic acid inteimediate at all. A reairangement of phenylalanine / tyrosine may 
well occur at a much eai'her stage in die biosynthesis, prior to condensation with the 
polyketide moiety. This is discussed in Chapter 4. 
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4. Alternative Rearrangement Mechanisms for tlie 
Biosyntiiesis of tlie Pyridone ring of Tenellin 
4.1 Introduction and Background 
4.1.1 Phenylalanine and tyrosine metabolism 
Phenylalanine and tyrosine ai^ synthesed in vivo, via the shikimate pathway, Uie main 
steps of which are shown below. The branch point occurs at prephenate which 
undergoes decarboxylation and aromatisation to phenylpynivate and 
4-hydroxyphenylpyruvate. These are reversibly transaminated to phenylalanine and 
tyrosine respectively'. 
CO,-
CO 2 
2 0 3 P O ^ ^ ^ " CO,-
H CO2 
OH X 
OH 
O CO2" 
OH 
shikimic acid chorismic acid 
4-hydroxylphenyl-pyruvate 
HO 
tyrosine 
HO H 
prephenic acid 
phenylpyruvate 
o.^  ,0-
NH,* 
phenylalanine 
Figure 4-1 The shikimate pathway to tyrosine and phenylalanine 
Reversible amination results in the interconversion of L and D forms of phenylalanine as 
for example in the case in the biosyntiiesis of cyclopenin and cyclopenol (4.1) by 
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Penicillium cydopium? and in the cytochalasin-D (4.2) producing fungus Zygosporium 
masonii.^ 
cyclopenin R=H (4 
cyclopenol R=OH 
O OAc M^ 
OH 
cytochalasin D (4.2) 
Figure 4-2 D and L-Phenylalanine derived secondary metabolites 
Both D- and L- phenylalanine are incorporated into die metabolites. Feeding experiments 
with stereospecifically labelled D-phenylalanine resulted in the complete loss of tritium 
f rom the a-position and extensive loss of nitium from the P-position, an observation 
consistent with the enoUsation of phenylpyruvate. (Reversible transamination is also 
known to occur in many antibiotic biosyntheses, including the penicillins, 
cephalosporins, gramicidin S, actinomycin and gUotoxin.^ 
NH3* 
(L)-phenylalanine 
OH 
phenylpyruvate 
NH3* 
(D)-phenylalanine 
Figure 4-3 Interconversion of (D) and (L)-phenylalanine 
Interestingly during the biosynthesis of myceUanamide (4.3) (from Penicillium 
griseofulvum), a metabolite related to cyclopenin and cyclopenol, no such 
interconversion between L - and D- tyrosine is obsei-ved prior to incorporation. High 
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retention of the 3-pro-S hydrogen of tyrosine and the complete loss of the 3-pro-R-
hydrogen was obsei"ved as the result of a stereospecific dehydrogenation step. 
N R 
mycelianamide (4.3) ^ 
Figure 4-4 Tyrosine derived mycelianamide 
Phenylalanine and tyrosine may also undergo stereospecific anti-ehminmon of the 3-pro 
S hydrogen together with ammonia, to give cinnamic acid (4.4) and para-coumanc acid 
(4.5) (para-hydroxy cinnamic acid) respectively. The transformations are catalysed by 
the enzymes phenylalanine ammonia lyase (PAL) and tyrosine ammonia lyase (TAL).'' 
Both of these enzymes are widespread in gi^ asses and some fungi.^ However most 
organisms seem to favour conversion of cinnamic acid into para-cowamc acid, rather 
than direct loss of ammonia from tyrosine. Cinnamic acids are key intermediates in the 
biosynthesis of the phenylpropanoids, the most common shikimate metabolites involved 
in the biosynthesis of many alkaloids and flavanoids.* 
L-phenylalanine 
ammonia lyase 
L-tyrosine 
ammonia lyase 
OH 
(4.4) 
cinnamic acid 
(4.5) 
p-coumaric acid 
Figure 4-5 Enzymes involved in phenylalanine metabolism 
Para-hydroxylation of phenylalanine to tyrosine is also the first step of phenylalanine 
degradation. This reaction may also be used to provide an additional source of tyrosine. 
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Such phenylalanine hydroxylases are widespread in microfungi, plants and higher 
animals.^ The process is catalysed by an iron (IE) containing phenylalanine hydroxylase 
(PAH), and requires the participation of the cofactor, biopterin. 
phenylalanine 
hydroxylase 
NH3* 
phenylalanine 
NH3* 
tyrosine 
tetrahydrobiopterin dihydrobiopterin 
Figure 4-6 Action of phenylalanine hydroxylase 
It has been postulated that the mechanism involves formation of an arene oxide (4.6), 
opening of which results in a carbocation at ring carbon-3. Migration of an hydride is 
observed from ring carbon-4 to carbon-3 (known as the NIH shift) which may result 
from the formation of an oxonium ion (4.7) followed by enolisation to tyrosine.' An 
epoxide intermediate was isolated after oxidising L-[2,5-H2]-phenylalanine witii PAH, 
consistent with this hypothesis.^ 
Figure 4-7 Proposed mechanism of the NIH shift 
Contrary to mammaUan PAH, it has recentiy been shown that phenylalanine hydroxylase 
from the bacterium Chromobacterium violacium does not require any redox active metal 
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such as iron for activity.^ Investigations of this metal independent hydroxylation and 
suggests that its mode of action is similar to mammalian PAH. Clearly any mechanistic 
analogy to the iron mediated cytochrome P-450 mediated oxidations discussed below is 
unlikely. More recentiy measurements of the kinetic isotope effects on hydi-oxylation 
have brought into question the obligatoiy nature of the arene oxide intermediate.'" The 
catalytic mechanism of PAH thus still remains undefined. 
4.1.2 Hydroxylase activities in Beauvaria sp. 
The Beauvaria are particulaiiy well known for their hydroxylase activities. When 
hydroxylation of an aromatic rmg is obsei-ved, ortho-hydroxylation is usually 
predominant, /'ara-hydroxylations, however, are also known amongst these 
biotransformations, notably in the species Beawaria sulfurescens. This species has 
consequentiy been used in preparative organic chemistry as an alternative to chemical 
hydroxylation of aromatic rings. Such chemical transformations can often be problematic 
and are generally never achieved witii complete pa/a-regioselectivity. The mechanism of 
this hydroxylation has been shown to involve tiie NIH shift, consistent with the 
formation of an arene oxide intermediate, and thus mimics tire mammaUan pathway of 
detoxification." A cytochi'ome P-450 mediated enzyme is implicated. 
Griffiths et al. have recentiy shown that tiie fungus Beauveria bassiana is capable of 
metabolising diazepam, warfarin and testosterone via oxidative reactions such as 
hydroxylation and N-demethylation. This activity was shown to be inhibited by 
cytochrome P-450 inhibitors, suggesting involvement of this enzyme system in the 
metabolism of these drugs.'' Thus it appears that Beauveria bassiana is able to employ a 
range of oxidative activities in its metabolism. 
The mechanism of cytochrome P-450 catalysed ai-omatic hydroxylation continues to be 
an area of debate. Similarly to phenylalanine hydroxylase reactions, the NIH shift 
sometimes occurs, but isotope effects are generally not observed, except in the formation 
of we/a-hydi"oxylated metaboUtes where lai'ge isotope effects may be observed.'^ Initial 
electrophilic attack of die cytochi'ome P-450 Fe(III)=0 on the ai'omatic ring, followed by 
formation of the hydroxylated benzene, possibly via arearrangement of a keto product, is 
emerging as the most likely mechanism.'"* 
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4.1.3 Rearrangements involving 1,2-carboxyl migration 
There are a number of known carbon skeleton reairangements which are mediated by 
coenzyme B j , . " Two such processes are shown below which require the 1,2-migration 
of a carboxyl moiety, and involve the migration of the COSCoA group with concuiTcnt 
1,2-back migration of a hydrogen atom. These reactions are mediated by the enzymes 
methylmalonyl-CoA mutase'^  and isobutyryl-CoA mutase respectively'\ In both cases 
the hydrogen replaces the COSCoA group with predominant retention of configuration. 
^* (2R)-methylmalonyl-CoA *H C O S C O A 
, COSCoA mutase \ ^ / 
H02C"^ _ 
^ CO2H 
^* isobutyryl-CoA \ 
^ COSCoA mutase ^ )— COSCoA 
H* 
Figure 4-8 Coenzyme B,2 mediated vicinal interchange processes 
Clearly tiiere is a superficial similarity between tiiese vicinal interchange process and die 
observed 1,2-cai-boxyl migi-ation of phenylalanine in tenellin biosynthesis. 
4.1.4 The biosynthesis of tropic acid 
As briefly discussed in Chapter 3, the biosynthesis of the tropic acid moiety of tiie Datura 
alkaloids, hyoscyamine and scopolamine, involves an intramolecular rearrangement of a 
phenylalanine derived phenylpropanoid unit. DL-[1,3-'^C2]-Phenylalanine (4.8) was 
incorporated intact into hyoscyamine (4.9), the '^ C labelled atoms having become 
contiguous. The observed '^C-'^C coupling in die '^C-NMR unequivocally established 
the intramolecular nature of the rearrangement.'* The apparent resemblance of this 
rearrangement to the rean-angement in tenellin biosynthesis was recognised by Leete and 
Vining.'^ 
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Datura 
innoxia 
NH3* OH 
(4.8) (4.9) 
hyoscyamine 
Figure 4-9 Incorporation of phenylalanine into hyoscyamine 
Considerable advances have been made in understanding this rearrangement.^ " Firsdy 
D-phenyllactic acid (4.11) was established as a direct precursor to the tropate ester (4.12) 
on the basis of intact incorporation of DL-[2-'^C"H]-phenyllactate.^' The retention of the 
deuterium (as observed as an a-shifted '^ C component in the '^C-NMR) eliminated the 
possibility that phenylpyruvic acid (4.10) is a closer precursor, although significant 
washout of deuterium was observed. Presumably this may be accounted for by the rapid 
interconversion of phenylpyruvate and phenyllactate. This interconversion also explains 
the observation that both '^C-labelled D and L-phenyllactic acids are incorporated into 
tropate. DL-[2-'^C^H]-Phenyllactate was resolved, and the separate enantiomers 
administered to D. stramonium. D-phenyllactic acid was incorporated into hyoscyamine 
with the '^C^H label intact, whereas its enantiomer had cleai-ly lost its deuterium label 
prior to incorporation. D-Phenyllactic acid is thus the true precursor to tropate.^' 
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(4.11) 
D-phenyllactic acid 
O ^ O R 
Figure 4-10 Incorporation of L - and D- phenyllactic acids into tropate esters 
The stereochemical features of this rearrangement have been fully investigated.^^ It was 
demonstrated that an inversion of configuration is occuring at both migration termini, and 
that no vicinal interchange (back migration of hydrogen) was operating."'' (Figure 4-11) 
.s\C02H 
inversion at C-2 and C-3 
Figure 4-11 Overall stereochemistry of the phenyllactate to tropate rearrangement 
Robins et al. have investigated the substrate for the rearrangement, and have 
demonstrated that httorine (4.13), the D-tropine ester of D-phenyllactate is rearranged 
directly to hyoscyamine (4.14). Littorine prepared from [/77e^/z}'/-^H3]-tropine and [1,3-
'^CjJ-phenylacetic acid appears to be rearranged to hyoscyamine intact. The level of 
incorporation of the quintuply-labelled molecule was inconsistent with hydrolysis of the 
ester prior to incorporation. 25 
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OH 
littorine (4.13) 
Datura 
stramonium 
OH 
hyoscyamine (4.14) 
Figure 4-12 The intact rearrangement of littorine to hyoscyamine 
Now that the possibility of a vicinal interchange process has been discounted, 
investigations are focusing on the nature of the reaixanging enzyme, and there is 
mounting evidence that a cytochrome P-450 enzyme is imphcated. LabeUing studies on a 
number of related minor alkaloids in the Datura species support this proposal,^* and it 
has been recently demonstrated that the conversion of littorine to hyoscyamine appears to 
be inhibited by the P-450 inhibitor chlotrimazole.^'' Incorporation of [2-'^C'*0^H]-
phenyllactic acid was studied to examine the oxygen content in hyoscyamine relative to 
littorine. It was anticipated that half of the '^0 label would be lost on collapse of the 
aldehyde hydrate (4.17) if an oxygen rebound process was operating. However the 
retention of 71-75% of the '^ O did not suppoit this. Model studies have been investigated 
by Newcombe^* on methylcyclopropane ring opening reactions, with the stabihzing 
substituents, aryl and oxygen, similar to littorine and hyoscyamine. The 
methylcyclopropane cation opens towards oxygen, whereas the radical opens towards 
the aryl group, and this cleai'ly supports a carbocation process and a two electron 
oxidation. Two electron oxidations have precedent in the P-450 mediated biosyntheses of 
thi'omboxane and prostacyclin.^' Alternatively the oxygen-18 result may be accounted for 
by a radical process involving either direct dispropoitionation of the product radicaP" or a 
partially stereospecific breakdown of the aldehyde hydrate. 
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(a) two electron oxidation 
(b) one electron oxidation 
' dehydrogenase 
75% retention of ^^ O 
(a) _ (b) 
Figure 4-13 FYoposed mechanism for the P-450 mediated rearrangement of littorine to hyoscyamine 
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4.2 Alternative Mechanistic Explanations for the Intramolecular 
Rearrangement in Tenellin Biosynthesis 
4.2.1 A direct rearrangement of phenylalanine? 
An alternative pathway to that proposed by Vining (discussed in Chapter 3) may be 
postulated for the biosynthesis of the pyiidone ring of tenellin, which would also account 
for the observed intramolecular rean-angement. Phenylalanine or some closely related 
metabolite, could rearrange prior to condensation with the polyketide cham (Figure 4-
14), giving the requisite carbon framework necessary to form the 6-membered pyridone 
ring directly. 
NH3* 
L-phenylalanine 
OH O 
I tenelhn 
OH 
Figure 4-14 Alternative mechanism for tenellin biosynthesis involving the rearrangement of 
phenylalanine directly 
Vining had attempted to rule out the possibility of any vicinal interchange mechanism 
involving a 1,2-hydride shift. When B. bassiana cultures were supplemented with non-
stereospecifically labelled [l-'^'C, 3-^H]-L-phenylalanine the tenellin isolated had lost at 
least 96% of the original tritium^'. It might be expected that oitium would be retained at 
position-6 on the pyridone ring. However if we consider that the reairangement would 
proceed in a stereospecific manner, the loss of tritium can also be accounted for as 
follows. Tritium is transferred from the benzylic position by a 1,2-hydride shift to either 
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the pro-R or the pro-S aminomethylene carbon. One hydrogen from this carbon is lost in 
the construction of the pyridone ring and if this occurs in a stereospecific manner, then 
the tritium ti^ ansfered from the benzylic position may be lost. The tenellin isolated would 
contain no tritium, and thus this experiment was not fail safe. 
4.2.2 The direct rearrangement of phenylalanine investigated 
Realisation that Vining's assertions were not conclusive led Cox^^ to investigate the 
possible intermediacy of the rearranged phenylalanine precursor in the biosynthesis of 
tenellin. A sample of 3-amino-2-phenylpropionic acid (4.19) bearing a '^ C label in the 3-
position was prepared and administered to cultiu'es of B. bassiana. However the tenellin 
isolated showed no evidence of incoiporation of the carbon-label. Thus it was concluded 
that 3-amino-2-phenylpropionic acid is not a true intermediate, and that phenylalanine 
does not undergo a direct rearrangement prior to condensation with a polyketide chain. 
B.bassiana 
— X — 
(4.19) tenellin 
Figure 4-15 3-Amino-2-phenylpropionic acid is not a precursor to tenellin 
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4.3 Further Investigations with Phenylalanine and Phenyllactic acid 
4.3.1 The origin of hydrogen-6 in the pyridone ring 
Of all the hydrogen atoms in tenellin, the oiigin of hydrogen-6 in the pyridone ring 
remains unknown. The body of labelling data suggests that this will be retained from 
carbon-2 of phenylalanine. Accordingly, DL-[2-^H]-phenylalanine (4.20) was pulse fed 
to cultures of B. bassiana to a final concentration of 6 mM. Tenellin (50mg) was isolated 
after a ten day incubation, and purified by HPLC. Analysis by 'H NMR did not indicate 
any incorporation of a deuterium label, at the signal coiresponding to C-6. 
HO 
B.bassiana 
tenellin 
Figure 4-16 Loss of deuterium from [2-D]-phenylalanine in tenelhn biosynthesis 
This result is intriguing, but can be rationalised in at least two ways, (i) a process which 
requires the obligate removal of this hydrogen during formation of the pyridone, or (ii) a 
process which requires transamination of the amino acid resulting in the removal of the 
deuterium label before phenylalanine is used in the biosynthesis. The latter process 
would result in the scrambhng of the nitrogen also. In an attempt to delineate these 
possibilities an expeiiment was conducted involving the synthesis and incorporation of 
triple labelled [2-'^C^H''N]-phenylalanine into tenelUn. 
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4.3.2 Synthesis of DL-[2-"C^Hi^N]-phenylaIanine 
O2C D 
(iv) (V) 
(i) CH2N2, (ii) LiAlD4, (iii) PCC / 3AMol sieves, CH2CI2, 
(iv) i^NH4Cl(3q), KCN, MeOH, (v) cone" HCl. 
OH 
D D 
(4.23) 
(iii) 
Figure 4-17 Synthesis of DL-P-'^C-H'^NHjl-phenylalanine 
The methyl ester of [1-'^C]-Phenylacetic acid (Aldrich) (4.21)was prepared in high yield 
using a solution of diazomethane in diethylether, generated from Diazald. After 
purification over silica the methyl ester (4.22) was reduced with a suspension of lithium 
aluminium deuteride in ether. Analytically pure [l-'^C^HjJ-phenylethanol (4.23) was 
obtained in high yield after purification over silica. The oxidation of the alcohol to 
[l-'^C^HjJ-phenylacetaldehyde (4.24) gave capricious yields with pyridinium 
chlorochromate and molecular sieves in dichloromethane. However previous experience 
in the group with this reaction had found these to be the optimum oxidative reaction 
conditions, and the yields were sufficient to progress material through the route."' The 
aldehyde was unstable to polymerisation on storage, and was routinely used immediately 
after isolation. The Strecker synthesis of [2-'^C'H'^N]-phenylalanine (4.25) from [1-
'^C^HjJ-phenylacetaldehyde, using an aqueous solution of ['^N]-ammonium chloride 
and potassium cyanide in methanol, was low yeilding. However with commercial 
phenylacetaldehyde (which contains stabihzers) high yields could be achieved. 
Furthermore the volume of water used had to be kept to a minimum, to avoid the 
production of phenyllactic acid and this could be minimised if excess [''N]-ammonium 
chloride was used. Hydi'olysis of the intermediate nitrile required two days reflux in 
concentrated hydrochloric acid. [2-'^C-H]-Phenyllactic acid (4.26) that was produced as 
a byproduct was separated and purified over Dowex (H^) and also used in feeding 
experiments described below. 
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The isotopically enriched signal DL-[2-'^C^H'^N]-phenylalanine in the " C { ' H } and 
"C{'H,='H} NMR are shown below The '"C'^N coupling of 5.9 Hz is clearly seen. A 
" similar labelling pattern is anticipated for carbon-6 of the pyridone ring of tenellin, if 
intact incorporation occurs. 
" C { ' H } N M R 
" C { ' H , 'H}NMR 
J"c?H = 21.8Hz 
J"c"N = 5.9Hz 
T" 
55 
"1 1 r- -I r 
54 53 
chemical shift / ppm 
Figiire 4-18 C-2 of '^C NMR of [2-"C^''N]-phenylalanine 
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4.3.3 Feeding experiments with [2-'^C^H'*N]-phenylaIanine 
DL-[2-"C^H'^N]-Phenylalanine was pulse fed to Beauvaria bassiana cultures to a final 
concentration of 4.5 molar during tenellin production. The resultant tenellin was purified 
and analysed by '^C-NMR. The carbon-13 label had become incorporated into C-6 as 
expected. However there was no evidence of coupling to nitrogen-15 in the carbon-13 
NMR spectrum, or of incorporation of an intact "CD unit (no observed a-shifted 
component). It is clear that the '^ C had become divorced from both '^N and ^H during 
the process. This reinforced the earlier result with [2-^H]-phenylalanine and suggests a 
very facile transamination process operates. Alternatively a mechanism which requires 
these bonds to be broken in an obligate manner may operate. 
(4.25) 
B.bassiana 
tenellin 
Figure4-19 Incorporation of [2-'^C^H''N]-phenylalanine into tenellin 
6 
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Figure 4-20 '^C NMR of tenellin after feeding widi DL-[2-''C^'=N]-phenylalanine 
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It is pertinent to reflect on the early biosynthetic experiments on tenellin. Firstly it had 
been shown that '^N-phenylalanine had become incorporated into teneUin and with the 
same efficiency as '^C-phenylalanine. It had thus been concluded that phenylalanine is 
incorporated with the C-N bond remaining intact.^' A similar conclusion had been drawn 
by Tanabe et alP on the basis of his investigations into the biosynthesis of the fungal 
pyridone ilicicolin, discussed in Chapter 3. They observed '^C-'^N coupling in the '^C-
NMR spectrum of ilicilolin after feeding the cultures with ['^N]-phenylalanine, and 
concluded that phenylalanine was incorporated without prior metabohsm to 
phenylpynivate. 
However in the Ught of the triple labelled experiment with phenylalanine, these 
conclusions were almost certainly overinterpreted. When a large excess of labelled 
precursor is fed to the cells, the niti-ogen pool is almost ceitainly flooded with '^N from 
the labelled phenylalanine, and this can account for the credible incorporation. Razal et 
al.^"^ have shown that during active phenylpropanoid metabohsm in plants, the ammonia 
released by phenylalanine ammonia lyase and tyrosine ammonia lyase is efficiently 
recycled back to phenylalanine and tyrosine with glutamate serving as a shuttle. Clearly 
such a process, or the transamination to phenylpyruvate could be operating in B. 
bassiana. The triple labelhng experiment does not support the intact incoiporation of the 
C-N bond of phenylalanine. 
4.3.4 Feeding experiments with [2-"C^H]-phenyIlactic acid 
In view of the sunilarity of the rearrangement during tenellin biosynthesis to that 
operating during the biosynthesis of tropic acid (Figure 4-12), phenyllactic acid (4.11) 
was investigated as a precursor to tenelhn. Such a process would requke transamination 
of phenylalanine to phenylpyi-uvate (4.10) followed by reduction by a phenylpyruvate 
dehydrogenase, and would account for the loss of ^H and '^N in the earUer experiment. 
Transamination would occur after condensation with the polyketide chain. 
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Figure 4-21 Alternative biosynthetic pathway for tenellin biosynthesis via phenyllactic acid 
[2-'^C^H]-Phenyllactic acid (4.26) was prepared as a byproduct of the synthesis of 
[2-'^C^H'^N]-phenylalanine and was pulse fed to cultures of B. bassiana during tenellin 
production. In the event no incoiporation was observed by '^ C NMR analysis of the 
isolated tenellin. Phenyllactic acid therefore, may be discounted as a true intermediate. 
Furthermore we may conclude from this negative result that Beauvaria bassiana does not 
have the requisite activities to convert phenyllactic acid (4.26) via phenylpyruvic acid 
(4.10), back to phenylalanine, a transformation which does appear to be reversible in the 
Datura species. '^ 
HO 
B.bassiana 
o- — X - ^ 
"O D (4.26) 
OH O 
tenellin 
(4.10) 
NH3* 
phenylalanine 
Figure 4-22 Phenyllactic acid is not incoiporated via phenylpyruvic acid into tenellin 
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4.4 A Reinvestigation of the Intermediacy of Tyrosine 
4.4.1 Feeding experiments with [3-"C]-tyrosine 
In the earlier biosynthetic studies on tenellin '"C labelled tyrosine showed neghgible 
incorporation when compared with the higher incorporation levels observed with '"C-
phenylalanine.^' In reU'Ospect, it is puzzling, that any incoiporation of tyi^ osine should be 
observed at all i f phenylalanine is the true precursor. Tyrosine is considerably less 
soluble than phenylalanine, and the results may have been a result of a solubihty problem 
in its administration to the cultures. In the hght of this, it was judged appropriate to 
repeat this feeding experiment, but with '^ C labelled tyrosine. 
[l-"C]-labelled phenylalanine (4.27) and [3-'^C]-labelled tyrosine (4.28) were 
administered to separate flasks of the same batch of B. Bassiana cultures, and at the same 
concentration (3.5 mM) in the media. Both amino acids required acidification followed 
by readjusting to pH6 to ensure solubility. Purification of the resultant teneUin and '^ C 
NMR analysis cleaiiy showed that both amino acids had become incorporated into 
tenelUn, phenylalanine at 8.5% and tyrosine at 6.1% enrichment. 
HO 
B.bassiana 
NH3* 
tyrosine 
(4.27) 
tenellin 
NH3* 
phenylalanine 
(4.28) 
HO 
B.bassiana 
tenellin 
Figure 4-23 Incorporation of [l-'^C]-phenylalanine and [3-'^C]-tyrosine into tenellin 
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Figure 4-24 '^C NMR of tenellin (a) natural abundance, (b) after feeding with [l-'^CJ-phenylalanine, 
(c) after feeding with [3-'^C]-tyrosine 
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As discussed above, pi/ra-hydroxylation of phenylalanine to tyrosine is well documented 
in the fungi. Thus it may be concluded that phenylalanine is first converted to tyrosine 
prior to involvement in the biosynthesis of tenellin. This result opens a new spectrum of 
plausible intermediates not previously considered for tenellin biosynthesis. It is possible 
that tyrosine condenses direcdy with the polyketide chain to form the tetramic acid 
intermediate as discussed in the previous chapter. Alternatively however, it may 
rearrange prior to condensation with the polyketide chain. Such processes are discussed 
below. 
4.4.2 Para-coumaric acid as a plausible intermediate? 
The widespread occun-ence of cinnamic acids in the biosynthesis of phenylpropanoids 
has led to the suggestion that they may be involved in the biosynthesis of tropic acid and 
tenellin.^^ It has been shown that the epoxycinnamate (4.29), when treated with boron 
trifluoride etherate, undergoes a rearrangement to a-formylphenylthiolacetate (4.30). 
Reduction with sodium cyanoborohydride generated the corresponding tropate ester 
(4.31)." It has been demonstrated that the thiol ester group migrates rather than the 
phenyl group.^ ^ 
\ ^ O 
SPh 
BF3.0Et NaBHsCN 
SPh ^OH 
(4.29) ^ (4.30) 
Figure 4-25 //; vitro rearrangement of the epoxide of cinnamate 
Feeding experiments to tropic acid in Datura species with the putative intermediates, 
cinnamic acid and its epoxide were unsuccessful.^' However no such investigations have 
been reported with Beauvaria bassiana. In the Ught of a role for tyrosine, para-coumaric 
acid (pa/ a-hydroxycinnamic acid) emerged as a plausible intermediate. 
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4.4.3 Synthesis of /?arfl-[2-"C]-coumaric acid and feeding to B. bassiana 
,0H 
H (4.34) 
HOOC 
OH (4.35) '(4.32) ^"(4.33) 
(i) aniline, pyridine, 40°C, (ii) 4-hydroxybenzaldehyde, 65°C, (iii) cone" HCl. 
Figure 4-26 synthesis of [2-'^C]-/;a/a-coumaric acid 
f ara-[2-'"^C]-hydroxycinnamic acid (p<7/a-coumaiic acid) was synthesised via a standard 
Doebner reaction, according to the procedure of Adams and Bockstahler."" 
[2-'^C]-Malonic acid was dissolved in pyridine with a catalytic amount of aniUne, and 
heated over sixteen hours with 4-hydroxybenzaldehyde. Anihne was found to be a 
superior base to piperidine'" for condensations with ortho- and para- substituted 
benzaldehydes. After acidification the crude crystalline product could be purified by 
recrystallisation from ethanol / water. 
An aqueous solution of the sodium salt of pfl/a-[2-'^C]-hydroxycinnamic acid (4.35) was 
prepared by neutralisation of the acid with dilute aqueous sodium hydroxide, for ease of 
admistration to B. bassiana. The solution was pulse fed to the cultures during teneUin 
production to a final concentration of 5 mM. '^ C NMR analysis of the teneUin hai-vested 
and purified after ten days showed no evidence of '^ C enrichment. Thus para-
hydroxycinnamic acid does not appeal" to be an intermediate in the biosynthesis of 
teneUin, ruling out a sequence of events going from tyrosine to para-coumaric acid to 
epoxycinnamate. 
B.bassiana 
0-Na* 
tenellin 
Figure 4-27 /'a/a-[2-"C]-coumaric acid is not incorporated into tenellin 
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4.4.4 Fara-hydroxyphenyllactic acid as a plausible intermediate? 
Although the intermediacy of phenyllactic acid in the biosynthesis of tenellin has been 
discounted, the appai'ent similaiity of the reaiTangement operating during the 
biosyntheses of tenellin and tropic acid remains intiiguing (see Figure 4-12). Now that 
tyrosine has been shown to be a more immediate precursor than phenylalanine, 
para-hydroxyphenyllactic acid or an ester thereof, emerged as candidate substrates for the 
rearranging enzyme. It can be envisaged that tyrosine is transaminated to 
para-hydroxyphenylpyi-uvic acid which on reduction would give 
para-hydi-oxyphenyllactic acid. In an effort to test this hypothesis 
pt/ra-hydi-oxyphenyllactic acid was synthesised in two forms, with deuterium label both 
at the we/a-position of the phenyl ring and also at carbon-2 of the propanoid moiety. 
4.4.5 Syntheses of [meta-^H^]- and [2-^H]- para-hydroxyphenyllactic 
acid 
(i) 9 % DCl , DoO, 80°C, sealed tube 
Figure 4-28 Synthesis of DL -[weto-'HJ- para -hydroxy phenyllactic acid 
DL-[meta-^H2]-para -hydi-oxy phenyllactic acid was synthesised from unlabelled DL-
para-hydroxyphenyUactic acid by acid catalyzed exchange at the aromatic ring according 
to the published procedure of Brink and Jakobs."*' Accordingly, DL-para-
hydroxyphenyllactic acid was heated in a sealed tube with 9% deuterium chloride in 
deuterium oxide at 80°C. Extraction, followed by recrystaUisation from ether, afforded 
the product in approximately 100% yield. 'H NMR confirmed that deuterium exchange at 
the wieto-position was almost quantitative. 
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HO' ^ (4.38) 
(i) NaBD4, H2O 
Figure 4-29 Synthesis of DL-[2-^H]- para -hydroxyphenyllactic acid 
DL-P-^HJ-Pa/a-hydroxyphenyllactic acid was synthesised by reduction of 
/?<3/-a-hydroxyphenylpuruvic acid using sodium borohydride. Although the yields were 
low using ethanol as the solvent, excellent yields could be obtained in aqueous media. 
4.4.6 Feeding experiments with [meta-^H^l- and [2-^H]-para-
hydroxyphenyllactic acid 
B. bassiana cultures were supplemented with [meta-^¥L^-para -hydroxyphenyllactic acid 
(4.37) to a final concentration of 4.5 mM over four days. The resultant tenellin was 
isolated and purified by H P L C and subjected to "H NMR anaysis. It was particularly 
interesting that deuterium incorporation could readily be observed into tenelUn, 
suggesting that this is indeed a true intermediate in the biosynthetic pathway. 
DMSO 
- 1 — . — I — 1 — I — r 
8 7 
- i — I — I — 1 — 1 — r 
6 5 
- p - . . 1 r—1 . r -
3 2 
chemical shift / ppm 
Figure 4-30 NMR of tenellin after feeding with [nieto-^HJ-para-hydroxyphenyllactic acid 
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The results suggest that cai-boxyl gi-oup migration occurs in an analogous manner to 
tropic acid biosynthesis (see Figure 4-13). This may be after esterification with the 
polyketide chain, but prior to ring cyclisation. Altematively another ester may be 
involved (route a, Figui'e 4-31). It cannot however be discounted that that 
poA-a-hydroxyphenyllactic acid is fii'st metaboUsed back to tyrosine (via para-
hydroxyphenylpyioivic acid (4.41), route b) which is then incoi"porated into tenellin. This 
would involve the loss of the hydrogen attached to carbon-2 of pa/-a-hydroxyphenyllactic 
acid 
B. bassiana 
HO H 
teneUin 
HO 
tyrosine 
Figure 4-31 Incorporation of [meto-^HJ- para -hydroxyphenyllactic acid into tenellin 
[2-^H]-Para -hydroxyphenyllactic acid was then pulse fed to B. bassiana cultures, during 
tenellin production, to a final concentration of 5 mM. After isolation and purification of 
the resultant tenellin, analysis by "H NMR did not indicate any deuterium emichment. 
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tenellin 
Figure 4-32 [2--H]-Para -hydroxyphenyllactic acid is not incorporated into tenellin 
The incorporation of the deuterium label from [2-"H]-/?<3rfl-hydroxyphenyllactic acid 
(4.39) would have established /?ara-hydroxyphenyllactic acid as a direct intermediate, as 
metabolism to tyrosine prior to incorporation would result in the loss of this label. Rapid 
transamination to and from tyrosine via para-hydroxyphenylpyruvic acid (route b. Figure 
4-31) may explain some of the loss of deuterium, but if /?a/'a-hydroxyphenyllactic acid is 
a closer intemiediate than tyi'osine it is unlikely that all of the deuterium label would have 
been washed out. However, even though this hydrogen will be retained in a putative 
rearrangement process to (4.40) as illustrated in Figure 4-31, the deuterium may, infact, 
be lost in a later stage of tenellin biosynthesis, during the formation of the pyridone ring 
system. 
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4.4.7 A suggested mechanism for the biosynthesis of the pyridone ring 
As described akeady for phenyllactate in ti'opic acid biosynthesis (Figure 4-13), a P-450 
mediated caitocation or radical reairangement process generates a rearranged aldehyde 
(4.18). A similar- reaiTangement may be envisaged for pfl/-a-hydroxyphenyllactate as 
shown in Figure 4-33. 
HO D HO D 
Figure 4-33 Putative mechanism for the P-450 mediated rearrangement of /?fl/a-hydroxyphenyllactate 
Transamination of the resultant aldehyde (4.44) would fumish the tyrosine isomer (4.45) 
which could condense with the polyketide moiety of tenellin (4.46) giving the reduced 
pyridone ring (4.47) directly. Deuterium should be retained up to this point. 
Dehydi'ogenation to the pyridone ring of tenellin (4.48) would however be 
stereoespecific and therefore may result in the specific loss of the deuterium at position-6 
of the pyridone ring. Hydi^oxylation of the nitrogen of the ring completes the 
biosynthesis. 
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D transaminase 
OH O 
dehydrogenase 
OH O 
N O .. . 
I tenellin 
OH 
Figure 4-34 A biosynthetic pathway for the biosynthesis of tenellin from /pwa-hydroxyphenyllactic acid, 
which fulfils all of the experimental data 
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4.5 Discussion 
Although it remains possible that po/a-hydroxyphenyllactic acid is utilized only after 
metabolism to tyrosine (route b. Figure 4-31) it had previously been shown that no '^C 
enrichment of tenellin was observed from [2-'^C^H]-phenyllactic acid, implying that 
B.bassiana is unable to metabolise this via phenylpyruvic acid to phenylalanine (see 
Figure 4-22). In conti-ast, the incorporation of pa/-a-hydi-oxyphenyllactic acid suggests, at 
the very least, that B. bassiana does recognise and utiUse this substrate in its 
phenylpropanoid metabolism. 
Thus it is concluded that the mechanism elaborated in Figure 4-34 best explains the data 
to date. Fui'ther investigation is required to establish the role of para-hydroxy lactic acid. 
Firstly the relative incorporation levels of po/a-hydioxyphenyllactic acid and tyrosine 
should be compared. Although these may have differing solubiUties and cell 
permeabilities it is likely to give an indication as to which is the closest percursor in 
tenellin biosynthesis. The successful incorporation of 3-amino-2-(pflra-
hydroxyphenyl)propanoic acid (4.45) would provide further evidence for the suggested 
pathway, and this is now a target compound for labelled synthesis. 
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PART 2 
P-AMINOISOBUTYRATE M E T A B O L I S M 
IN 
S T R E P T O M Y C E S SP. 
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5. Aminoisobutyrate Metabolism in Streptomyces sp. 
5.1 Introduction and Background 
5.1.1 Bacterial polyketide biosynthesis 
The Actinomycetes, and particularly the subclass Streptomyces, are soil bacteria which 
are able to produce a great variety of polyketides. These metabolites are generally 
structurally more complex than fungal polyketides due to the utilisation of propionate and 
butyrate units in addition to acetate units during biosynthesis. The incorporation of 
propionate and butyrate results in pendant methyl and ethyl groups respectively attached 
to the polyketide backbone. 
Acetate, propionate, and butyrate units are activated by acyl-CoA carboxylases to give 
malonyl-CoA, methylmalonyl-CoA, and ethylmalonyl-CoA respectively. The synthase 
enzymes are programmed to select each substrate in the correct order, and as the 
polyketide chain is modified by reducing enzymes the methyl and ethyl branches adopt 
either the D or L configuration. 
The malonyl-CoA precursors to the acetate, propionate and butyrate precursors from 
which the polyketide chain is assembled are also derived from the catabolism of various 
primary metabolites. Amino acids, fatty acids and the products of the citric acid cycle are 
known to contribute carbon atoms to the propionate and butyi'ate pools. Once cells enter 
the stationary stage of cell growth primary metabolites are broken down to these essential 
precursors and secondary metabolism can begin. 
5.1.2 Biosynthesis of monensin A 
Monensin-A (5.3) is a polyether antibiotic produced by Streptomyces cinnamonensis. It 
was first isolated in 1967.' Commercially it has been used as an antibiotic in die control 
of coccidiosis in poultry, and in the improvement of feed utihsation in ruminant 
livestock.^ Polyether antibiotics consist of an array of tetrahydrofuranyl and 
tetrahydropyranyl rings, arranged in such a way that like crown ethers they are 
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ionophores, able to complex alkali metals. Their antibiotic activity is derived from this 
ability to complex sodium and potassium ions which results in the disruption of the Na+ 
/ K + balance across bacterial membranes. The polyethers are assembled from acetate, 
propionate and butyrate units, and it was suggested by Westiey^ that microbial 
epoxidation of diene or triene intermediates followed by a cascade cyUsation could 
generate the tetrahydrofuranyl and tetrahydropyranyl rings. 
The carbon atoms of monensin A (5.1) were first shown to derive from five acetate 
(5.2), seven propionate (5.3) and one butyrate (5.4) moiety after feeding experiments 
using '''C-labelled precursors, followed by isolation and degradation of die isotopically 
labelled monensin.'' The methoxyl carbon is derived from subsequent methylation of the 
hydroxyl functionality at C-3, by S-adenosyl methionine. 
monensin A (5.1) 
H O ^ - ^ O H 
Figure 5-1 Monensin A 
Monensin B, a co-product of monensin A from S. cinnamonensis, has a methyl in place 
of an ethyl group at C-16. This aiises as a result of the incorporation of a propionate unit 
in place of butyrate during monensin biosynthesis.' 
Carbon and proton NMR spectra of monensin A have been fully assigned allowing the 
use of '^C and NMR spectroscopy to interpret the results of feeding experiments.^ 
Cane et al, and Robinson et al. performed a series of feeding experiments with '^0 and 
'^C labelled precursors identifying seven out of die eleven skeletal oxygen atoms as 
having their origins in the acetate, and propionate units.^ When monensin A was 
biosynthesised under an atmosphere of '^02 it was found to be enriched at the otiier four 
sites.^ Consistent with the Westiey hypothesis, three of tiiese enrichments can be 
rationalised if monensin assembly proceeds via an all-E-triene precursor (5.5) which 
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undergoes a series of epoxidations utilising molecular oxygen, to form a triepoxide 
(5.6). Attack of the C-5 hydroxyl at the C-9 carbonyl carbon would then initiate the 
cascade of ring closures to generate the polyether rings (Figure 5-2). The oxygen 
attached to C-26 was also shown to derive from atmospheric oxygen.' This 
hydroxylation is thought to be a post assembly modification, as a mutant has been 
isolated which produces 26-deoxymonensin.'° 
O- (5.2) 
O 
vAo- (5.3) ^""^vAo- (5.4) 
5x acetate 7x propionate Ix butyrate 
O O 
cascade cychsation 
ENZS 
HOzC^ \ monensin-A HO OH 
Figure 5-2 Proposal for monensin A biosynthesis from acetate, propionate and butyrate 
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5.2 Links between Primary and Secondary metabolism 
5.2.1 Introduction 
It is well established that the catabolic products of amino acids, fatty acids and the citric 
acid cycle are sources of the acetate, propionate and butyrate units necessary for 
polyketide biosynthesis. However die role of DNA bases in providing these units was 
only recentiy investigated, and is discussed below. 
Studies on candicin production in Streptomyces griseus^^ and methylenomycin 
production in Streptomyces coelicolor^^ have demonstrated that the maximum 
concentration of antibiotic in the culture medium is reached when DNA synthesis ceases 
in the idiophase. It is therefore suggested that catabolic products of DNA may be utilised 
as substrates for secondary metabolism. 
The role of the DNA base tiiymine as a contributor to the methylmalonyl-CoA pool (i.e. a 
precursor to the propionate units) and as a precursor to the butyrate units was fu-st 
investigated by Sarah Rogers.'^ Although the relative importance of tiiymine as a source 
of methylmalonyl-CoA, as compared to other primary metaboUtes, was not investigated, 
it was demonstrated tiiat both thymine and P-aminoisobutyrate are indeed efficiently 
incorporated into the propionate units and also the butyrate units of monensin-A.''' 
Central to the following discussion are the catabolic pathways of L-vaUne and thymine. 
5.2.2 The catabolism of L-valine 
In both mammals and bacteria the amino acid L-valine contributes carbon atoms to the 
methylmalonyl-CoA and ethylmalonyl-CoA pools.'^ The importance of this cataboUc 
pathway has been demonstrated for macrolide biosynthesis in actinomycetes.'* L-Valine 
is catabolised to iso-butyryl-CoA (5.7) which contributes to the metiiybnalonyl-CoA 
(5.12) pool, presumably via the intermediacy of methacrylyl-CoA (5.10). Alternatively 
isobutyryl-CoA (5.7) is isomerised to butyiyl-CoA (5.8) (discussed below), which is 
then activated to ethyhnalonyl-CoA for incoiporation into the polyketide. 
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It is also known that in mammals L-valine is catabolised to (S)-P-aminoisobutyric acid 
by the reversible transamination of S-methylmalonic semialdehyde (5.14),^° as 
summarised in Figure 5-3 below. 
•o,c 
CoAS 
CoAS 
O ^ H (5.14) 
S-P-aminoisobutyric acid 
(in mammals) 
L-valine 
mutase 
CoAS 
CoAS 
CoAS 
CoAS 
T^K O ^ O H (5.12) 
mutase 
SCoA 
HO. 
(5.8) 
602H (5.9) 
butyrate units 
propionate units 
(5.13) 
Figure 5-3 Catabolism of L-valine 
Stereospecific interconversion of isobutyryl-CoA (5.7) and butyryl-CoA (5.8) is 
mediated by the co-enzyme-B^^ dependent isobutyryl-CoA mutase. In an analogous 
manner to metiiylmalonyl-CoA mutase, this intramolecular rearrangement involves 
migration of the carboxyl carbon of isobutyryl-CoA to the 2-pro-S metiiyl group, with 
concomitant back migration of hydrogen, predominantiy into the 3-pro-R position in 
butyrate. (Robinson et al. however, have shown recentiy that there is some loss of 
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stereospecificity in this process.'^) This rearrangement is the pivotal link between straight 
and branched chain fatty acid metabolism in Streptomyces.'^ 
proS 
H3 
H3C^= 
proR H 
SCoA SCoA 
(5.7) (5.8) 
Figure 5-4 Action of isobutyryl-CoA mutase 
The interconversion of die methylmalonyl-CoA (5.12) pool witii succinyl Co-A (5.13) 
mediated by methylmalonyl-CoA mutase'^ also has important implications which wUl be 
considered in the following discussion of previous feeding experiments with isotopically 
labelled precursors. 
5.2.3 The catabolism of thymine 
Thymine (5.15) is catabolised to (2R)-P-aminoisobutyric acid (5.16) in mammalian 
systems as shown below.^ " 
OH 
I 
H 
thymine (5.15) 
H02C>^.aCH3. 
" ^ H 
OH 
N 
CH3 
0 * ' ^ N ' (5R)-dihydrothyniine I 
H 
H02C^ ,^ ' CH3 
.A. 
H 
H2N N p-ureidoisobutyric acid 
(2R)-p-aminoisobutyric acid (5.16) 
HoN 
Figure 5-5 Catabolism of thymine in mammalian systems 
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A small number of microorganisms are known to degi'ade pyiimidines via this reductive 
pathway.^^ P-Aminoisobutyric acid may then be converted to (2S)-methylmalonyl-CoA 
(the activated form of propionate) via transamination to (R)-methylmalonic 
semialdehyde. 
HOaC^CHa 
(2R)-p-amino-
isobutyric acid 
I I CH; I I CH3 
SCoA 
OH 
(R)-methylmalonic (2S)-methylmalonyl- propionate 
semialdehyde CoA units 
Figure 5-6 Pathway from (2R)-p-amino-isobutyric acid to propionate units 
Key mtermediates of tiie thymine and vaUne cataboUc pathways were synthesised by 
Rogers, labelled with '^ C and deuterium and used in feeding experiments to 5. 
cinnamonensis}^ The results of these studies are discussed below. 
5.2.4 The results of previous feeding experiments 
When [methyl- '^C^H3]-thymine was administered to cultures of Streptomyces 
cinnamonensis incoiporation was obsei'ved not only into the propionate but also into the 
butyrate units. 
It was clear from the '^C{'H, ^H} NMR that there was a small peak corresponding to a 
'^C^Hj, a-shifted to higher frequency from the natural abundance peak. This 
corresponds to carbon-33 of monensin A, resulting from the unexpected incorporation of 
a butyi-ate unit, labelled with an intact ^^C'^H^-methyl group. The enrichment was very 
small, (0.2 fold), but significant. The methyl groups derived from the propionate groups 
were also enriched (1-2 fold) but three components could be seen for each methyl group, 
a-shifted due to the attachment of one, two or three deuterium atoms, '^C^H'H^, 
'^C^Hj'H, '^ C^H3, in the ratio 1:2:3. There was clearly a partial loss of deuterium from 
the labelled methyl group occuring en route to the propionate units. 
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Propionate is derived via methylmalonyl-CoA (5.17) and the intramolecular 
rearrangement of (5.17) to succinyl-CoA (5.18), mediated by methylmalonyl-coA 
mutase, is well established. The operation of this enzyme results in hydi'ogen exchange 
and therefore readily explains the loss of deuterium from the methyl group of the 
propionate units. Conversely the intact incoiporation of the ^^C^H^-methyl into the 
butyrate units implies a pathway which does not involve the intermediacy of 
methylmalonyl-CoA. 
CoAS 
O D 
isobutyryl-CoA 
minor 
u u 
N 
H 
thymine 
major 
P(H) 
(H) 
(H) 
CoAS 
SCoA 
methylmalonyl-CoA (5.17) 
(activated propionate unit) 
D 
butyryl-CoA 
D 
D CoAS 
HO 
SCoA 
O DD 
succinyl-CoA (5.18) 
D 
D 
CO2H D 
ethylmalonyl-CoA 
(activated butyrale unit) 
Figure 5-7 Origin of differently labelled propionate and butyrate units from ['^C-Hj-me///}'/]-thymine 
I f thymine is degraded by a reductive pathway in Streptomycetes, similar to that known 
in mammals, it would expected that (3-aminoisobutyrate would be similarly incorporated 
into monesin. This compound was synthesised bearing a '^ C label at the carboxyl group 
and also with a '^ C label at the methyl group, and administered to cultures of 5. 
cinnamonensis. The results were consistent with those for thymine. (R,S)-[3-'^C]-P-
Aminoisobutyrate labelled carbon-4 of the butyrate (1.5 fold) and carbon-3 of the 
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propionate groups (6-7 fold) in monensin A. The aminomethyl group becomes the pro-S 
methyl in isobutyrate. 
thymme 
P-aminoisobutyrate 
minor 
mutase 
CoAS CO2" 
methylmalonyl-CoA 
CoAS CoAS H 
isobutyrate butyrate 
monensin 
HO OH 
Figure 5-8 Incorporation of (R,S)-[3-"C]-P-aminoisobutyrate into monensin A 
(R,S)-[l-'^C]-p-Aminoisobutyrate labelled carbon-16 of monensin (2-3 fold), 
corresponding to carbon-1 of the butyi'ate unit, but was not observed to label the 
propionate units. This is consistent with the pathway outlined for the conversion of 
(3-aminoisobutyrate to propionate via methylmalonyl-CoA, in which the amino-methyl 
carbon of (3-aminoisobutyrate becomes the thioester carbonyl of methylmalonyl-CoA. 
Loss of the original carbonyl by decarboxylation results in loss of the isotope at carbon-
1. 
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*H3N' 
p-aminoisobutyrate 
mutase 
CoAS CoAS H 
isobutyrate 
methylmalonyl-CoA 
HOgC^ \ 
CoAS 
butyrate 
monensin-A 
— OH 
Figure 5-9 Incorporation of (R,S)-[l-"C]-P-aminoisobutyrate into monensin A 
Intermediates on tiie L-valine catabolic pathway, sodium (R,S)-[3-'^C]-isobutyrate and 
sodium [mer/jy-'^CJ-methaciylate were also synthesised and administered to S. 
cinnamonensis cultures. (R,S)-Sodium [3-'^C]-isobutyrate was shown to emich cai-bon-
3 of all the propionate groups by a magnitude of 2.5 fold and carbon-2 and cai-bon-4 of 
the butyrate groups to a magnitude of 9 fold relative to tiie natural abundance signals. 
This is consistent with tiie catabolic pathway discussed for L-vaUne. Both carbon-2 and 
carbon-4 of the butyrate group in monensin A were emiched as the sodium [3-'^C]-
isobutyrate used was a racemic mixture, half the molecules having the pro-R methyl 
labelled and half the pro-S metiiyl labelled. 
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o 
mutase 
SCoA - / ^ SCoA 
H 
^ O 
f \ l \ mutase 
* SCoA 9r ^ SCoA 
H 
Figure 5-10 Action of mutase, resulting in differently labelled butyrate groups 
'^C NMR analysis of the monensin-A isolated after feeding with sodium [methyl-^^C]-
methacrylate showed carbon-3 of the propionate groups to be enriched by about 1.4 fold, 
and carbon-4 of the butyrate group of monensin A to be also enriched by a magnitude of 
4.3 fold relative to the natural abundance signals. Methacrylyl-CoA must therefore be 
reduced in a stereospecific manner as previously described^" to (R)-[3-'^C]-isobutyryl-
CoA, followed by isomerisation to [4-'^C]-butyryl-CoA. Sodium [l-'^C]-methacrylate 
similarly showed incorporations into carbon-1 of the propionate groups with a 1 fold 
enrichment and into carbon-1 of the butyrate groups with about 3 fold enrichment relative 
to natural abundance signals. These results indicate that methacrylate is a true 
intermediate in valine catabolism in S. cinnamonensis, and that the interconversion of 
isobutyryl-CoA and methacrylyl-CoA is reversible. Methaciylate would appear to have 
been incorporated into p-hydroxyisobutyrate in Pseudomonas pudda and the lalselling 
observed in the propionate units in monensin A suggest a simlar pathway in 
Streptomyces cinnamonensis. Of significance also, is the observation that isobutyrate 
and methacrylate feeding experiments give similar partition ratios for butyrate to 
propionate incorporation, approximately 3.5 : 1. This is consistent with the exogenously 
added materials intercepting the same metabohc pathway. Fuithermore these labeUing 
patterns ai'e consistent with those observed for (3-aminoisobutyrate. 
A further question remains as to the route by which (3-aminoisobutyric acid is 
incorporated into the butyrate unit of monensin-A. The above results indicate that 
methylmalonyl-CoA is not an intermediate, but rather that a more direct pathway, 
possibly via methacrylyl CoA to isobutyryl-CoA is operating. If this is the case then 
alternative pathways can thus be envisaged as shown in Figure 5-11. 
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• Route A, in which P-aminoisobutyi-ate is deaminated directiy to metiiacrylate. This is 
attractive as it is a non redox process. (R)-P-Aminoisobutyrate, the catabolic product 
of thymine, could be the substrate for such a putative deaminase. However no 
P-aminoisobutyrate deaminase has been reported. 
• Route B would proceed via metiiyknalonylsemialdehyde. This would be tiie reverse 
process of L-valine cataboUsm to (S)-P-aminoisobutyrate which occurs in mammals 
(Figure 5-3). 
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L-valine 
mutase O 
CoAS^ 
CoAS 
CoAS 
CoAS 
butyrate units 
9 (R),(S) 
O^'^SCoA 
(R),(S) 
mutase 
propionate units 
Figure 5-11 Links between thymine and valine catabolism and the propionate and butyrate units 
The above figure summarises the Unks already established between thymine and L-vaUne 
cataboUsm and incorporation of the cataboUc products into monensin-A. 
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5.3 Investigations to Delineate between Route A and Route B 
5.3.1 The proposed strategy 
In order to deUneate between routes A and B, DL-[3-'^C-H2]-P-aminoisobutyric acid 
(5.22)was synthesised, and administered to 5. cinnamonensis. Action of tiie deaminase 
enzyme on [3-'^C^H2]-p-aminoisobutyric acid wiU generate metiiacrylate in vivo, witii 
retention of both deuterium atoms attached to the '^C. Thus carbon-2 of butyrate would 
have a '^ C^H2 label. Alternatively for route B only a single deuterium atom would be 
retained, as one deuterium atom would be lost duting oxidation of P-aminoisobutyrate to 
methylmalonyl semialdehyde. 
A compUcation immediately emerges however, as C-2 of butyrate, when incorporated 
into monensin-A, becomes C-16 of the antibiotic, a quatemary carbon, having lost both 
attached deuterium / hydrogen atoms from the precursor. However S. cinnamonensis 
also produces isopalmitic acid, an iso-C^^ fatty acid which utilises isobutyryl-CoA as its 
starter unit. Analysis of incorporation of [3-'^C'HJ-P-aminoisobutyric acid into tiie 
starter unit of this fatty acid, rather tiian monensin A, should aUow us to verify whetiier 
one or two deuterium atoms are retained, and thus deUneate between pathways A and B. 
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monensin-A 
Route A 
ACoS 
Route -n CoAS 
D D/H 
mutase 
iso-Ci6 fatty acid 
Figure 5-12 Incorporation of DL-[3-''C-H2]-P-aminoisobutyric acid via route A into iso-Ci^ fatty acid and 
monensin-A 
'^C-( 'H, -H} NMR of the fatty acid extract can be used to distingish between these 
routes. I f both deuterium atoms are incorporated, an a-shift for the enriched methyl 
carbon con-esponding to two directiy bonded deuterium atoms will be observed (route 
A). If the pathway proceeds via route B then an a-shift coiresponding to only one 
directiy bonded deuterium atom will be observed. The coupUng patterns observed in the 
' ^ C - { ' H } NMR spectrum will further distinguish between incorporation of an '•'C^Hj 
group or an '^C^H group. GCMS analysis of the fatty acid methyl esters (FAMEs) was 
used in the study, although there was concern at the outset that the anticipated low 
incorporations may be less than the threshold detection level for the M-i-2 peaks (due to 
natural abundance '^C) by this method of analysis. Enrichment of the M-i-3 peaks may 
however be observable. 
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5.3.2 Culture maintenance of Streptomyces cinnamonensis 
Production media of S. cinnamonensis were inoculated from frozen samples of 
production medium and ceU growth was evident after a few days. Altiiough monensin 
production was capricious branched chain fatty acids were consistentiy produced and it 
was possible to continue with these cultures for die DL-[P-'^C^H2]-p-aminoisobutyric 
acid feeding experiment. 
5.3.3 Isolation of lipids from Streptomyces cinnamonensis 
The production media was were first centiifuged and tiie pellet was washed tiioroughly 
with phosphate buffer (pH7) before tiie Upid fraction was extracted. This was to ensure 
that aU of the intracellular Upids were isolated, and the extraceUular Upids discarded. 400 
MHz 'H NMR showed a clear doublet (0.8 ppm) corresponding to tiie terminal metiiyl 
groups of the branched lipids. 
5.3.4 Analysis of the fatty acids by GCMS 
Although GCMS proved too insensitive a technique to detect isotope incorporation 
accurately in the fatty acid fraction, it was used to confirm the presence of the iso-C^^ 
lipid. The Upids first had to be prepared for analysis as metiiyl esters of the fatty acids 
(FAMEs). This required removal of the fatty acid chains from tiieir triglycerides by 
saponification of the lipids with saturated KOH in metiianol, foUowed by esterification 
with acidified metiianol. 
Mass spectroscopy under EI mode gave no observable molecular ion but comparison of 
tiie fragmentation patterns with Ubrary mass spectra confirmed tiie presence of metiiyl 
esters of fatty acids with a branched terminus. CI mode ionisation assigned two peaks 
from the gas chromatogi-aph to have M" of 270, (C„02H34). Comparison with tiie EI 
spectra confirmed that the first of tiiese to elute off the gas chromatography column was 
the iso-C,6 fatty acid (isopalmitate). Sti-aight chain palmitate eluted soon afterwards. 
The M-i-2 ion of the isopalmitate peak was 3-5% of tiie natural abundance M-i-1 peak. To 
estabUsh unambiguously accurate incorporation of deuterium alone would therefore 
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require at least 5% incoiporation of the precursor into the fatty acid. However previous 
feeding experiments resulted in incorporations of only 4%, and thus the incorporations 
are below the rehable detection threshhold. 
5.3.5 Assignment of the methyl groups for isopalmitate in the "C NMR 
It was important at the outset to assign unambiguously the resonance in the '^ C NMR of 
the fatty acid extract corresponding to the methyl groups of the isobutyryl-CoA starter 
unit of iso-C16 fatty acid. This was achieved by a feeding experiment with sodium 
[3-'^C]-(R,S)-isobutyrate (5.19) which was pulse fed to 5. cinnamonensis production 
medium cultures early in the growth cycle to a final concentration 10 mM. The isolated 
fatty acid extract was analysed by '^ C NMR, and incorporation of the label was clearly 
seen at 22.67 ppm as shown in Figure 5-14. A very high enrichment of the methyl 
groups of the branched chain fatty acid was observed with the peak height approximately 
30 times greater than the natural abundance peak. The methyl esters of this fatty acid 
extract were also analysed by GCMS. An impressive 50% labelUng of the M-i-1 peak of 
isopalmitate was observed. 
5. cinnamonensis ) 0 -< 
O" 
(5.19) 
Figure 5-13 Incorporation of sodium [3-''C]-(R,S)-isobutyrate into isopalmitate 
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Figure 5-14 Section of the '^C NMR of the fatty add extract from S. cinnamonensis fed with sodium 
[3-'^C]-(R,S)-isobutyrate 
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5.3.6 Synthesis of DL-P-^^C^^HJ-p-aminoisobutyric acid 
The syntiietic route developed for DL-P-'^C'HjJ-P-aminoisobutyric acid (5.22) is 
shown in below. 
O 
1,11 
(5.20) '^^^ (5.21) 
65% i l l 
IV 
t 
O 
OH 
(5.22) 
(i)Na2C03, C H 3 C N , r.t., 3h, (u )K13CN , KOH, HjO, 65-80°C, 4h, HCl(aq), 
(iii) D 2 , PtOj in MeOD-CDClj (10 : 1), 1 atm, r.t., 18h, (iv) H+ Dowex. 
Figure 5-15 Synthesis of DL-[3-"C-HJ-P-aminoisobutyric acid 
a-Bromopropionoic acid (5.20) was first converted to its sodium salt, then treated with 
an excess of potassium ['^C]-cyanide in potassium hydroxide solution to yield [2-'^CN]-
a-cyanopropanoic acid (5.21). The latter reaction gave only impure product as a yeUow 
oil, and in a moderate 41% yield. The major impurity (7%) was the starting material, a-
bromopropionoic acid. A minor impurity (2.5%), detectable by NMR, was a-
hydi'oxypropionic acid foirned by hydroxide ratiier tiian cyanide substitution. The yield 
of desired product could not be increased by extending tiie reaction time or increasing tiie 
temperature. To maximise the ratio of product to starting material successive syntheses 
were attempted using increased ratios of potassium cyanide to sodium a-
bromopropionate. A ratio of 1.2 : 1 (mol : mol) gave a much improved yield of about 
60%. Increasing the ratio of potassium cyanide to sodium a-bromopropionate even 
higher to 1.5 : 1 (mol : mol) gave a product with much increased purity, but reduced 
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yield. Thus it was decided to settie for a lower yield (50%) to obtain the product with 
only a small amount of starting material present. This crude product oil was then reduced 
using deuterium gas and PtOj as a catalyst at room temperature in deuterated solvents. 
With non-deuterated solvents hydrogenation rather than deuteration occuired, indicating 
that the reaction proceeds by a process in which solvent hydrogens are labiUsed by the 
catalyst. After purification by Dowex (H* form), impurities were still present in the oil. 
These could be removed by recrystalUsation in ethanol affording essentially pure DL-[3-
^^C^HJ-P-aminoisobutyric acid (5.22). 
5.3.7 Feeding of DL-[3-"C^H3]-(3-aminoisobutyric acid to 5 . 
cinnamonensis lipids 
DL-[P-'^C"HJ-P-Aminoisobutyric acid (5.22) was pulse fed to S. cinnamonensis 
production medium cultures to a final concentration of 5 mM, early in the growth cycle 
as the fatty acids are produced during the trophophase. '^C{'H} NMR of the fatty acid 
extract isolated from the cultures showed no observable a-shift associated with the '^ C 
resonance at 22.7 ppm. No enrichment of the peak at 22.7 ppm was observed either, as 
would be expected from incorporation of '^ C with loss of both deuteriums. '^ C { 'H, } 
NMR of the fatty acid extract further confirmed that there was no observable 
incorporation of a '^C^H group, and there was no observable difference between the 
'^C{'H, ^H} NMR and the '^C{'H} NMR spectra (Figure 5-16). 
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Figure 5-16 Section of the NMR of fatty acids extract from S.cinnamonensis fed with DL-[P- '^C^2]-
P-aminoisobutyric add. 
The absence of incorporation was somewhat unexpected, particularly as DL-[3-'^C^H2]-
P-aminoisobutyric acid had previously been incorporated into the butyrate unit of 
monensin A at about 4%. The experiment was repeated using a higher concentration of 
DL-[p-'^C^H2]-P-aminoisobutyric acid (lOmmolar), but again no incorporation was 
observed. The methyl esters of tiie fatty acid extracts fed with DL-[p-'^C^H2]-P-
aminoisobutyric acid were analysed by GCMS. A tentative 4.5% labelling of the M-i-2 
peak was observed, but this value is not within the expected limits of exfjerimental error 
for such analyses. 
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5.3.8 Feeding of sodium [l-^'C]-methacrylate to 5. cinnamonensis 
Monensin-A is produced in the idiophase when cell growth is established, and it is at this 
stage that many of the primaiy metabolites produced in the trophophase are catabolised to 
provide the building blocks for construction of the secondary metabolites. As sodium 
[l-'^C]-methacrylate was shown previously to be a source of the butyrate units in 
monensin A, it was also pulse fed to production medium cultures of 5. cinnamonensis 
early in tiie growth phase to establish whether earUer intermediates in the proposed 
pathway can be incorporated into the iso-C^^ fatty acid. 
Sodium [l-'^C]-methacrylate (5.23) was pulse fed to S. cinnamonensis production 
medium cultui-es to a final concentration of 6.5 mM, on days 0 to 3. '^C{'H} NMR of 
the fatty acid extract isolated from the cultures showed a clear enrichment (12%) at 38.03 
ppm, as expected from labelling of the methylene adjacent to the isopropyl group of 
isopalmitate. This result suggests that the enzymes responsible for catalysis of the 
pathway ai"e expressed in the trophophase. However incoiporation levels of earUer 
intermediates may be too low to be observable. Thus another approach had to be taken to 
resolve this issue and this is discussed in the next section. 
K 
/ o-
(5.23) 
5. cinnamonensis 
Figure 5-17 Incorporation of sodium [l-"C]-methacrylate into isopalmitate 
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Figure 5-18 '^C NMR of fatty acids extract from 5. cinnamonensis fed with with (a) sodium [3-''C]-
methacrylate (5.23), and (b) natural abundance. 
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5.4 Studies with bkd negative Streptomyces avermitilis 
5.4.1 Biosynthesis of the avermectins 
The avermectins are a group of 16-membered macrolide polyketide metabolites produced 
by Streptomyces avermitilis, a gram positive filamentous soil bacteria. They consist of 
eight distinct, yet closely analogous stnictures, which can be subdivided into two groups 
of four. Group A generally predominate in bacterial fermentation and are derived from 
0-methylation at C-5 of the group B metabolites. They contain a spiroketal (C-17 -
C-25), a feature common to many polyethers, as weU as a 16-membered lactone, 
reminiscent of the macroUde antibiotics. 
OCH3 
Avermectin 
Ala: R ' = C H 3 , R2 = C2H5, X - Y - C H = C H 
Alb: = = C H 3 , X - Y = C H = C H 
A2a: R ' = CH3, R ' = C2H5, X - Y = CH2-CH(0H) 
A2b: R^ = R^ = CH3, X - Y = CH2-CH(0H) 
Bla: R ' = H , R2 = C2H5, X - Y = C H = C H 
Bib: R^ = H , R ' = CH3, X - Y - C H = C H 
B2a: R^ = H , R ^ = C2H5, X - Y = CH2-CH(0H) 
B2b: R ' = H , R2 = C H 3 , X - Y = CH2-CH(0H) 
Figure 5-19 Structure of avermectins 
Despite their apparent stractural similaiities to the macrohde antibiotics e.g. tylosin, the 
avermectins appear- to exhibit no antibacterial or antifungal activity. However they ai^ e 
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among the most potent anthelmintic, insecticidal and acaricidal compounds known. 
Avermectin B,^ is greater than 95% effective against gastrointestinal nematodes and 
lungworms of cattle at a single oral dose of 0.1 mg / kg, and is effective against 
hookworms of dogs at 0.005 mg / kg." 
As confmned by incoiporation experiments with '^ C and '^ 0-acetates and propionates, 
the polyketide backbone is derived from seven acetate and five propionate units, 
extended from an a-branched chain fatty acid starter unit starter unit.^" Incorporation of 
S(-i-)-a-methylbutyric acid gives rise to the major subgroup (a) and incorporation of 
isobutyric acid gives rise to the minor subgroup (b). 
5.4.2 Sources of a-branched chain fatty acids 
The primary metabolic route to the a-branched chain fatty acid starter units S(+)-a-
methylbutyric acid and isobutyric acid, is the cataboUsm of the amino acids L-isoleucine 
and L-valine. This involves the action of branched-chain amino acid transaminase, 
followed by a branched chain a-keto acid dehydi-ogenase (BCDH) reaction. Branched 
chain fatty acids may also aiise from branched chain a-keto acids produced by de novo 
synthesis. This is summaiised in Figure 5-20. 
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H3C 
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I 
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a-Methylbutyryl-CoA H O 
Degradation Pathway 
Propionyl-CoA 
Methylmalonyl-CoA 
Degradation Pathway 
Acetyl-CoA 
Propionyl-CoA 
Methylmalonyl-CoA 
Acyl-CoA branched-chain fatty acid 
[Acyl-CoA synthetase] 
Exogenous branched-chain fatty acid 
Figure 5-20 Pathways of L-valine and isoleucine catabolism and their relationship to avermectin 
biosynthesis 
The branched-chain a-keto acid dehydrogenase (BCDH) complex is a multienzyme 
complex composed of four functional components: a BCDH and decarboxylase (Ela 
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and EIP), a dihydrolipoamide acyltransferase (E2), and a dihydroUpoamide 
dehydrogenase (E3). The BCDH complex catalyzes the oxidative decarboxylations of a-
keto-isovalerate, a-keto-P-methylvalerate and a-ketoisocaproate (the deamination 
products of valine, isoleucine and leucine), generating the coiTesponding acyl-CoA 
analogs and NADH. 
5.4.3 Mutagenesis of S. avermitilis 
In order to test whether the degradative pathways for the 2-oxo acid analogues of 
isoleucine, leucine and valine provide the precursor acids requked for avermectin 
biosynthesis, a mutant strain of Streptomyces avemitilis was isolated after chemical 
mutagenesis, in the Central Research Division of Pfizer. This mutant contained no 
functional branched chain a-keto acid dehydrogenase (BCDH) activity.^^ In contrast to 
its parent it was unable to grow with either a mixture of L-isoleucine, valine and leucine, 
or their a-keto derivatives, as sole cai'bon sources. The mutant grew nearly as well as the 
parent strain on glucose minimal medium or rich medium. Importantly it was incapable 
of synthesising natural avermectins in media lacking both S(+)-2-methylbutyric acid and 
isobutyric acid. Production of the conesponding four natural aveimectins could be 
restored by supplementation with either of these acids. Thus it was concluded that 
branched chain 2-oxo acid degradation is not absolutely essential for acetate and 
propionate production, and that these precursors may be obtained from other sources, for 
example succinyl-CoA. Appai^ ently this activity uniquely supplies the branched-chain 
fatty acid starter units. Again, supplementation with R(-)-2-methylbutyric acid yielded 
the novel isomeric aveirnectin, and several analogues of branched chain fatty acids have 
been shown to be similarly used by the mutant strain to synthesise novel avermectins^ .^ 
Many of these new precursors are unlikely to be degraded to acetate and propionate 
lending support to the conclusion above that the cells can make these acids by at least one 
other route. 
In order to understand fuither the relative impoitance of the BCDH-catalyzed reaction as 
a source of precursors for natural avermectin production, and to manipulate the 
production of these antibiotics, the gene cluster bkdFGH encoding the E l a. El (3 and E2 
components of an BCDH complex from 5. avemitilis has subsequently been cloned and 
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characterised. Deletion of the genomic region compiising the 5' end of bkdF resulted in 
the construction of a mutant, which exhibited a typical Bkd- phenotype: it lacks El 
BCDH activity, and has accordingly lost the ability to grow on solid minimal medium 
containing L-isoleucine, leucine and vaUne as sole carbon source and is consequently 
unable to make the natural aveimectins, or branched chain fatty acids.^ ^ Supplementation 
of the fermentation media with either one of these compounds restores production of the 
corresponding avermectin, bearing the isopropyl or (S)-i'ec-butyl group at C-25. This 
M'c/F-disrupted strain is stable and can be used to generate and study the production of 
novel C-25 substituted antiparasitic avermectins in a large selection of avermectin 
production strains. 
5.4.4 Thymine as a source of isobutyrate in avermectin biosynthesis? 
Accordant with the studies witii Streptomyces cinnamonensis, we predicted the catabohc 
products of tiiymine would provide an alternative source of isobutyrate in otiier 
Streptomyces species. |3-Aminoisobutyrate should therefore be a precursor to 
isobutyrate, the staiter unit in aveiTnectin (b) biosynthesis. Feeding expeiiments with 
isotopically labelled P-aminoisobutyrate to S. aveimitilis bkd mutant cultures became 
attractive as incorporation levels should be high. There will be no competition from 
unlabelled isobutyrate produced as a result of the cataboUsm of L-valine. Branched chain 
fatty acids produced by these mutants could also be analyzed for isotopic eniichments. 
Analysis of either the branched-chain iso-fatty acids or the avermectins after 
supplementation of the mutant cultures with DL-[3-'^C-H2]-p-aminoisobutyrate would 
enable us to differentiate between the two possible routes of incorporation: route A, 
implicating a deaminase enzyme or route B, proceeding via methylmalonylsemialdehyde. 
Incorporation of either a '^C^H unit or a '^C^H2 unit could be determined by GCMS 
analysis. 
5.4.5 Feeding experiments to bkd-negative 5. avermitilis 
The following feeding expeiiments were performed by Dr Hamish McArthur at Pfizer 
Centi-al Research Division, Groton, USA. GCMS analysis was undertaken by Dr Kevin 
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Reynolds at the Department of Pharmaceutical Science, University of Maryland, 
Baltimore. 
Two flasks were innoculated with DL-[3-'^C-H2]-P-aminoisobutyrate to a concentration 
of 8.5 mM at the beginning of avermectin production, and the cultures were grown for 
15 days, 29°C, 200rpm. Sample 1 was isolated from a culture grown in production 
medium. Sample 2 was isolated from a cultuie grown in paiticulate free production 
medium. These cultui-e media were not free from potential precursors to branched chain 
fatty acids. For this reason a small level of iso-fatty acid and avermectin production is 
observed. However the levels of production are negligible, and production of the fatty 
acids and avermectins due to conversion of the putative intermediates administered to 
branched-chain fatty acid starter units would be expected to be considerable. In the event 
avermectin production was veiy low and only the fatty acid extracts were analysed for 
isotopic enrichments from DL-[3-'^C^H2]-P- aminoisobutyrate. 
5.4.6 Analysis of the fatty acids 
After work-up, both fatty acid extracts were converted to their methyl esters (FAMEs) 
for analysis by GCMS. 
Two methods of MS anaysis were employed, a is more sensitive and therefore more 
accurate. 
• a. MS was sweeping 240-280 AMU 
• b. MS was sweeping 50-250 AMU 
Significant incorporations were observed as evinced by the M-i-2 peaks of both 
isomyristate (/5-o-Ci4 fatty acid) and isopalmitate (iso-Ci^ fatty acid). There was no 
obvious increase in labelling of the M+1 peak for these fatty acids. Increase in labelling 
of the M-i-3 peaks could be attributed solely to natural abundance '^ C labelling of the 
M+2 species. 
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M-i-2 labelling of M-t-2 labelling of 
isomyrisate * isopalmitate * 
Sample 1 29% (a) 12% (a) 
28% (b) 15% (b) 
Sample 2 12% (a) 14% (a) 
14% (b) 15% (b) 
* % values above natural abundance from reference spectra. 
It is clear from these results that [S-'^C^HJ-P-aminoisobutyrate has been incorporated 
into the isobutyrate starter unit of the fatty acids, bearing only one deuterium atom 
attached to the '^C. Enrichments were observed solely in die M-i-2 peak resulting from 
the incorporation of a '^C'H unit. This result is inconsistent with the action of a 
deaminase enzyme (route A) converting P-aminoisobutyrate directiy to methacrylate. 
Rather the results strongly support route B. Thus it would appeal" that p-
aminoisobutyrate is first oxidised to methylmalonyl semialdehyde, resulting in the loss of 
one deuterium atom, and then reduced to P-hydroxyisobutyric acid. This is die reverse of 
the pathway known to occur in mammalian L-valine catabolism.^ ^ 
O o ° 
^"Y" -O^ S^  - C O A S - - ^ 
* H 3 N ' ' ^ D 
(5.22) 
O ^ D 
(R), (S) 
CoAS 
CoAS 
iso-fatty acids 
Figure 5-21 Route B: incorporation of P-aminoisobutyrate into fatty acids 
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5.5 Discussion 
These results illustrate the potential of studies with mutant microorganisms when the 
incoiporation levels of putative inteirnediates are expected to be low. The low level of 
iso-branched chain fatty acid production obsei-ved in this experiment however indicates 
that the pathway from P-aminoisobutyrate to isobutyrate is a very minor one. Thus it 
may be concluded that the catabolic products of thymine are unlikely to be major 
contributors to the isobutyrate and butyrate pools. The low enrichments observed into 
monensin may largely be due to overloading die cells witii p-aminoisobutyrate, thus 
forcing the metabolism along an 'unnatural' pathway. According to the results of the 
Central Research Division of Pfizer, no natural aveimectins or branched chain fatty acids 
are produced by die mutant sti-ain of S. avermitilis unless die media is supplemented with 
the branched chain fatty acids starter units. Thus it appears there is normally no 
contribution from the thymine degradation route. It remains a possibility however that the 
production of monensin in S. cinnamonensis utilises these intermediates to a greater 
extent. 
Despite the modest incorporations the experiment clearly distinguished between the two 
proposed routes, A and B, and rule out die the action of a novel deaminase enzyme. The 
alternative pathway, which appears to be in operation, via methyhnalonyl semialdehyde 
requires transamination of P-aminoisobutyrate, followed by reduction to P-
hydroxyisobutyric acid and is die longer pathway of die two. However, diis is die 
reverse of the pathway occuring in mammalian vaUne catabolism. It is of interest tiiat the 
end product of this pathway is (S)-P-aminoisobutyrate, whereas (R)-P-aminoisobutyrate 
is produced as the product of diymine catabohsm in mammals. Presumably in 
Streptomyces both these enantiomers may be converted to methylmalonyl semialdehyde, 
allowing a link between the two catabohc pathways. Two separate enzymes may be 
involved. An altemative possibility is diat only die (R)-enantiomer, from thymine 
catabolism is processed. It would be interesting to repeat die experiments widi 
enantiomerically pure samples of p-aminoisobutyrate. 
The discussion so far has considered only die possibiMty of the reductive cataboUsm of 
thymine. A relatively small number of microorganisms are known to degrade 
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pyrimidines along this pathway.^ '* Only Hydrogenomonas facilis "^and Candida iitilis 
'^are thought to utilise the carbon atoms from this degradative pathway. The results 
indicate that a degi'adative pathway from thymine to P-aminoiosbutyrate is also occuring 
in Streptomyces. However the operation of an oxidative catabohc pathway cannot be 
excluded. Uracil and thymine ai-e known to be oxidised to barbituric acid and 5-
methylbarbituric acid respectively by ui-acil dehydrogenase in bacteria able to grow 
aerobically. The thymine oxidising enzymes appear to be induced by growth on 
thymine.^^ Barbituric acid can further be degraded to urea and malonic acid by the action 
of barbiturase. The fate of 5-methylbarbituric acid is unknown. It is unaffected by the 
action of bai-biturase, but a similai- degradation to ui-ea and methylmalonic acid may 
occur. This pathway would also account for the obseived incorporations from thymine 
into the butyrate and propionate units of monensin. Incoiporation of intermediates such 
as dihydrothymine from the reductive pathway are needed to test this. 
The incorporation of both P-aminoisobutyrate and thymine suggest a reductive pathway, 
however. The products of this pathway may be used in Sd-eptomyces sp. as precursors 
to the propionate butyrate units. This is summai'ised below in Figure 5-22. 
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Figure 5-22 Suggested pathway for thymine catabolism in Streptomyces sp. and incorporation of 
catabolic products into butyrate and propionate units of polyketide metabolites 
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6. Experimental 
6.1 General 
NMR spectra were recorded on Varian Gemini 200 MHz spectrometer ( IH at 199 977 
MHz, 13C at 50.30 MHz), Vaiian XL-200 ( IH at 200.057 MHz), Varian VXR 400(S) 
( I H at 399.952 MHz, 13C at 100.577 MHz), Bruker AMX 500 ( IH at 500.137 MHz, 
13C at 125.759 MHz, 2H at 76.775 MHz), and Varian VXR-600 (University of 
Edinburgh) (13C at 150.869 MHz). Chemical shifts are quoted relative to TMS standard 
(6=0). IR spectra were recorded on a Perkin-Elmer F. T. 1720X or 1600 spectrometer, 
or Perkin Elmer Paragon 1000 (Golden Gate single reflection). Low resolution mass 
spectra were recorded on a VG Analytical 7070E Organic mass spectrometer. High 
resolution mass spectra were recorded on a VG-ZAB specti-ometer. HPLC analysis and 
purification was accomplished using a Varian Star 9012 solvent deUvery pump, and 
peaks recorded on a Varian Star 9050 variable wavelength UV-VIS detector. LCMS 
analysis was recorded on a fmnagan Matt MS TSQ700 or 7000 and samples were 
injected using a Gilson autosampler with a Hewlett Packard 1050 pump. Separations 
were over a Hypersil C-18 BDS-protected reverse-phase column (5|im, 250 x 4.6mm). 
Melting points were determined using a digital Gallenkamp melting point apparatus and 
are uncorrected. Solvents were routmely dried and distilled prior to use: tetrahydrofuran 
and diethylether (sodium benzophenone, under nitrogen), dichloromethane (calcium 
hydride), ethanol and methanol (dry magnesium tuming, iodine). Reactions requiring 
anhydrous conditions were carried out under a nitrogen atmosphere. Flash 
chromatography was accompUshed over Fluka silica gel-60 (35-70 |im) or Sorbsil-C60-
H (40-60 lam). 
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PARTI 
6.2 Production, Isolation and Analysis of Tenellin 
6.2.1 Growth of Beauvaria bassiana 
The teneUin producing culture of Beauvaria bassiana (Bals.) Vuill. (No 110.25), was 
obtained from die CBS culture collection, Oosterstrat, Delft, Netherlands. Growth was 
initiated onto com meal agar plates from seven day old production cultures, and die 
plates incubated at 20°C, after which the cultures were initiated into seed media before 
subculturing into a production media. 
Routinely, growth of B. bassiana was initiated by transfer of an aUquot of seven day old 
frozen production medium (2mL) into a 250mL Erlenmeyer flasks containing sterile 
production medium (50mL). This flask was shaken for seven days at 200rpm, 32°C in 
the dark. The resultant culture was used to initiate a batch of 250mL Erlenmeyer 
production medium flasks, each containing production medium (50mL), by the transfer 
of 2mL aliquots, and the cultures incubated under the same conditions for seven days. 
New production media flasks were subcultured from seven day old production medium 
flasks. 
6.2.2 Seed medium 
To distilled water (990mL) was added glucose (20g), ammonium tartrate (4.6g), 
K H 2 P O 4 (l.Og), MgS04.7H20 (0.5g), NaCI (O.lg), CaCl, (O.lg) and a mineral ion 
solution (lOmL) containing CuSO^ (39.3mgL'), B(0H)3 (5.7mgL'), 
{m^\Mo^O^^.AU^O (3.68 mgL ' ) , MnSO^.Hp (6.1mgL-'), ZnS04 .7H20 (879mgL-') 
FeS04.7H20 (99.6mgL"'). The pH was adjusted to 7.0 prior to steriUsation. Portions 
(50niL) were sterUised in 250mL Erlenmeyer flasks, plugged with cotton wool. 
6.2.3 Production medium 
To distilled water (990mL) was added D-mannitol (50g), KNO3 (5.0g), KH^PO^ (l.Og), 
MgS04.7H20 (0.5g), NaCl (O.lg), CaCl^ (O.lg), FeSO .^TH^O (20mg) and a mineral 
ion solution (lOmL) containing CUSO4.5H2O (40mgL'), B(0H)3 (6.0mgL'), 
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(NH,)^Mo^02,.4H^O (4.0mgL '), MnSO .^H^O (7.5mgL '), ZnS04.7H20 (880mgL'). 
50mL portions were sterilised in 250 mL Erlenmeyer flasks plugged with cotton wool. 
6.2.4 Isolation and purification of tenellin 
The mycelia were obtained by centrifugation (45,000rpm, 45min, 4°C), washed with 
distilled water and exhaustively extracted into acetone in a soxhlet extractor. The yellow 
acetone extract was reduced to an orange soHd residue in vacuo and re-dissolved into 
dichloromethane. This was repeatedly washed with brine to remove sugars and other 
water solubles. 10% aqueous HCl was added to assist separation of the layers. The 
organic phase was dried (MgS04), filtered and evaporated in vacuo and the remaining 
yellow solid residue triturated with hexane to remove the hpids. Filtration afforded crude 
teneUin (30-50mg per flask) as a yellow solid. TeneUin could be purified by reverse 
phase HPLC (methanol: water, 85 : 15,0.1% trifluoroacetic acid). 
6.2.5 Analysis of tenellin 
TeneUin was dissolved in DMSO-Dg for 'H and ''C NMR, DMSO for 'H NMR. 
5H(DMS0-Dg, 399.96 MHz) 0.80 (3H, t, J 7.6, CH3), 0.96 (3H, d, J 6.7, CH3), 1.32 
(2H, m, C H 2 ) , 1.83 (3H, s, CH3), 2.49 (IH, m, CH), ), 5.96 (IH, bd, J 9.6, CH), 
6.76 (2H, d, J 8.8, 2x CH), 7.28 (2H, d, J 8.8, 2x CH), 7.51 (IH, d, J 15.2, CH), 
7.89 (IH, d, J 15.2, CH), 8.15 (IH, s, CH), 9.52 (IH, s, OH), 11.73 (IH, bs, OH), 
16.98 (IH, s, OH). 
5D(DMSO, 76.774 MHz, natural abundance) 0.77 (bs, CH3), 0.85 (bs.CHj), 1.27 
(bs,CH2). 
6c(DMSO-D6, 100.58MHz) 11.8 (CH3), 12.4 (CH3), 19.9 (CH3), 29.4 (CH^), 34.6 
(CH), 105.9 (C), 110.9 (C), 115.0 (2xPh), 122.7 (C), 123.1 (CH), 130.3 (2xPh), 
132.6 (C), 140.3 (CH), 149.9 (CH), 151.1 (CH), 156.9 (COH), 157.5 (CO), 173.1 
(COH), 193.8 (CO). 
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6.3 Synthesis of Putative Polyketide Intermediates 
6.3.1 N, N'-Dipropionylcystamine (2.26) 
Propionyl chloride (20g, 216mmol) was added dropwise, to an ice cooled solution of 
cystamine dihydrochloride (22.5g, lOOmmol) in HjO (20mL). Throughout the addition 
of propionyl chloride the reaction mixture was maintained above pH 8.2, by the addition 
of 12.5M KOH solution (35g of KOH in 50mL of H^O). The resulting white precipitate 
was collected by vacuum filtration and washed thoroughly with cold water. After drying, 
the white solid of N,N'-dipropionyl cystamine (14.27g, 54.38mmol, 54.4%) was stored 
in the dessicator; m.p. 97-98°C; SHCCDCI,) 1.17 (4H, t, J 7.6, C H 3 ) , 2.26 (4H, q, J 
7.6, CH2), 2.84 (4H, t, J 6.5, CH^), 3.58 (4H, dt, J 6.3 and 5.8, CH^), 6.32 (2H, bs, 
NH); ScCCDCy 10.31 (CH3), 30.03 (CH^), 38.32 (CH^), 38.90 (CH^), 175.09 (CO) 
v^„(nujol)/cm-' 3258, 3058, 1620, 1543; m/z (CI) 265 (M+1, 23.94%), 134 (100%). 
6.3.2 3% Sodium amalgam 
Distilled mercury (430g, 2.14mol) was carefully di'opped onto small pieces of sodium 
(13g, 0.56mmol) under an atmosphere of N j . The reaction was kept hot, to maintain 
continuous reaction by heating with a bunsen burner. The hot hquid was poured into a 
glass dish and cut up into small pieces before the sodium amalgam cooled and solidified 
as a solid block. 
6.3.3 N-Propionyl cysteamine (2.27) 
3% Sodium amalgam (43g) was added to a solution of N,N'-dipropionyl cystamine 
(4.39g, 16.7mmol) in dry methanol (lOOmL) under N j , and the reaction mixture stirred 
for 90 minutes at room temperature. The remaining mercury was removed by filtration, 
and the resulting liquid added to dilute HCl and extracted into dichloromethane. Drying 
(MgS04) and concentration of the dichloromethane extract afforded N-propionyl 
cystamine (2.07g,15.7mmol, 47%), a colourless oil. 5H(CDC13) 1.02 (3H, t, J 7.7, 
CH3), 1.34 ( I H , t, J 9.4, SH), 2.12 (2H, q, J 7.6, CH^), 2.54 (2H, dt, J 8.4 & J 5.5, 
CH2), 3.29 (2H, dt, J 7.9 and J 6.2, CH2), 7.30 ( IH, bs, NH); 5c(CDCl3) 10.35 
(CH3), 24.91 (CH2), 29.99 (CH^), 42.91 (CH,), 174.94 (CO); v^,(neat)/cm ' 3297, 
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3079, 3078, 2977, 2937, 2878, 2549(w), 2240(w), 1644, 1547, 1233, 911, 732; nVz 
(EI) 134 (M+1, 100%). 
6.3.4 Diethyl 2-ethyI-2-methyImaIonate (2.21) 
A suspension of sodium hydride (940mg, 36mmol) in tetrahydrofuran (20mL) was 
prepared from sodium hydride dispersion in mineral oils (1.5g), by extraction of the 
mineral oils into tetrahydrofuran. Diethyl malonate (3.76g, 20mmol), and methyl iodide 
(2.84g, 20mmol) were cai-efuUy added to this under nitrogen at 20°C. The solution was 
heated under reflux for 2 hours, cooled to room temperature and quenched with ethanol 
(lOmL). The cleai- brown solution was added to water (20mL), and extracted into 
dichloromethane (2x 25mL). The combined organic extracts were dried (MgS04), 
reduced in vacuo to yield an orange oil, which was distilled under vacuum giving a 
colourless oil, dietiiyl 2-ethyl-2-metiiyhnalonate, (b.p. 50°C, O.lmbar, 2.20g, 
10.9mmol, 54%). 6H(CDC13) 0.63 (3H, t, J 6.0, C H 3 ) , 1.00 (6H, t, J 7.1, 2x C H 3 ) , 
1.13 (3H, s, C H 3 ) , 1.67 (2H, q, J 6.0, CH^), 3.93 (4H, t, J 7.1, 2x CH,). 8 ^ ( 0 0 0 3 ) 
8.8 ( C H 3 ) , 14.2 (2x C H 2 ) , 19.4 ( C H 3 ) , 28.7 (CH,), 54.2 (C), 61.1 (2x CH^), 172.3 
(CO) v„,^ (neat)/cm-' 2981, 2935, 1736, 1465, 1380, 1310; m/z (CI) 203 (M+1, 100%). 
6.3.5 2-EthyI-2-methylinalonic acid (2.22) 
Diethyl 2-ethyl-2-methylmalonic acid (1.70g, 8.41mmol) was dissolved in aqueous 
potassium hydi'oxide (40mL, IM) and the solution heated under reflux for 24 hours. 
After cooling to room temperature the solution was acidified by the dropwise addition of 
concentrated hydrochloric acid, and extracted into diethyl ether (5x lOOmL), dried 
(MgS04), and the ether removed in vacuo yielding a white waxy solid, 2-ethyl-2-
methylmalonic acid, (1.13g, 7.74mmol ,92%). 5H(D20) 0.70 (3H, t, J 7.5, CH3), 1.24 
(3H, s, CH3), 1.71(2H, q, J 7.5, CH,). 
6.3.6 Sodium 2-methylbutyrate (2.23) 
2-Methyl-2-ethylmalonic acid (0.70g, 4.79mmol) was taken up in demineralised water 
(lOmL) and transferred to a carius tube. The contents of the tube were frozen, the air 
evacuated and the tube sealed. The tube was heated in a steel bomb at 180°C for 3 hours. 
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After cooUng the contents of the tube were acidified with dilute sulphuric acid, 
lyophaUsed to purify the product acid. The lyophilisate was adjusted to pH 8 with dilute 
aqueous sodium hydroxide and freeze dried to yield an amoiphous white solid, sodium 
2-methylbutyrate, (0.49g, 3.95mmol, 82%). m.p. 249.4°C; 5H(D20) 0.72 (3H, t, J 7.0, 
C H 3 ) , 0.91 (3H, d, J 7.0, C H 3 ) , 1.27 (2H, m, CH^), 2.08 ( IH, q, J 7.0, CH); d^iDfi) 
14.4 ( C H 3 ) , 20.3 ( C H 3 ) , 30.2 (CH^), 47.6 (CH), 190.2 (CO). 
6.3.7 N-Propionyl cysteainine-2-methylbutyrate (2.29) 
Sodium 2-methylbutyrate (0.30g, 2.42mmol) was dissolved in distilled H^O (5mL), 
acidified with dilute HCl and extracted into diethyl ether (5x 50mL). The ether extracts 
were dried (MgS04), filtered and reduced in vacuo to give 2-methylbutyric acid, (0.24g, 
97%) as a yellow oil. To a solution of 2-methylbutyric acid (0.20g, 2.0mmol) in dry 
etiier (25mL), was added 1,3-dicyclohexylcarbodiimide (0.4 Ig, 2.0mmol), 
4-dimethylaminopyiidine (0.24 g, 2.0mmol) and N-propionyl cysteamine (0.40g, 
3.0mmol), and tiie reaction mixture was stirred under N , at room temperature for 12 
hours. The white precipitate formed was removed by filtration and discarded, and the 
filtrate concentrated and purified over silica gel (chloroform: ethyl acetate, 70 : 30). The 
active fractions were combined and concentrated to afford N-propionylcysteamine-2-
metiiylbutyi-ate (0.43g, 1.99mmol, 98.9%) as a colourless oil. This was stored in an 
evacuated flask at 4°C. 5H(CDC13) 0.82 (3H, t, J 7.6, C H 3 ) , 1.05 (3H, t, J 7.4, C H 3 ) , 
1.06 (3H, d,J 8.3, CH3), 1.50 (2H, dm, J 7.6, CH^), 2.14 (2H, q, J 7.2, CH^), 2.50 
( I H , m, CH), 2.95 (2H, t, J 6.8, CHj), 3.34 (2H, dt, J 8.0 and 6.0, CH^), 6.3 ( I H , 
bs, NH); 5c(CDCl3) 10.2 (CH3), 12.0 (CH3), 17.6 (CH3), 27.6 (CH^), 28.5 (CH,), 
30.0 (CH2), 40.1 (CH2), 50.6 (CH), 174.6 (CO), 204.2 (CO); v^Jneat) / cm ' 3293, 
3076, 2971, 2935, 2877, 2360 (w), 2341 (w), 1690, 1650, 1546, 1461,1231, 936, 
755; m/z (CI) 218 (M+1, 44.69%), 190 (22.95%), 134(38.44%); Found 218.1214, 
C10H20O2SN (M+1) requires 218.1215. 
6.3.8 Diethyl [2-we//i>'/-^H3]-2-ethyl-2-inethylnialonate (2.21) 
Sodium hydride (1.49g, 62.08mmol), diethyl ethylmalonate (6.49g, 34.49mmol), and 
[^HjJ-methyl iodide (5.0g, 34.39mmol) were used to prepare diethyl [l-methyl-'Vi^-l-
ethyl-2-methylmalonate by the method described for diethyl 2-ethyl-2-methylmalonate. 
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The product was distilled under vacuum as a colourless oil (b.p. 50°C, O.lmmHg, 
3.55g, 17.30mmol, 51%). 5H(CDC13) 0.80 (3H, t, J 6.0, CH3), 1.18 (6H, t, J 7.1, 2x 
CH3), 1.81 (2H, q, J 6.0, CH^), 4.10 (4H, t, J 7.1, 2x CH^); 5c(CDCl3) 9.1 (CH3), 
14.5 (2x CH2), 22.3 (m,CD3), 28.8 (CH2), 54.2 (C), 61.4 (2x CH^), 172.3 (CO). 
6.3.9 [2-Afer;i^/-'H3]-2-ethyl-2-methylmalonic acid (2.22) 
Diethyl [2-me%/-^H3]-2-ethyl-2-methylmalonate (3.50g, 17.05mmol) was dissolved in 
aqueous potassium hydroxide (80mL, IM) and the esters hydrolysed and isolated as 
described for 2-ethyl-2-methylmalonic acid, yielding a white waxy solid, [2-methyl-
^H3]-2-ethyl-2-methylmalonic acid (2.33 g, 15.63 mmol ,92%). ^^(^^0) 0.69 (3H, t, J 
7.5, CH3), 1.71 (2H, q, J 7.5, CH2). 
6.3.10 Sodium [2-/ne/M-^H3]-2-methylbutyrate (2.23) 
[2-mer/j>'/-^H3]-2-ethyl-2-methylmalonic acid (2.33g, 15.63mmol) was decarboxylated 
as described for sodium 2-methyl-butyrate, yielding a white crystalUne solid, sodium [2-
mer/j>'/-^H3]-2-methylbutyrate, (1.63g, 12.79mmol, 82%). m.p. 249.0°C; 5H(D20) 0.70 
(3H, t, J 7.5, CH3), 1.27 (2H, m, CHj), 2.08 ( IH, bq, J 7.5, CH). 5c(D20) 14.4 
(CH3), 19.5 (m, CD3), 30.1 (CH2), 47.3 (CH), 190.2 (CO). 
6.3.11 N-Propionyl cysteamine-[2-me/;i^;-^H3]-2-methylbutyrate (2.29) 
Sodium [^H3-me%/]-2-methylbutyrate (1.61g, 13mmol) was dissolved in distilled HjO 
(20mL), acidified with dilute HCl and extracted into diethyl ether (5x lOOmL). The ether 
extracts were dried (]VIgS04), filtered and reduced in vacuo to give ^Yi^-methyl]-!-
methylbutyric acid (1.23g, 93%) as a yellow oil. To a solution of ^'W^-methyiyi-
methylbutyric acid (1.16g, llmmol) in dry ether (50mL), was added 1,3-
dicyclohexylcarbodiimide (2.27g, llmmol), 4-dimethylaminopyridine (1.34 g,llmmol) 
and N-propionyl cysteamine (1.85g, 14mmol), and the reaction mixture was stirred 
under at room temperature for 12 hours. The white precipitate formed was removed 
by filtration and discarded, and the filtrate was concentrated and purified over sUica gel 
(chloroform : ethyl acetate, 70 : 30). The active fractions were combined and 
concentrated to afford N-propionylcysteamine-[^H3-we%/]-2-methylbutyrate (2.07 g. 
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9.39mmol, 85%) as a colourless oil. This was stored in an evacuated flask at 4°C. 
V C D C y 0.91 (3H, t, J 7.4, C H 3 ) , 1.14 (3H, t, J 7.6, C H 3 ) , 1.60 (2H, m, CH^), 
2.20 (2H, q, J 7.7, CH^), 2.55 ( IH, bm, CH), 3.03 (2H, t, J 6.3, CH,), 3.44 (2H, dt, 
J 6.5 and J 5.9, CH^), 6.35 ( IH , bs, NH); 5c (CDCL3) 10.2 ( C H 3 ) 12.0 ( C H 3 ) , 16.5 (m, 
C D 3 ) , 27.0 ( C H 2 ) , 28.6 (CH,), 30.0 (CH,), 40.1 (CH^), 50.1 (CH), 174.7 (CO), 
203.7 (CO); v„„(neat) / cm ' 3292, 3076, 2967, 2933, 2877, 2227 (w), 2070 (w), 
1687, 1653, 1547, 1461,1231, 999, 872; m/z (CI) 221 (M+1, 85.91%), 134 (23.57%); 
Found 221.1403, CioHi^DjO^SN (M+1) requires 221.1406. 
6.3.12 Ethyl 3-oxopentanoate (2.31) 
A solution of Meldi-um's acid (43.24g, 300mmol) in dried and distilled pyridine (60mL) 
was added dropwise to a solution of piopionyl chloride (27.76g, 300mmol) in dried and 
distilled dichloromethane (125mL) at 0°C. This was left stirring at room temperature for 
16 hours. The orange/red solution was poured into 2M hydrochloric acid (300mL), the 
lower layer separated and washed with distilled water (5x lOOmL) and the organic layer 
was diied (Na2S04), and reduced in vacuo yielding a brown oil which was refluxed in 
dry edianol (200mL) for 5 hours. The ethanol was removed //; vacuo and die product 
purified by distillation to give ethyl-3-oxo-pentanoate as a colouriess oil, (b.p. 100°C, 
20mmHg, 31.14g, 216mmol, 72%). 8H(CDC13) 1.08 (3H, t, J 7.3, C H 3 ) , 1.28 (3H, t, J 
7.2, C H 3 ) , 2.59 (2H, q, J 7.2, CH^), 3.46 (2H, s, CH^), 4.18 (2H, q, J 7.3, CHj); 
5c(CDCl3) 7.8 ( C H 3 ) , 14.4 ( C H 3 ) , 36.6 (CH^), 49.3 (CH^), 61.6 (CH^), 167.7 (CO), 
203.8 (CO); v^Jneat)/cm-' 2981, 2941, 2907, 1744, 1716, 1622, 1312, 1249, 1159; 
m/z (EI) 145 (M+1, 100%), 99 (21.57%), 57 (66.05%). 
6.3.13 Ethyl 3-oxo-2-methylpentanoate (2.32) 
Ethyl 3-oxo-pentanoate (5.04g, 35mmol) was added to a stirred solution of sodium 
ethoxide (2.38g, 35mmol) in dried and distilled ethanol (50mL) at 13°C. The solution 
was heated under reflux for 10 minutes, then methyl iodide (4.97g, 35mmol) was added 
dropwise, and the solution heated under reflux for a further 16 hours. After cooling the 
ethanol was removed in vacuo and the mixture added to diethyl ether (50mL), filtered to 
remove all insolubles, and reduced in vacuo. The yellow oil was purified by bulb to bulb 
distillation yielding a cleai- oil, ethyl 3-oxo-2-methyl pentanoate, (b.p. 95°C, 15mmHg, 
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3.70g, 23.4mmol, 67%). 6H(CDC13) 1.08 (3H, t, J 7.3, CU,), 1.27 (3H, t, J 7.2, 
CH3), 1.34 (3H, d, J 7.2, CH3), 2.58 (2H, m, CH^), 3.54 ( IH , q, J 7.3, CH), 4.19 
(2H, q, J 7.3, CH2); 5c (CDCI3) 7.76 (CH3), 12.86 (CH3), 14.05 (CH3), 34.70 (CH^), 
53.00 (CH), 61.32 (CH,), 170.74 (CO), 206.57 (CO); v„„(neat)/cm-' 2983, 2941, 
1743, 1715, 1195; m/z (El) 159 (M+1, 61.15%), 113 (29.25%), 57(100%). 
6.3.14 Ethyl 2,4-dimethyl-3-oxohexanoate (2.33) 
A slurry of sodium hydride (0.96g, 24mmol) in tetrahydrofuran (40mL) was prepared 
and stirred under nitrogen for 10 minutes at 0°C. To this ethyl 2-methyl-3-oxohexanoate 
(3.16g, 20mmol) in tetrahydrofuran (lOmL) was added dropwise, at 0°C. Ten minutes 
after addition was complete a 1.6M hexane solution of butyUithium (15mL) was added, 
and the mixture stirred for 10 minutes at 0°C. To this bright yellow solution was added 
ethyl bromide (2.62g, 24mmol) in tetrahydrofuran (4mL), and stirring continued at room 
temperature for 30 minutes. The reaction was quenched with 10% hydrochloric acid 
(40mL), the organic layer separated, and washed with brine. The aqueous layer was 
further extracted into ether (2x 40mL), washed with brine, and the combined organic 
layers reduced in vacuo . The resulting yellow oil was distilled under vacuum to give 
ethyl 2,4-dimethyl-3-oxohexanoate as a cleai- oil, (b.p. 45°C, 0.2mmHg, 2.60g, 
14mmol, 69.8%). 5H(CDC13) 0.88 & 0.87 (3H, 2 xt, J 7.4, CH3), 1.10 & 1.09 (3H, 2 
xd, J 6.9, CH3), 1.26 (3H, t, J 7.1, CH3), 1.32 & 1.31 (2H, 2 xd, J 7.2), 1.2-1.7 (2H, 
m, CH2), 2.70 ( IH , m, CH), 3.68 & 3.67 (1H,2 x q,J 7.0, CH), 4.19 (2H, q, J 7.2, 
CH2); v„„ (neat)/cm-' 2970, 2938, 2877, 1744.53, 1714, 1460, 1196; m/z (EI) 187 
(M-i-1, 100%). 
6.3.15 Ethyl 2,4-dimethyl-3-hydroxyhexanoate (2.34) 
Ethyl 2,4-dimethyl-3-oxohexanoate (1.86g, lOmmol) in dried and distilled ethanol 
(3mL) was added to a solution of sodium borohydride (0.19g, 5mmol) in dried and 
distilled ethanol (30mL) at 0°C. The mixture was stirted at 0°C for 30 minutes. Excess 
sodium borohydride was destroyed by the addition of 10% hydrochloric acid (lOmL). 
The reaction mixture was reduced in vacuo to half the volume, and the product isolated 
by extraction with diethyl ether (3x 30mL), dried (MgSOJ, and reduced in vacuo. The 
product was purified over silica (ethyl acetate : hexane, 25 : 75), and alumina (ethyl 
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acetate : hexane 25 : 75) to give a colourless oil, ethyl 2,4-dimethyl-3-hydroxyhexanoate, 
(0.94g, 5mmol, 50%). 6^ ( C D C I 3 ) 0.8-1.4 ( I I H , m, 3x C H 3 , CH,), 1.26 (3H, t, J 7.2, 
C H 3 ) 2.6 ( I H , bs, OH), 3.58 ( IH, m, CH), 4.10 (2H, q, J 7.2, C H 2 ) ; v„„(neat)/cm-' 
3500 (br), 2963, 2935, 2877, 1731, 1715, 1461, 1377, 1185; m/z (EI) 189 (M+1, 
71.18%), 171 (100%). 
6.3.16 Ethyl (E).2,4-diniethyl-2-hexenoate (2.35) 
Ethyl 2,4-dimethyl-3-hydroxyhexanoate (376mg, 2.0mmol) was added to a mixture of 
aluminium ethoxide (324mg, 2.0mmol) and aluminium chloride (133.4mg, l.Ommol) in 
tetrahydrofuran (lOmL) under nitrogen. The heterogenous mixture was stirred at room 
temperature for 30 minutes. Lithium diisopropylamide was prepared in a nitrogen 
flushed dry flask from 1.6M butyllithium solution in hexane (3.75mL, 6.0mmol), and 
diisopropylamine (0.79mL, 6.0mmol). Tetrahydrofuran (6niL) was added to give a I M 
solution, which was transfen'ed to the heterogenous reaction mixture. The temperature 
was raised to 65°C for 1 hour. On cooling the resulting cleai- orange solution was 
quenched with 10% aqueous hydrochloric acid (20mL), diluted with diethyl ether 
(80mL), and the organic layer dried (MgS04) and reduced in vacuo yielding a yellow 
oil. This was chromatographed over silica (hexane : diethyl ether, 90 : 10) to give the 
desired unsaturated ester, ethyl (E)-2,4-dimethyl-2-hexenoate as a yellow oil, (0.15g, 
0.88mmol, 44%). 5H(CDCL3) 0.84 (3H, t, J 7.3, C H 3 ) , 0.99 (3H, d, J 6.7, C H 3 ) , 1.26 
(3H, t, J 7.1, C H 3 ) , 1.38 (2H, m, CH,), 1.83 (3H, d, J 1.4, C H 3 ) , 2.38 ( IH, m, CH), 
4.18 (2H, q, J 7.4, CH,), 6.50 ( IH, dq, J 10.7 and 1.4, CH); 5c(CDCl3) 11.8 ( C H 3 ) , 
12.5 ( C H 3 ) , 14.2 ( C H 3 ) , 19.6 ( C H 3 ) , 29.6 (CH), 34.8 (CH^), 60.3 (CH^), 126.5 (C), 
147.8 (CH), 168.4 (CO); v ^ , (neat)/cm-' 2961, 2931, 2873, 1711, 1649, 1271, 1238, 
734. 
6.3.17 (E)-2,4-Dimethyl-2-hexenoic acid (2.36) 
Ethyl (E)-2,4-dimethyl-2-hexenoate (lOOmg, 0.59mmol) was added to a solution of 
sodium hydroxide (300mg) in methanol (3mL). The solution was heated under reflux for 
5 hours, cooled and acidified with 10% aqueous hydrochloric acid. The product was 
extracted into ether (5 x 50mL), dried (MgS04), filtered and reduced in vacuo, to give a 
yellow oil (E)-2,4-dimethyl-2-hexenoic acid (0.07g, 0.50mmol, 84%). 5H(CDC13) 0.82 
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(3H, t, J 7.3, C H 3 ) , 0.97 (3H, d, J 6.7, C H 3 ) , 1.35 (2H, m, CH,), 1.81 (3H, d, J 1.4, 
C H 3 ) , 2.40 ( I H m, CH), 6.66 ( IH, dq, J 10.1 & 1.4, CH); 8 ^ ( 0 0 0 1 3 ) 12.4 ( C H 3 ) , 
12.4 ( C H 3 ) , 20.0 ( C H 3 ) , 30.0 ( C H 2 ) , 35.6 (CH), 126.2 (C), 151.1 (CH), 174.8 (CO); 
Vn,ax(neat)/cm-' 3408 (b), 2960, 2929, 2873, 2657, 1686, 1644, 1457, 1420, 1290, 
1280, 1218; m/z (EI) 143 (M+l, 64.17%), 125 (100%). 
6.3.18 N-Propionyl cysteamine-(E)-2,4-dimethylhexenoate (2.37) 
1,3-Dicyclohexylcarbodiimide (144mg, 0.70mmol), 4-dimethylaminopyridine (86mg, 
0.70mmol) and N-propionylcysteamine (145mg, l.lmmol) were added to a solution of 
(E)-2,4-dimethylhexenoic acid (lOOmg, 0.70mmol) in dry ether (6mL). The reaction 
mixture was stirred under dry N , at room temparture for 12 hours. A white precipitate 
formed which was removed by filtration and discarded. The filtrate was concentrated and 
the resultant oil was puiified over silica (chloroform : ethyl acetate, 70 : 30). The active 
fraction were combined and concentrated to give a waxy solid, N-propionyl cysteamine-
(E)-2,4-dimethyl hexenoate (113mg, 44mmol, 63%). NOE Studies confirmed this to be 
the (E) isomer. 5H(CDC13) 0.80 (3H, t, J 7.0, CH3), 0.95 (3H, d, J 6.5, CH3), 1.07 
(3H, t, J 7.5, CH3), 1.31 (2H, m, CH^), 1.81 (3H, d, J 1.2, CH3), 2.13 (2H, dt, J 7.5 
& 6.5, CH2), 2.38 ( IH , m, CH), 3.00 (2H, t, J 6.5, CH^), 3.20 (2H, q, J 7.0, CH^), 
6.10 ( I H , bs, NH), 6.46 ( IH, dq,J 9.6 & 1.2, CH); 5c(CDCl3) 9.7 (CH3), 11.8 (CH3), 
12.5 ( C H 3 ) , 19.4 ( C H 2 ) , 28.3 ( C H 3 ) , 29.5 (CH,), 33.9 (CH), 35.0 (CH,), 39.6 (CH^), 
134.5 (C), 147.4 (CH), 174.0 (CO), 194.2 (CO); v„„ (neat)/cm-' 3318, 3075, 2970, 
2927, 2874, 2851, 1656, 1547, 1437, 1241, 1035, 879; m/z (CI) 258 (M-^1 100%), 
125 (62.76%); Found C,3H2402NS (MH+) 258.1527, requires 258.1528. 
6.3.19 Ethyl [2-»i^/^3'/-^H3]-3-oxo-2-methylpentanoate (2.32) 
Ethyl 3-oxo-pentanoate (9.95g, 69mmol) was added to a stin-ed solution of sodium 
ethoxide (4.70g, 69mmol) in dried and distilled ethanol (lOOmL) at 13°C. The solution 
was heated under reflux for 10 minutes, then [^H3]-methyl iodide (lOg, 69mmol) was 
added dropwise, and the solution heated under reflux for a further 16 hours. After 
cooling the ethanol was removed in vacuo and the mixture added to diethyl ether 
(lOOmL), filtered to remove all insolubles, and reduced in vacuo. The yellow oil was 
purified by bulb to bulb distillation yielding a clear o i l , ethyl [2-methyl-^Hj]-3-o\o-2-
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methyl pentanoate, (b.p. 97°C, 15mmHg, 8.20g, 50.87mmol, 74%). 5H(CDC13) 1.05 
(3H, t, J 7.3, CH3), 1.24 (3H, t, J 7.1, CH3), 2.52 (2H, m, CH^), 3.48 ( IH, bs, CH), 
4.17 (2H, q, J 7.2, CH^); 5c(CDCl3) 7.5 (CH3), 11.9 (CD3), 13.9 (CH3), 34.5 (CH^), 
52.2 (CH), 61.1 (CH2), 170.5 (CO), 206.3 (CO); v^(neat)/cm-' 2982, 2941, 1743, 
1715, 1189; m/z (EI) 162 (M+1, 100%), 116 (23.65%), 57(68.08%). 
6.3.20 Ethyl [2-/ne//i3'/-^H3]-2,4-diinethyl-3-oxohexanoate (2.33) 
A slurry of sodium hydride (1.44g, 60mmol) in teti-ahydrofuran (lOOmL) was prepared 
and stirred under nitrogen for 10 minutes at 0°C. To this ethyl [2-mer//3'/-^H3]-2-methyl-
3-oxohexanoate (8.06g, 50mmol) in tetrahydrofuran (25mL) was added dropwise, at 
0°C. Ten minutes after addition was complete of 1.6M hexane solution of butyUithium 
(38mL) was added, and the mixture stiired for 10 minutes at 0°C. To this bright yellow 
solution was added ethyl bromide (6.54g, 60mmol) in teti-ahydi-ofuran (lOmL), and 
stirring continued at room temperature for 30 minutes. The reaction was quenched with 
10% hydrochloric acid (lOOmL), the organic layer separated, and washed with brine. 
The aqueous layer was further extracted into ether (2x lOOmL), washed with brine, and 
the combined organic layers reduced in vacuo. The resulting yellow oil was distilled 
under vacuum to give ethyl [2-wer/2}'/-"H3]-2,4-dimethyl-3-oxohexanoate as a clear oil, 
(b.p. 43°C, 0.2mmHg, 5.85g, 30.91mmol, 62%). 5H(CDC13) 0.82 & 0.82 (3H, 2 x t, J 
7.4, C H 3 ) , 1.03 (3H, m, C H 3 ) , 1.20 (3H, t, J 6.9, C H 3 ) , 1.2-1.7 (2H, m, CH,), 2.63 
( IH , 2 X q, J 6.8 CH), 3.60 & 3.57 (1H,2 x bs, CH), 4.11 (2H, q, J 7.2, CH,); v ^ , 
(neat)/cm ' 2968, 2937, 2877, 1745, 1714, 1461,1237, 1186; m/z (EI) 190 (M+1, 
100%). 
6.3.21 Ethyl [2-/nef/i3'/-^H3]-2,4-dimethyl-3-hydroxyhexanoate (2.34) 
Ethyl [2-me//2>'/--H3]-2,4-dimethyl-3-oxohexanoate (5.85g, 30.9mmol) in dried and 
distUled ethanol (lOmL) was added to a solution of sodium borohydride (0.585g, 
15.5mmol) in dried and distilled ethanol (90mL) at 0°C. The mixture was stirred at 0°C 
for 30 minutes. Excess sodium borohydride was destroyed by the addition of 10% 
hydrochloric acid (30mL). The reaction mixture was reduced in vacuo to half the 
volume, and the product isolated by extraction into diethyl ether (3x lOOmL), dried 
(MgS04), and reduced in vacuo. The product was purified over silica (ethyl acetate : 
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hexane, 25 : 75), and alumina (ethyl acetate : hexane 25 : 75) to give a colourless oil, 
ethyl [2-/7re%/--H3]-2,4-dimethyl-3-hydroxyhexanoate, (3.60g, 18.82mmol, 61%). 
6H(CDC13) 0.41-0.90 (6H, m, 2x C H 3 ) 1.10-1.80 (4H, m, 2 x C H , 1 x C H 2 ) , 1.22 
(3H, t, J 7.1, C H 3 ) , 2.6 ( I H , bs, O H ) , 3.58 ( I H , m, C H ) , 4.10 (2H, q, J 7.2, C H 2 ) ; 
v„„(neat)/cm-' 3501 (br), 2966, 2935, 2876, 1717, 1464, 1374, 1184, 1034; m/z (EI) 
192 (M+l, 87.69%), 174 (100%). 
6.3.22 Ethyl [2-/ne/M.'H3]-(E)-2,4-dimethyl-2-hexenoate (2.35) 
Ethyl [2-mef/j3'/-^H3]-2,4-dimethyl-3-hydroxyhexanoate (3.60g, 18.8mmol) was added 
to a mixture of aluminium ethoxide (3.05g, 18.8mmol) and aluminium chloride (1.25g, 
9.41mmol) in tetrahydrofuran (lOOmL) under nitrogen. The heterogenous mixture was 
stirred at room temperature for 30 minutes. Lithium diisopropylamide was prepared in a 
nitrogen flushed dry flask from 1.6M butyllithium solution in hexane (35.3mL, 
56.5mmol), and diisopropylamine (7.40mL, 56.5mmol). Tetrahydrofuran (50mL) was 
added to give a I M solution, which was transferred to the heterogenous mixture above. 
The temperature was raised to 65°C for 1 hour. On cooling the resulting clear orange 
solution was quenched with 10% aqueous hydrochloric acid (150mL), diluted with 
diethyl ether (300mL), and the organic layer dried (MgS04), reduced in vacuo yielding a 
yeUow oil. This was chromatographed over silica gel (hexane : diethyl ether, 90 : 10) to 
give the desired unsaturated ester, ethyl [2-mer/i>'/-^H3]-(E)-2,4-dimethyl-2-hexenoate as 
a yellow oil, (0.67g, 3.88mmol, 21%). 5H(CDC13) 0.78 (3H, t, J 7.2, C H 3 ) , 0.93 (3H, 
d, J 6.8, C H 3 ) , 1.22 (3H, t, J 7.2, C H 3 ) , 1.34 (2H, m, C H 2 ) , 2.38 ( IH, m, CH), 4.12 
(2H, q, J 7.2, C H 2 ) , 6.47 ( IH, d, J 10.0, CH); 5^  ( C D C I 3 ) 11.9 ( C H 3 ) , 14.3 ( C H 3 ) , 
19.5 ( C H 3 ) , 29.5 (CH), 34.8 ( C H 2 ) , 60.3 ( C H 2 ) , 126.1 (CH), 146.9 (CH), 168.2 
(CO); v„,,(neat)/cm ' 2960, 2928, 2872, 1715, 1697, 1643, 1236, 1152, 727. 
6.3.23 [2-Mef/ij/-^H3]-(E)-2,4-dimethyl-2-hexenoic acid (2.36) 
Ethyl [2-me//?}'/-^H3]-(E)-2,4-dimethyl-2-hexenoate (0.66g, 3.15mmol) was added to a 
solution of sodium hydroxide (2.1g) in methanol (21mL). The solution was refluxed 
gently for 5 hours, cooled and acidified with 10% aqueous hydrochloric acid. The 
product was extracted into ether (4x 100 mL), dried (MgS04), filtered and reduced in 
vacuo, to give a yellow oil [2-»je%/-^H3]-(E)-2,4-dimethyl-2-hexenoic acid (0.39 Ig, 
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2.30mmol, 85%). 5H(CDC13) 0.84 (3H, t, J 7.3, C H 3 ) , 1.0 (3H, d, J 6.7, C H 3 ) , 1.35 
(2H, m, C H 2 ) , 2.40 ( IH m, CH), 6.68 ( IH, d, J 10.1, CH); 5c(CDCl3) 12.3 ( C H 3 ) , 
20.0 ( C H 3 ) , 30.0 (CH,), 35.6 (CH), 126.1 (CH), 151.4 (CH), 174.7 (CO); 
v„,ax(neat)/cm-' 3000 (br), 2961, 2873, 2650, 1689, 1636, 1420, 1279; m/z ( E I ) 145 
(M+, 33.90%), 73 (79.17%), 56 (100%). 
6.3.24 N-Propionyl cysteainine-[2-/nefM-^H3]-(E)-2,4-
dimethylhexenoate (2.37) 
1,3-Dicyclohexylcarbodiimide (720mg, 3.40mmol), 4-dimethylaminopyridine (330mg, 
2.68mmol) and N-propionylcysteamine (570mg, 4.29mmol) were added to a solution of 
[2-^H3-we%/]-(E)-2,4-dimethylhexenoic acid (390mg, 2.68mmoI) in di-y ether (25mL). 
The reaction mixture was stirred under dry N, at room temparture for 12 hours. A white 
precipitate formed which was removed by filtration and discarded. The filtrate was 
concentrated and the resultant oil was purified over silica gel (chloroform : ethyl acetate, 
70 : 30). The active fraction were combined and concentrated to give a waxy solid, N-
propionyl cysteamine-[2-^H3-we//2}'/]-(E)-2,4-dimethyl hexenoate (326mg, 1.30mmol, 
47%). 5H(CDC13) 0.79 (3H, t, J 7.2, C H 3 ) , 0.95 (3H, d, J 6.8, C H 3 ) , 1.07 (3H, t, J 
7.2, C H 3 ) , 1.32 (2H, m, CH^), 2.13 (2H, dt, J 7.6 & 6.8, CH,), 2.37 ( IH , m, CH), 
3.00 (2H, t, J 6.8, C H 2 ) , 3.39 (2H, q, J 7.2, CH^), 6.15 ( IH, bs, NH), 6.46 ( IH, d ,J 
10.0, CH); 5c(CDCl3) 9.7 ( C H 3 ) , 11.8 ( C H 3 ) , 19.4 (CH^), 28.2 ( C H 3 ) , 29.4 (CH^), 
33.9 (CH), 35.0 (CH^), 39.5 (CH^), 134.3 (C), 147.4 (CH), 174.0 (CO), 194.1 (CO); 
v^Jneat)/cm-' 3297, 3075.08, 2961, 2928, 2873, 1655, 1545, 1460, 1231, 1210, 
1075, 860; m/z ( C I ) 261 (M+1 100%), 128 (28.87%). 
6.4 Feeding of Putative Polyketide Intermediates 
6.4.1 Growth of Beauvaria bassiana in 6.6% D^O 
Two production media flasks (50mL) prepared with 6.6% D 2 O were innoculated with 7 
day old production media (5mL), and shaken and 300 rpm, 32°C in the dark. On day 8 
tenellin (20mg) was exttacted and purified. 5D(CDC13) 0.77 ( C H 3 ) , 0.92 ( C H 3 ) , 1.23 
( C H 2 ) , 1.79 ( C H 3 ) , 6.8 (Ph), 7.3 (Ph). 
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6.4.2 Sodium ['H3]-acetate 
Sodium [^H3]-acetate was prepaied from a solution of [-H3]-acetic acid in distilled water 
by neutralisation with O . I M NaOH. The sodium salt (0.125g, 1.47mmol) was dissolved 
in distilled water (16mL). This was pulse fed to four production media flasks (50mL), 
through a micropore filter, on days 3, 4, 5 and 6, to give a final concentration 7 .35 
mmolar in each flask. Tenellin (72mg) was extracted and purified by HPLC on day 10. 
5D(CDC13) 0.72 ( C H 3 ) . 
6.4.3 N-Propionyl cysteamine-[2-me//i3'/-^H3]-2-methylbutyrate, during 
idiophase 
N-Propionylcysteamine-[-H3-/7jer/z}'/]-2-methyIbutyrate (204mg, 0.93mmol) was shaken 
with sterilised water (12mL) to form an emulsion. This emulsion was pulse fed to four 
production media cultures (50mL) of B. bassiam on days 1, 2 and 3 such that the final 
concentration was 4.6 mmolar. Tenellin (60 mg) was isolated and purified on day 7. No 
incorporation of deuterium was observable by ^H NMR. 
6.4.4 N-Propionyl cysteamine-[2-mef^3'/-^H3]-2-methylbutyrate, during 
trophophase 
N-Propionylcysteamine-[^H3-»rer/j>'/]-2-methylbutyrate (271mg, 1.23mmol) was shaken 
with sterilised water (16mL) to form an emulsion. To increase the solubility ethanol 
(ImL) was added and this was pulse fed to four production media cultures (50mL) of B. 
bassiana, on days 3, 4, 5 and 6 such that the final concentration was 6.2mmolar. 
Tenellin (98mg) was isolated on day 10. 5 D ( D M S 0 ) (before HPLC purification) 1.79 
( C H 3 - I 6 ) , 0.97 ( C H 3 - I 5 ) , 0 .74 ( C H 3 - I 4 ) , ratio of peak intensities approx. 1 : 5 : 5 . 
Impurity peak at S^^ j 5.65; 5^  54.90. 
This experiment was repeated on a larger scale and the tenellin purified by reverse phase 
HPLC. N-Propionylcysteamine-[^H3-wgr/?_y/]-2-methylbutyrate (551mg, 2.5mmol) was 
dissolved in a mixture of ethanol (8mL) and distilled water (lOmL) and this was pulse 
fed to ten production media cultures (50mL) of B. bassiana, on days 3, 4, 5, 6 and 6 
such that the final of concentration was 5.0mmolar. Crude tenellin (500mg) was 
subsequently isolated on day 10. Purification by reverse phase HPLC (methanol : water. 
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85 : 15) yielded tenelhn as a yellow crystalline solid (290mg). 5D(DMS0) 1.77 ( C H 3 -
16), 0.85 ( C H 3 - I 5 ) , 0.70 ( C H 3 - I 4 ) , ratio of peak intensities 1 :2 :7 . 
6.4.5 N-Propionyl cysteamine-[2-»ie//i>'/-^H3]-2-methyIbutyrate, to 
senescent cells 
N-propionylcysteamine-[^H3-/7je//2>'/]-2-methylbutyrate (230 mg, 1.04mmol) was shaken 
with sterilised water (16mL) to form an emulsion. To increase the solubility in the 
solution ethanol (ImL) was added and tiiis was pulse fed to four production media 
cultures (50mL) of B. bassiana on days 9, 10, 11 and 12 such that the final 
concentration was 5.2 mmolai\ Tenellin (50 mg) was isolated and puiified on day 14. 
No incorporation of deuterium was obsei^ vable by ^H NMR. 
6.4.6 N-Propionyl cysteaniine-[2-we/^j'/-^H3]-(E)-2,4-dimethyIhexenoate 
N-propionylcysteamine-[^H3-/7ze//2}'/]-(E)-2,4-dimethylhexenoate (300mg, 1.15mmol) 
was dissolved in a 1 : 1 mixtui-e of ethanol : water (14mL) and this was pulse fed to 7 
cultures (50mL) of B. bassiana, 0.5mL to each flask on days 3, 4, 5, 6, to give a final 
concentration in each flask of 4.6mmolar. TenelUn (80mg) was isolated on day 10, and 
purified by HPLC. No incorportion of deuterium was observable by ^H NMR. 
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6.5 Synthesis of Putative Tetramic acid Intermediates 
6.5.1 (1,1-Dimethyl-N-propylidene) ethylamine (3.37) 
Propionaldehyde (29g, 0.5mol) was added dropwise over the course of 2 hours to 
'butylamine (36.5g, 0.5mol), stirred at 0°C. When addition was complete stirring was 
stopped and KOH pellets (20g) were added. The solution was left to separate at 0°C for 
12 hours before the yellow upper layer was carefully decanted. This was distilled three 
times over KOH at atmospheric pressure and the title compound collected under dry N2 
as a clear colourless oil (25.4g, 224mmol, 45%, b.p. 103-105°C, 1 atm), which could 
be stored over molecular sieves, at 0°C. 5H(CDC13) 0.96 (3H, t, J 7.6, CH3), 1.10 (9H, 
s, 3x CH3), 2.17 (2H, qd, J 7.6 & 4.9, CH3), 7.52 ( IH, t, J 4.9, CH); 5,(CDCl3) 11.2 
(CH3), 30.2 (3x CH3), 55.9 (CH2), 102.1 (C), 160.6 (CH); v„,, (neat)/cm-' 2965, 
2934, 2873, 1671, 1461, 1361, 1227, 1215; m/z (EI) 114 (M+l , 18.82%), 113 (M+, 
30.20%), 98 (100%). 
6.5.2 E-2,4-Dimethyl-2-hexenal (3.39) 
A solution of freshly distilled (1,1-dimethyl-N-propylidene) ethylamine (5.65g, 50 
mmol) in tetrahydrofuran (30mL) was stirred under dry N2 and cooled to "78°C. 
Butyllithium (1.6M in hexanes, 34.5mL, 55mmol) was added via a dry N2 flushed 
syringe, dropwise over ten minutes. The solution was warmed to 0°C, stirred for 20 
minutes, then cooled to 78°C. 2-Methylbutyraldehyde (3.88g, 45mmol, distilled 
b.p.92°C, latm) was added dropwise via a dry N2 flushed syringe and the solution 
allowed to warm to 0°C and stirred for 4 hours, at this temperature. An aqueous slurry 
of oxalic acid (30g in 1 lOmL H2O) was added and the biphasic mixture was vigorously 
stirred for 72h at room temperature. The mixture was filtered and the filtrate extracted 
into dichloromethane (3x75mL). The combined organic layers were dried (MgSO^) and 
evaporated in vacuo to yield the crude aldehyde as a pale yellow aromatic oil (5.42g, 
42.9mmol, 95%). This was purified over silica (CH2CI2, Rf 0.75). The oil was stable for 
a few days at 20°C under dry N j , but needed to be repurified prior to use. 5H(CDC13) 
0.84 (3H, t, J 7.3, CH3), 1.02 (3H, d, J 6.6, CH3), 1.40 (2H, m, CHj), 1.71 (3H, d, J 
1.4, CH3), 2.58 ( IH , m, CH), 6.22 ( IH, dd, J 9.9 & 1.4, CH), 9.36 ( IH, s, CHO); 
5,(CDCl3) 11.3 (CH3), 13.8 (CH3), 21.4 (CH3), 31.4 (CH2), 37.1 (CH), 140.1 (C), 
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162.3 (CH), 197.4 (CO); v^^,(neat)/cm-' 2963, 2929, 2875, 2817, 2707, 1689, 1641, 
1459, 7349; m/z (EI) 126 (M+, 10.88%), 41 (100%); Found 126.1040, C8H,40 (M+) 
requires 126.1045. 
6.5.3 2,2-Diniethyl-6-chloroniethyl-l,3-dioxin-4-one (3.41) 
Freshly distilled 2,2,6-trimethyl-l,3-dioxin-4-one (acetone diketene adduct) (7.1g, 50 
mmol, b.p. 36°C, 0.03 mbai-) was added dropwise to a solution of LDA (SOmmol) 
stirred at -78°C under dry Nj. The bright yellow suspension which formed was stirred 
for 15 minutes. It was then carefully transferred dropwise, over a period of 30 minutes, 
via dry Teflon tubing to a stirred solution of hexachloroethane (17.7g, 75 mmol), in 
tefrahydrofuran (30 mL), which was cooled to -50 °C under dry Nj. The red solution 
thus formed was allowed to warm slowly to -20°C over 1 hour, after which die reaction 
mixture was quenched by addition of ice cold dilute aqueous HCl (150 mL). The acidic 
solution was shaken to dispel colour and extracted into diethyl ether (3x lOOmL). The 
combined ether layers were washed with a saturated aqueous solution of NaC03 (2x 
50mL), dried (MgS04), and reduced in vacuo to afford a yellow oil containing crystalline 
hexachloroethane. This was removed by trituration with hexane (2x 50 mL). The crude 
title compound (4.9g, 27.7 mmol, 55%) could be purified over siUca (CH2CI2), but was 
routinely used without further purification. 5H(CDC13) 1.66 (6H, S, 2X CH3), 3.99 (2H, 
s, CH2), 5.50 ( IH, s, CH); 5,(CDCl3) 26.7 (2x CH3), 43.0 (CH2CI), 97.5 (CH), 109.4 
(C), 162.3 (C), 166.6 (CO); v„,,(neat)/cm ' 3103, 3000, 2946, 1729, 1642, 1391, 
1377.66, 1274, 1203, 1016. 
6.5.4 2,2-Dimethyl-6-(diethylphophononiethyl)-l,3-dioxin-4-one (3.42) 
Dietiiylphosphite (20.7g, 150 mmol, distilled b.p. 27°C, O.OOlmbar) was added 
dropwise to a solution of potassium 'butoxide (16.8g, 150mmol) in dimetiiylfoiTnamide 
(lOOmL), cooled to 0°C under dry N,. After 30 minutes, 2,2-dimethyl-6-chloromethyl-
l,3-dioxin-4-one (5.50g, 31.14mmol) in DMF (25mL) was added dropwise over 20 
minutes, and the deep purple solution generated was stirred at 0°C for a further 30 
minutes. Dropwise addition of lOM HCl (6mL) dischai'ged the colour, and the pale 
brown mixtui'e was filtered tiirough celite, and the celite pad washed with diethyl ether 
(lOOmL). The combined organic washings were evaporated in vacuo keeping the bath 
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temperature below 40°C. Excess dimethylformamide and diethyl phosphite were 
removed by vacuum distillation (0.01 mbar, <45°C) affording the crude title compound 
as a thick brown oil, which was diluted with ethyl acetate, left at 0°C overnight. The 
solution was decanted from the crystals thus formed, and reduced in vacuo. Purification 
by silica gel flash clu'omatography (ethyl acetate, Rf 0.19) yielded the title compound as a 
pale yellow oil (7.27g, 26.13mmol, 84%), which was stored under N2 at 0°C. 
6H(CDC13) 1.28 (6H, t, J 7.0, 2x CH3), 1.65 (6H, s, 2x CH3), 2.75 (2H, d, J 22.5, 
CH2), 4.07 (4H, m, 2x CH2) 5.33 ( IH, d, J 3.7, CH); 5^(CDCl3) 16.2 (d, J,3cp 6.57, 
2x CH3), 24.5 (2x CH3), 31.0 (d, J,3cp 132.00, CH2), 61.9 (d, J,3cp 6.58, 2x CH2), 
95.5 (d, J,3cp8.81, CH), 106.6 (C), 159.9 (C), 164.3 (CO); v ^ , (neat)/cm-' 3400 (br), 
2984, 2934, 2911, 1730, 1634, 1444, 1376, 1259, 1025. 
6.5.5 2,2-Dimethyl-6-(E,E-3,5-dimethylhepta-l,3-dienyl)-l,3-
dioxin-4-one (3.43) 
A solution of 2,2-dimethyl-6-(diethylphosphonomethyl)-l,3-dioxin-4-one (4.17g, 
15mmol) in THE (30mL) was added, via a dry N 2 flushed syringe, to a solution of 
lithium hexamethyldisilazide (15 mmol) in tetrahydrofuran (lOOmL), cooled to 0°C, and 
stiired under dry Nj. The resultant red solution was stiired for 20 minutes before cooUng 
to -78°C. Freshly puiified E-2,4-dimethyl-2-hexenal (1.89g, ISmmol) was added and 
the solution allowed to warm to room temperature over a period of 4 hours, followed by 
stirring for a further 8 hours at this temperature. Solvent was removed by evaporation in 
vacuo (bath temperature below 40°C), and the resulting red solid dissolved in 
dichloromethane (30mL). Colloidal inorganics were removed by vacuum filtration 
through glass wool, and the filtrate reduced in vacuo. The title compound was obtained 
by purification over silica (dichloromethane, Rp0.21) as a pale yellow oil (1.59g, 
6.37mmol, 43%). 6H (CDC13) 0.80 (3H, t, J 7.0, CH3), 0.94 (3H, d, J6.25, CH3), 1.32 
(2H, m, CH,) 1.66 (6H, s, 2x CH3), 1.75 (3H, s, CH3), 2.41 ( IH, m, CH), 5.25 ( I H , 
s, CH), 5.60 ( I H , d, J 9.0, CH), 5.84 ( IH, d, J 14.5, CH), 6.92 ( IH , d, J 14.5, CH); 
5,(CDCl3) 11.9 (CH3), 12.3 (CH3), 20.2 (CH3), 24.9 (CH3), 25.0 (CH3), 30.0 (CHj), 
34.9 (CH), 93.5 (CH), 106.1 (C), 117.0 (CH), 131.7 (C), 143.3 (CH), 148.0 (CH), 
162.1 (C), 164.1 (CO); v_(neat)/cm-' 2961, 2927, 2871, 1720, 1624, 1388, 1375, 
1272, 1203, 1017; m/z (CI) 251 (M+l , 44.2%), 167 (100%); Found 251.1647, 
C,5H2303 (MH+) requires 251.1647. 
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6.5.6 (DL)-Phenylalanine hydrochloride (3.48) 
A solution of NH^Cl (2.67g, 50mmol) in water (30mL) was slowly added to a stirred 
solution of phenylacetaldehyde (3g, 25mol) in methanol (60 mL) cooled to -5°C. After 
10 min stirring, KCN (1.63g, 25mmol) was added and stiixing continued at 20°C for 24 
h. Methanol was removed in vacuo and the aqueous solution exQ-acted into methylene 
dichloride, dried (MgSO^) and evaporated in vacuo to afford a brown oil. This was 
heated under reflux with concentrated aqueous hydrochloric acid (lOOmL) for 48 hours. 
Solvent was removed in vacuo and the resulting solid washed with cold acetone (lOOmL) 
leaving a white amorphous solid, (DL)-phenylalanine hydrochloride (4.40g, 21.8mmol, 
87%). m.p 230-230.5°C (lit. 230°C)' 5H(D,0) 3.07 ( IH, dd, Jg,„ 14.6, J,;, 7.6, CH^), 
3.23 ( I H , dd, Jg,^  14.6, J,i, 5.9, CH^); 4.24 ( IH, dd, J,,, 7.8, J,„ 5.6, CH), 7.27 (5H, 
m, Ph); 6,(D,0) 40.0, (CH^), 58.6 (CH), 132.5 (Ph CH), 133.7 (Ph CH), 133.9 (Ph 
CH), 138.4 (Ph C), 175.9 (CO); v„„(neat)/cm ' 2060 (br), 1732, 1601, 1486, 1413, 
1226, 1194, 731, 699; m/z (CI) 166 (M+1, 69.94%), 120 (100%); Found 166.0868, 
CgHiiNOj (MH+) requires 166.0868. 
6.5.7 (DL)-Phenylalanine methyl ester (3.49) 
Thionyl chloride (1.78g, 15mmol) was added dropwise to a solution of (DL) 
phenylalanine hydrochloride (2.02g, lOmmol) in methanol (15mL) and cooled to 0°C. 
The suspension was stirred at room temperature until product formation was complete, 
as observed by t.l.c. (silica plates eluted with nPrOH : NH3 (aq con''), 7 : 3 , (developed 
with ninhydiin). Solvent was removed /// vacuo, and the sohd residue redissolved in 
saturated aqueous NaHC03 (25mL). The aqueous solution was extracted into diethyl 
ether (5x 75mL) and the organic extracts were dried (MgS04) before removal of the 
solvent in vacuo to afford the title compound as a pale yellow oil (1.66g, 9.26mmol, 
93%). 5H(CDC13) 1.55 (2H, bs, NH^), 2.84 ( IH , dd, J^ .^  14.9, J,,, 7.8, CH,), 3.08 
( I H , dd, Jg,„ 14.9, J,i, 5.3, CH,), 3.69 (3H, s, COOCH3), 3.69 ( IH, m, CH), 7.22 
(5H, m, Ph); 5,(CDCl3) 43.1 (CH,), 54.0 (OCH3), 57.8 (CH), 128 8 (Ph CH), 130.6 
(Ph CH), 131.3 (Ph, CH), 139.2 (Ph C), 177.4 (CO); v„„(neat)/cm-' 3619 (br), 3379, 
3312, 3028, 2951, 2853, 1953 (w), 1737, 1603, 1495, 1454, 1437, 1198, 1174, 746, 
702; m/z (CI) 180 (M+1, 100%). 
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6.5.8 (L)-Phenylalanine methyl ester (3.51) 
(^-phenylalanine (4g, 24.21mmol) was methylated as above affording the title 
compound as a pale yellow oil (4.33g, 24.16mmol, 99%). 5H(CDC13) 1.71 (2H, bs, 
NH^), 2.82 ( IH , dd, Jg,„ 14.9, J.^ , 7.8, CH^), 3.06 ( IH, dd, J^ ,^  14.9, J.^ , 5.3, CH,), 
3.69 (3H, s, COOCH3), 3.69 ( IH, m, CH), 7.20 (5H, m, Ph). 
6.5.9 (DL)-N-(E,E-3-Oxo-6,8-diniethyldeca-4,6-dienoyl) phenylalanine 
methyl ester (3.44) 
A solution of 2,2-dimethyl-6-(E,E-3,5-dimethylhepta-l,3-dienyl)-l,3-dioxin-4-one 
(0.25g, l.Ommol) and (DL)-phenylalanine methyl ester (0.20g, 1.12mmol) in toluene 
(lOmL) was heated under reflux temperature for Ihour. After cooling, solvent was 
removed in vacuo and the resultant red oil purified by silica gel flash chromatography 
(chloroform : methylene dichloride, 25 : 75, 0.11) yielding the title compound as an 
orange oil (0.20g, 53.8mmol, 54%). 5H(CDC13) 0.85 (3H, t, J 7.3, CH3), 0.98 (3H, d, 
J 6.1, CH3), 1.33 (2H, m, CH^), 1.78 (3H, s, CH3), 2.43 ( IH, m, CH), 3.11 (2H, m, 
CH,), 3.53 (2H, s, CHj), 3.70 (3H, s, CH3), 4.87 ( IH, m, CH), 5.8 ( IH , d, J 10.0, 
CH), 6.10 ( IH, d, J 16.0, CH), 7.25 (6H, m, Ph & CH), 7.51 ( IH , bd, J 8.4, NH); 
5,(CDCl3) 13.9 (CH3), 14.4 (CH3), 22.0 (CH3), 31.9 (CH,), 37.2 (CH), 39.9 (OCH3), 
48.6 (CH2), 54.3 (CH2), 55.5 (CH), 125.6 (CH), 129 1 (Ph), 130.6 (Ph), 131.3 (Ph), 
133.9 (C), 137.9 (Ph), 152.9 (CH), 153.7 (CH), 167.8 (CON), 173.7 (COOCH3), 
197.2 (CO); v„„(neat)/cm-' 3329 (br) 3029, 2960, 2927, 2873, 1746, 1588, 1454, 
1416, 1360, 1259, 1215, 1178, 701. 
6.5.10 Attempted Dieckmann cyclisation of (DL)-N-(E,E-3-Oxo-6,8-
dimethyldeca-4,6-dienoyl) phenylalanine methyl ester (3.45) 
A solution of (DL)-N-(E,E 3-oxo-6,8-dimethyldeca-4,6-dienoyl) phenylalanine methyl 
ester (0.130g, 0.35mmol) in ?m-butanol (ImL), was added to a stirred solution of 
freshly subUmed potassium r^/t-butoxide (0.09Ig, 0.81mmol) in tett-butanol (6mL) 
under nitrogen. After 30 minutes stiiring the red solution was quenched with dilute 
aqueous hydrochloric acid (6mL). The organics were extracted into diethyl ether (Ix 
30mL), washed with water (Ix 5mL), diied (MgSO^) and evaporated in vacuo affording 
(DL)-N-(E,E-3-oxo-6,8-dimethyldeca-4,6-dienoyl) phenylalanine as an orange / red wax 
200 
(0.125g, 0.35mmol, 100%). 5H(CDC13) 0.79 (3H, t, J 7.3, CH,), 0.94 (3H, d, J 6.6, 
CH3), 1.28 (2H, m, CH,), 1.72 (3H, s. CH3), 2.41 ( IH, m, CH), 3.01 ( IH, dd, J .^^  
14.3, J,i , 8.1, CH,), 3.28 ( IH, dd, J^,„, 14.3, J,;, 5.31, CH3), 3.50 (2H, s, CH,), 4.79 
( I H , m, CH), 5.75 ( IH , d, J 10.1, CH), 6.04 (d, J 15.8, CH), 7.18 (6H, m, Ph & 
CH), 7.72 ( I H , bd, J 8.4, NH), 8.50 ( IH, bs, COOH); 8,(CDCl3) 11.9 (CH3), 12.3 
(CH3), 19.9 (CH3). 29.8 (CH2), 35.2 (CH), 37.3 (CH^), 46.0 (CH^), 53.6 (CH), 
123.3 (CH), 127.0 (Ph), 128.5 (Ph), 129.3 (Ph), 131.9 (C), 135.8 (Ph), 151.2 (CH), 
152.1 (CH), 166.8 (CON), 174.5 (COOH), 195.4 (CO). 
6.5.11 (DL)-N-(2,4-Dimethoxybenzyl) phenylalanine methyl ester (3.51) 
Methanolic HCl was added to a stkred solution of phenylalanine methyl ester (1.59g, 
8.87mmol) in methanol (50mL) to adjust to pH 6. 2,4-Dimethoxybenzaldehyde (1.50g, 
9.03mmol) was added and the solution stirred at room temperature for 30 minutes. 
NaBHjCN (0.69g, 1 l.Ommol) was then added and the reaction stirred at room 
temperature for a further 16 hours. Methanol was removed /// vacuo, distilled water 
(20mL) added and the aqueous mixture extracted into diethyl ether (3x 50mL). The 
organic extracts were combined, washed with an aqueous solution of FeS04, dried 
(MgSOJ, filtered and reduced in vacuo, affording the crude product as a pale yellow oil. 
Impurities of 2,4-dimethoxybenzylalcohol were removed by distillation under reduced 
presure (furnace temparature 110°C, O.lmmHg). The product could be further purified 
over silica (hexane: ethylacetate, 50 : 50) (1.94g, 5.89mmol, 66%). 5H(CDC13) 2.1 ( IH, 
bs, NH), 2.95 (2H, m, CH^), 3.50 ( IH, m, CH), 3.60 (3H, s, COOCH3), 3.63 (3H, s, 
OCH3), 3.76 (3H, s, OCH3), 3.75 (2H, d, J 9.6, CH2), 6.36 (2H, m, Ph), 7.14 (6H, 
m, Ph); 5,(CDCl3) 41.6, (CH^), 49.3 (NCH^), 53.6 (COOCH3), 57.1 (OCH3), 57.3 
(OCH3), 64.0 (CH), 100.4 (Ph CH), 105.6 (Ph CH), 122.0 (Ph CH), 128.6 (Ph CH), 
130.4 (Ph CH), 131.2 (Ph CH), 132.4 (Ph C), 139.5 (Ph C), 160.6 (Ph CO), 162.2 
(Ph CO), 176.9 (CO); v^^^(neat)/cm-' 3250 (br), 3025, 2999.46, 2947, 2835, 2240 (w), 
2028 (w), 1731, 1611, 1587, 1505, 1453, 1437, 1286.92, 1260, 1205, 1154, 1130, 
1032, 699; m/z (EI) 330 (M+1, 100%), 329 (M+, 50.26%), 328 (M-1, 100%); Found 
329.1627, CigH^jNO^ (M+) requires 329.1627. 
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6.5.12 (L)-N-(2,4-Dimethoxybenzyl) phenylalanine methyl ester (3.51) 
(L)-Phenylalanine methyl ester (4.33g, 24.16mmol) was N-protected with the 2,4-
dimethoxybenzyl group as above affording the title compound as a colourless oil (3.7Ig, 
11.26mmol, 47%), [«]^' = -65.22 (c 1.01, ethanol). 5H(CDC13) 2.14 ( IH , bs, NH), 
2.89 ( IH , dd, Jg,„ 13.8, 7.8, CH,), 2.97 ( IH, dd, J^ .^  13.8, J.^ , 6.5, CH,), 3.49 
( I H , dd, J,i, 7.8, J,i, 6.5, CH), 3.59 (3H, s, COOCH3), 3.61 (3H, s, OCH3), 3.76 
(3H, s, OCH3), 3.79 (2H, d, J 8.1, CH,), 6.39 (2H, m, Ph), 7.16 (6H, m, Ph); 
5,(CDCl3) 39.5, (CH,), 47.1 (NCH,), 51.5 (COOCH3), 55.0 (OCH3), 55.2 (OCH3), 
61.8 (CH), 98.2 (Ph CH), 103.4 (Ph CH), 119.8 (Ph CH), 126.5 (Ph CH), 128.3 (Ph 
CH), 129.0 (Ph CH), 130.3 (Ph C), 137.3 (Ph C), 158.5 (Ph CO), 160.1 (Ph CO), 
174.7 (CO). 
6.5.13 (DL)-N-(2,4-Dimethoxybenzyl)-N-(E,E-3-oxo-6,8-dimethyldeca-
4,6-dienoyl) phenylalanine methyl ester (3.52) 
Pyridiniumpara-toluene sulphonate (0.25Ig, l.OOmmol) was added to a solution of 2,2-
dimethyl-6-(E,E-3,5-dimethylhepta-1,3-dienyl)-1,3-dioxin-4-one (0.250g, 1 .OOmmol) 
and (DL)-N-(2,4-dimethoxybenzyl)-phenylalanine methyl ester (0.335g, 1.02mmol) in 
toluene (lOmL), and the mixture heated to reflux temperature for 3 hours with stirring. 
After cooling the solvent was removed in vacuo and the resultant red oil purified over 
silica (petroleum ether : ethyl acetate, 6 : 4, 0.51) yielding the title compound as a 
yellow oil (0.217g, 0.416mmol, 42%). The NMR was complicated by the presence of 
both the enol and keto tautomers. 6H(CDC13) 0.738 0.762 (3H, 2x t, J 7.4, CH3), 0.87 
0.91 (3H, 2x d, J 6.4, CH3), 1.27 (2H, m, CH,), 1.65 1.73 (3H, 2x s, CH3), 2.35 
( I H , m, CH), 3.05 3.29 (2H, m, CH,), 3.49 3.52 (3H, 2x s, COOCH3), 3.64 3.65 
(3H, 2x s, OCH3), 3.68 3.69 (3H, 2x s, OCH3), 3.74 (m, CO^HjCO), 3.90 4.27 (2H, 
m, CH,), 4.03 4.42 ( IH, m, CH), 5.10 (s, COCH=COH), 5.47 5.70 ( IH, 2x d, J 9.6, 
CH), 5.67 6.14 ( IH , 2x d J 15.6, CH), 6.28 (2H, m, Ph), 7.05 (7H, m, Ph & CH), 
14.0 (0.5H, bs, OH) ; 5,(CDCl3) 11.8 (CH3) 12.2 (CH3), 20.0 20.2 (CH3), 29.8 30.0 
(CH,), 34.6 35.0 (CH), 35.0 35.4 (CH,), 46.5 47.6 (CH,), 48.7 (CH,), 51.8 52.0 
(COOCH3), 54.9 55.0 (OCH3), 55.2 55.2 (OCH3), 60.2 61.4 (CH), 89.3 
(COCH=COH), 98.0 98.4 (Ph CH), 103.5 103.6 (Ph CH), 115.8 116.4 (Ph C), 120.3 
123.5 (CH), 126.3 126.2 (Ph CH), 128.2 128.4 (Ph CH), 129.1 129.3 (Ph CH), 129.1 
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130.4 (Ph CH), 131.7 131.9 (Ph C), 137.9 138.2 (C), 141.1 149.8 (CH), 145.4 150.5 
(CH), 157.7 (Ph COCH3), 158.6 (Ph COCH3), 160.2 160.8 (CON), 170.1 170.6 
(COOCH3), 172.8 (C=COH), 193.7 (CO); v_(neat)/cm-' 2956, 2871, 2126, 1738, 
1613, 1576, 1506, 1454, 1206; m/z (CI) 522 (M+1, 3.51%), 330 (100%); Found 
522.2855, CjiH^oNO^ (MH+) requires 522.2856. 
6.5.14 (L)-N-(2,4-Dimethoxybenzyl)-N-(E,E-3-oxo-6,8-dimethyldeca-
4,6-dienoyl) phenylalanine methyl ester (3.52) 
(L)-N-(2,4-dimethoxybenzyl)-N-(E,E-3-oxo-6,8-dimethyldeca-4,6-dienoyl) 
phenylalanine methyl ester was prepared as above from (L)-N-(2,4-dimethoxybenzyl)-
phenylalanine methyl ester (0.412g, 1.25mmol), pyridinium para-toluene sulphonate 
(0.26g, 1.04mmol) and 2,2-dimethyl-6-(E,E-3,5-dimethylhepta-l,3-dienyl)-l,3-dioxin-
4-one (0.261g, 1.04mmol) in toluene (6mL), yielding the title compound as a yellow oil 
(0.34g, 0.65mmol, 62%). The NMR was complicated by the presence of both the enol 
and keto tautomers. 5H(CDC13) 0.83 (3H, 2x t, J 7.4, CH3), 0.96 (3H, 2x d, J 6.4, 
CH3), 1.30 (2H, m, CH,), 1.72 1.79 (3H, 2x s, CH3), 2.42 ( IH, m, CH), 3.11 3.37 
(2H, m, CH2), 3.56 3.59 (3H, 2x s, COOCH3), 3.72 3.73 (3H, s, OCH3), 3.76 3.77 
(3H, s, OCH3), 3.80 (m, COCH2CO), 3.94 4.34 (2H, m, CH,), 4.09 4.50 ( IH, m, 
CH), 5.15 ( IH , s, COCH=COH), 5.54 5.77 ( IH, 2x d, J 9.6, CH), 5.72 6.21 ( IH, 2x 
d J 15.6, CH), 6.35 (2H, m, Ph), 7.16 (7H, m, Ph & CH), 14.2 (0.5H, bs, OH) ; 
6,(CDCl3) 11.9 (CH3), 12.4 (CH3), 20.1 20.3 (CH3), 29.9 30.1 (CH^), 34.8 35.1 
(CH), 35.2 35.5 (CH^), 46.5 47.8 (CH^), 48.7 (CH^), 52.0 52.1 (COOCH3), 55.1 
(OCH3), 55.3 (OCH3), 60.2 60.5 (CH), 89.4 (COCH=COH), 98.2 98.5 (Ph CH), 
103.7 (Ph CH), 116.0 116.6 (Ph C), 120.4 123.6 (CH), 126.4 (Ph CH), 128.3 128.5 
(Ph CH), 129.3 129.4 (Ph CH), 130.5 129.1 (Ph CH), (Ph CH), 131.8 132.0 (Ph C), 
138.0 138.3 (C), 141.2 150.0 (CH), 145.6 150.6 (CH), 157.8 (Ph COCH3), 158.7 (Ph 
C:0CH3), 160.3 160.9 (CON), 170.2 171.3 (COOCH3), 172.9 (C=COH), 193.8 (CO). 
6.5.15 5(DL)-N-(2,4-Dimethoxybenzyl)-3-(E,E-4,6-dimethylocta-2,4-
dienoyl)-5-benzyl-2,4-dioxopyrrolidine (3.53) 
To a stirred solution of freshly sublimed potassium re/t-butoxide (0.047g, 0.42mmol) in 
tert-hutanol (8mL), was added a solution of (DL)-N-(2,4-dimethoxybenzyl)-N-(E,E 3-
0x0-6,8-dimethyldeca-4,6-dienoyl) phenylalanine methyl ester (0.1 lOg, 0.21mmol) in 
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tert-huXano\ (4mL). After 30 minutes stining the resultant red solution was quenched 
with dilute aqueous hydrochloric acid (5mL). The organics were exti-acted into diethyl 
ether (Ix 30mL), washed with water (Ix 5mL), dried (MgS04) and evaporated in vacuo 
to afford the title compound as a yellow oil (0.095g, 0.19mmol, 92%). Two tautomers 
in the ratio 84 : 16 were obsei-vable by NMR. 5^(00013) 0.76 0.77 (3H, 2x t, J 7.3, 
CH3), 0.92 (3H, d, J 6.6, CH3), 1.30 (2H, m, CH,), 1.76(16%) 1.81(84%) (3H, d, J 
1.01, CH3), 2.20(16%) 2.41(84%) ( IH, m, CH), 3.08 (2H, d, J 4.7, CH,), 3.70 (3H, 
s, OCH3), 3.71 (3H, s, OCH3), 3.78(84%) 3.94(16%) ( IH, t, J 4.7, CH), 4.08(84%) 
4.16(16%) ( IH , d, Jg,„ 14.6, CH,), 4.92(84%) 4.98(16%) ( IH, d, J^ .^  14.6, CH,), 
5.72 ( I H , d, J 9.7, CH), 6.36 (2H, m, Ph), 7.13 (7H, m, Ph & CH), 7.36 ( IH, d, J 
15.4, CH); 5,(CDCl3) 11.9 (CH3), 12.4 (CH3), 20.0 (CH3), 29.9 (CH,), 35.1 (CH), 
35.2 (CH,), 38.4 (CH,), 55.3 (OCH3), 55.3 (OCH3), 62.2(16%) 64.8(84%) (CH), 
98.4 (Ph CH), 100.3 (C), 104.2 (Ph CH), 115.9 (CH), 116.0 (Ph C), 126.7 (Ph CH), 
128.3 (Ph CH), 129.5 (Ph CH), 131.3 (Ph CH), 133.0 (Ph C), 135.6 (C), 149.5 (CH), 
151.5 (CH), 158.5 (Ph C), 160.7 (Ph C), 173.8 (CON) 173.8 (COH), 194.3(84%) 
203.6(16%) (CO); v^„(neat)/cm-' 3028, 2960, 2927, 2871, 2837, 2360 (w), 2341 (w), 
1695, 1614, 1571, 1508, 1458, 1294, 1262, 1209, 1037, 614; m/z (CI) 490 (M+l, 
9.14%), 151 (100%); Found 490.2593, C30H36NO5 (MH+) requires 490.2593. 
6.5.16 5(L)-N-(2,4-Dimethoxybenzyl)-3-(E,E-4,6-dimethylocta-2,4-
dienoyl)-5-benzyl-2,4-dioxopyrrolidine (3.53) 
5(L)-N-(2,4-Dimethoxybenzyl)-3-(E,E-4,6-dimethylocta-2,4-dienoyl)-5-benzyl-2,4-
dioxopyrrolidine was prepared as above from (L)-N-(2,4-dimethoxybenzyl)-N-(E,E-3-
oxo-6,8-dimethyldeca-4,6-dienoyl) phenylalanine methyl ester (0.161g, 0.31mmol) and 
freshly sublimed potassium te/Y-butoxide (0.165mL of I M solution in rm-butanol, 
0.615mmol) in tert-hutanol (12mL) affording the title compound as a yellow oil (0.152g, 
0.31mmol, 100%). Two tautomers in the ratio 84 : 16 were observable by NMR. 
V C D C y 0.82 0.83 (3H, 2x t, J 7.5, CH3), 0.97 (3H, d, J 6.5, CH3), 1.31 (2H, m, 
CH,), 1.84(16%) 1.88(84%) (3H, d, J 1.01, CH3), 2.30(16%) 2.50(84%) ( IH, m, 
CH), 3.14 (2H, d, J 4.6, CH,), 3.72 (3H, s, OCH3), 3.76 (3H, s, OCH3), 3.85(84%) 
3.99(16%) ( I H , t, J 4.3, CH), 4.14(84%) 4.21(16%) ( IH, d, Jg,„ 14.6, CH,), 
4.97(84%) 4.98(16%) ( IH, d, Jg,„ 14.8, CH,), 5.78 ( IH, d, J 10.0, CH), 6.41 (2H, 
m, Ph), 7.13 (7H, m, Ph & CH), 7.42 ( IH, d, J 15.9, CH); 5,(CDCl3) 11.9 (CH3), 
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12.4 (CH,), 20.0 (CH3), 29.9 (CH^), 35.2 (CH), 35.2 (CH^), 38.4 (CH^), 55.3 
(OCH3), 55.4 (OCH3), 62.6(16%) 64.9(84%) (CH), 98.4 (Ph CH), 100.3 (C), 104.3 
(Ph CH), 116.0 (CH), 116.1 (Ph C), 126.8 (Ph CH), 128.3 (Ph CH), 129.5 (Ph CH), 
131.3 (Ph CH), 133.0 (Ph C), 135.7 (C), 149.5 (CH), 151.5 (CH), 158.5 (Ph C), 
160.8 (Ph C), 173.8 (CON & COH), 194.4(84%) 204.6(16%) (CO). 
6.5.17 5(DL)-3-(E,E-4,6-Dimethylocta-2,4-dienoyl)-5-benzyl-2,4-
dioxopyrrolidine (3.54) 
5(DL)-N-(2,4-Dimethoxybenzyl)-3-(E,E-4,6-dimethylocta-2,4-dienoyl)-5-benzyl-2,4-
dioxopyrrolidine (59.2mg, 0.12mmol) was dissolved in trifluoroacetic acid (5mL) and 
the bright red solution stin-ed under nitrogen for 5 minutes. The reaction mixture was 
quenched with ice, resulting in the fonnation of a pale yellow precipitate. This was 
extracted into dichloromethane (2x 20niL), washed with saturated aqueous NaC03 
solution, dried (MgS04), and concentrated in vacuo. The residue was redissolved in 
methanol (5mL), and filtered to remove white solid impurities. The filtrate was reduced 
in vacuo to give the title compound as a waxy yellow solid (36.6mg, 0.1 Immol, 92%). 
Two tautomers in the ratio 85 : 15 were obsei-vable by NMR. 5H(CDC13) 0.79(85%) 
0.82(15%) (3H, t, J 7.2, CH3), 0.95(85%) 1.04(15%) (3H, d, J 6.6, CH3), 1.27 (2H, 
m, CH,), 1.82(15%) 1.85(85%) (3H, s, CH3), 2.43 ( IH, m, CH), 2.58 ( IH , m, CH^), 
3.23 ( I H , m, CH2), 3.96(85%) 4.08(15%) ( IH, m, CH), 5.62(15%) 5.80(85%) ( I H , 
d, J 9.6, CH), 6.32 ( IH , bs, NH), 7.07 ( IH, J 15.6, CH), 7.19 (5H, m, Ph), 
7.48(85%) 7.99(15%) ( IH , d, J 15.6, CH); 6,(CDCl3) 11.9 (CH3), 12.4 (CH3), 20.0 
(CH3), 29.9 (CH,), 35.3 (CH), 38.4 (CH^), 61.1(15%) 63.4(85%) (CH), 99.4 (C), 
115.7 (CH), 127.1 (Ph CH), 128.8 (Ph CH), 129.1 (Ph CH), 133.0 (Ph C), 136.7 (C), 
150.6 (CH), 152.5 (CH), 175.5 175.6 (CON & COH), 194.1 (CO); v„,,(neat)/cm-' 
3189 (br), 3063, 2959, 2923.24, 2871, 2853, 2345, 1701, 1655, 1612, 1571, 1431, 
1289, 980, 694; m/z (EI) 339 (M+, 8.16%), 91 (100%), Found 339.1834, C^.H^jNOj 
(M+) requires 229.1834. 
6.5.18 5(L)-3-(E,E-4,6-Dimethylocta-2,4-dienoyl)-5-benzyl-2,4-
dioxopyrrolidine (3.54) 
Deprotection of 5(L)-N-(2,4-DimethoxybenzyI)-3-(E,E-4,6-dimethylocta-2,4-dienoyl)-
5-benzyl-2,4-dioxopynolidine (0.129g, 0.263mmol) was accomplished as above in 
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trifluoroacetic acid (5mL) to give the title compound as a waxy yellow solid (84.5mg, 
0.249mmol, 95%). Two tautomers in the ratio 85 : 15 were observable by NMR. 
5H(CDC13) 0.84 (3H, t, J 7.3, CH3), 1.00(85%) 1.11(15%) (3H, d, J 6.2, CH3), 1.31 
(2H, m, CH,), 1.86(15%) 1.90(85%) (3H, s, CH3), 2.49 ( IH, m, CH), 2.65 ( IH, m, 
CH,), 3.26 ( IH , m, CH,), 3.99(85%) 4.10(15%) ( IH, bm, CH), 5.66(15%) 
5.85(85%) ( I H , d, J 9.7, CH), 6.32 ( IH, bs, NH), 7.12 ( IH, J 15.6, CH), 7.22 (5H, 
bm, Ph), 7.52(85%) 7.96(15%) ( IH, d, J 15.4, CH); 5,(CDCl3) 11.9 (CH3), 12.3 
(CH3), 20.0 (CH3), 29.9 (CH,), 35.3 (CH), 38.2 (CH,), 61.0(15%) 63.5(85%) (CH), 
99.4 (C), 115.7 (CH), 127.0 (Ph CH), 128.7 (Ph CH), 129.1 (Ph CH), 133.0 (Ph C), 
136.7 (C), 150.5 (CH), 152.3 (CH), 175.4 175.6 (CON & COH), 194.3 (CO). 
6.5.19 (DL)-[1-"C]-Phenylalanine hydrochloride (3.48a) 
A solution of NH4CI (1.60g, 29.91mmol) in water (18mL) was slowly added to a stirred 
solution of phenylacetaldehyde (1.82g, 15.15mmol) in methanol (35mL) cooled to -5°C. 
After 10 min stirring, K'^CN (Ig, 15.13mmol) was added and stirring continued at 20°C 
for 24 h. Methanol was removed in vacuo and the aqueous solution extracted into 
methylene dichloride , dried (MgS04) and evaporated in vacuo to afford a brown oil. 
This was heated under reflux with concentiated aqueous hydrochloric acid (50mL) for 
48 hours. Solvent was removed //( vacuo and the resulting solid washed with cold 
acetone (75mL) leaving a white amorphous solid, (DL)-[l-'^C]-phenylalanine 
hydrochloride (2.74g 13.52mmol, 83%). 5H(D,0) 3.08 ( IH , ddd, J^^ 14.8, J,;, 7.8, 
JH,3C 4.6, CH,), 3.22 ( IH , ddd, J^ ^^  14.8, J.^ , 5.6, JH,3C 4.8, CH,); 4.18 ( IH, dd JH^C 
13.2, J,., 5.6, CH), 7.24 (5H, m, Ph); 5,(D,0) 35.4 (CH,), 54.1 (d, J 58.7, CH), 
127.8 (Ph CH), 129.0 (Ph, CH), 129.2 (Ph CH), 133.8 (Ph C), 171.5 (CO, enriched); 
v„3,(neat)/cm-' 2852 (br), 1690, 1599, 1484, 1398, 1222, 1185, 724, 699; m/z (CI) 167 
(M-Hl, 100%), 120 (11.01%). 
6.5.20 (DL)-[1-"C]-Phenylalanine methyl ester (3.49a) 
Thionyl chloride (0.892g, 7.5mmol) was added di-opwise to a solution of (DL)-[1-'^C]-
phenylalanine hydrochloride (l.lOg, 5mmol) in methanol (8mL) cooled to 0°C. The 
suspension was sttn'ed at room temperature until product formation was complete, as 
observed by t.l.c. (silica plates eluted with nPrOH : NH3 (aq con') 7 : 3, (developed with 
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ninhydrin). Solvent was removed in vacuo, and the solid residue redissolved in saturated 
aqueous NaHC03 (15mL). The aqueous solution was extracted into diethyl ether (5x 
30mL) and the organic extracts were dried (MgS04), before removal of the solvent in 
vacuo to afford the title compound as a pale yellow oil (0.649g, 3.60mmol, 72%). 
5H(CDC13) 1.54 (2H, s, NH^), 2.82 ( IH, ddd, J^,„ 14.9, J,., 7.81, JH.JC 3.6, CH^), 
3.06 ( I H , ddd, Jg,„ 14.7, J,i, 5.3, JH,3C 4.0, CH,), 3.68 (3H, d, JH.JC 3.7, COOCH3), 
3.68 ( IH , m, CH), 7.24 (5H, m. Ph); 6,(CDCl3) 43.1 (CH,), 53.9 (d, J 3.9, OMe), 
57.8 (d, J 58.7, CH), 128.8 (Ph CH), 130.5 (Ph CH), 131.3 (Ph CH), 139.2 (Ph C), 
177.4 (CO, enriched); v„,, (neat)/cm-' 3599 (br), 3378, 3313, 3027, 2950, 2854, 1954 
(w), 1693, 1603, 1495, 1454, 1434, 1195, 1156, 755, 701; m/z (CI) 181 (M+1, 
100%). 
6.5.21 (DL)-[l-"C]-N-(2,4-Dimethoxybenzyl) phenylalanine methyl 
ester (3.51a) 
Methanolic HCl was added to a stured solution of (DL)-[l-'^C]-phenylalanine methyl 
ester (0.598g, 3.32mmol) in methanol (20mL) to adjust to pH 6. 2,4-
Dimethoxybenzaldehyde (0.565g, 3.40mmol) was added and the solution stured at room 
temperature for 30 minutes. NaBH3CN (0.252g, 4.01mmol) was then added and the 
reaction stured at room temperature for a further 16 hours. Methanol was removed in 
vacuo, distilled water (lOmL) added and the aqueous mixture extracted into diethyl ether 
(3x 50mL). The organic extracts were combined, washed with an aqueous solution of 
FeS04, dried (MgS04), filtered and reduced in vacuo, affording the crude product as a 
pale yellow oil. Impurities of 2,4-dimethoxybenzylalcohol were removed by distillation 
under reduced presure (furnace temparature 110°C, O.lmmHg). The product could be 
further purified over silica gel flash chi-omatography (hexane: ethylacetate, 50 : 50) 
(0.877g, 2,65mmol, 80%). 5H(CDC13) 2.20 ( IH, bs, NH), 2.95 (2H, m, CH,), 3.50 
( I H , m, CH), 3.59 (3H, d, JHI3C 3.7, COOCH3), 3.61 (3H, s, OCH3), 3.74 (3H, s, 
OCH3), 3.70 (2H, d, J 9.0, CH,), 6.35 (2H, m, Ph), 7.17 (6H, m, Ph); 5,(CDCl3) 
41.6, (CH,), 49.3 (NCH,), 53.6 (d, J 2.9, COOCH3), 57.1 (OCH3), 57.3 (OCH3), 
63.8 (d, J 59.2, CH), 100.3 (Ph CH), 105.6 (Ph CH), 122.0 (Ph CH), 128.6 (Ph CH), 
130.4 (Ph CH), 131.2 (Ph CH), 132.4 (Ph C), 139.5 (Ph C), 160.6 (Ph CO), 162.2 
(Ph CO), 176.9 (CO, enriched); v„„(neat)/cm' 3334 (br), 3027, 3001, 2949, 2835, 
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2251 (w), 2065 (w), 1693, 1613, 1588, 1507, 1463, 1289, 1261, 1208, 1157, 1037, 
734, 701; m/z (EI) 331 (M+1, 34.23%), 151 (100%). 
6.5.22 (DL)-[l-"C]-N-(2,4-Dimethoxybenzyl)-N-(E,E-3-oxo-6,8. 
dimethyldeca-4,6-dienoyl) phenylalanine methyl ester (3.52a) 
Pyridiniumpara-toluene sulphonate (0.415g, 1.65mmol) was added to a solution of 2,2-
dimethyl-6-(E,E-3,5-dimethylhepta-l,3-dienyl)-l,3-dioxin-4-one (0.409g, 1.63mmol) 
and (DL)-[l-"C]-N-(2,4-dimethoxybenzyl)-phenylalanine methyl ester (0.628g, 
1.90mmol) in toluene (15mL), and the mixtui-e heated to reflux temperature for 3 hours 
with stirring. After cooling the solvent was removed in vacuo and the resultant red oil 
purified over silica (petroleum ether : ethyl acetate, 6 : 4 , R^  0.51) yielding the title 
compound as a yellow oU (0.323g, 0.618mmol, 38%). The NMR was complicated by 
the presence of both the the enol and keto tautomers. 5jj(CDCl3) 0.85 (3H, 2x t, J 7.4, 
CH3), 0.98 (3H, 2x d, J 6.7, CH3), 1.30 (2H, m, CH,), 1.74 1.82 (3H, 2x s, CH3), 
2.45 ( IH , m, CH), 3.14 3.39 (2H, m, CH,), 3.56 3.59 (3H, 2x d, l^,^^ 3.9, 
COOCH3), 3.74 3.75 (3H, 2x s, OCH3), 3.78 3.79 (3H, 2x s, OCH3), 3.80 (m, 
COCH2CO), 4.10 4.37 (2H, m, CH,), 4.09 4.40 ( IH, m, CH), 5.14 ( IH, s, 
COCH=COH), 5.56 5.79 ( IH, 2x d, J 9.6, CH), 5.74 6.24 ( IH, 2x d J 15.6, CH), 
6.39 (2H, m, Ph), 7.20 (7H, m, Ph & CH), 14.0 (0.5H, bs, OH); 6,(CDCl3) 11.8 
(CH3) 12.2 (CH3), 20.0 20.2 (CH3), 29.8 30.0 (CH,), 34.6 35.0 (CH), 35.0 35.4 
(CH,), 46.5 47.6 (CH,), 48.7 (CH,), 51.8 52.0 (COOCH3), 54.9 55.0 (OCH3), 55.2 
55.2 (OCH3), 60.2 61.4 (2x d, J 67.0, CH) 89.4 (COCH=COH), 98.0 98.4 (Ph CH), 
103.5 103.6 (Ph CH), 115.8 116.4 (Ph C), 120.3 123.5 (CH), 126.3 126.2 (Ph CH), 
128.2 128.4 (Ph CH), 129.1 129.3 (Ph CH), 130.4 129.1 (Ph CH), 131.7 131.9 (Ph 
C), 137.9 138.2 (C), 141.1 149.8 (CH), 145.4 150.5 (CH), 157.7 (Ph COCH3), 158.6 
(Ph COCH3), 160.2 160.8 (CON), 170.1 170.6 (COOCH3, enriched),, 176.6 
(C=COH), 193.7 (CO); v„^(neat)/cm-' 2957, 2927, 2871, 2361, 1698, 1630, 1579, 
1465, 1456, 1209, 529; m/z (CI) 523 (M+1, 17.34%), 331 (100%). 
6.5.23 5(DL)-[4-"C]-N-(2,4-DimethoxybenzyI)-3-(E,E-4,6-
dimethylocta- 2,4-dienoyl)-5-benzyl-2,4-dioxopyrrolidine (3.53a) 
To a stUTed solution of freshly sublimed potassium re/t-butoxide (0.139g, 1.24mmol) in 
tert-b\xtmo\ (20mL), was added a solution of (DL)-[4-'^C]-N-(2,4-dimethoxybenzyl)-N-
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(E,E-3-oxo-6,8-dimethyldeca-4,6-dienoyl) phenylalanine methyl ester (0.323g, 
0.618mmol) in tert-butanol (lOmL). After 30 minutes stiiring the resultant red solution 
was quenched with dilute aqueous hydrochloric acid (5mL). The organics were extracted 
into diethyl ether (Ix 50mL), washed with water (Ix lOmL), dried (MgS04) and 
evaporated in vacuo to afford the title compound as a yellow oil (0.298g, 0.61mmol, 
99%). Two tautomers in the ratio 84 : 16 were observable by NMR. 5H(CDC13) 0.75 
(3H, 2x t, J 7.3, CH3), 0.90 (3H, d, J 6.6, CH3), 1.30 (2H, m, CH,), 1.76(16%) 
1.79(84%) (3H, s, CH3), 2.40 ( IH, m, CH), 3.08 (2H, dd, J 4.7 J^^,^ 4.7, CH,), 3.68 
(3H, s, OCH3), 3.69 (3H, s, OCH3), 3.78(84%) 3.94(16%) ( IH, m, CH), 4.08(84%) 
4.16(16%) ( I H , d, Jg,„, 14.7, CH,), 4.90(84%) 4.96(16%) ( IH, d, J^,„ 14.9, CH,), 
5.70 ( I H , d, J 9.9, CH), 6.34 (2H, m, Ph), 7.12 (7H, m, Ph & CH), 7.36 ( IH , d, J 
15.6, CH); 5,(CDCl3) 14.0 (CH3), 14.5 (CH3), 22.1 (CH3), 32.0 (CH,), 37.1 (CH), 
37.3(CH,), 40.5 (CH,), 57.4 (2x OCH3), 64.6(16%) 66.4(84%) (d, J 40.5, CH), 
100.4 (Ph CH), 102.4 (d, J 63.4, C), 106.4 (Ph CH), 118.0 (CH), 118.2 (Ph C), 
128.8 (Ph CH), 130.4 (Ph CH), 131.6 (Ph CH), 133.3 (Ph CH), 135.0 (Ph C), 137.7 
(C), 151.6 (CH), 153.5 (CH), 160.6 (Ph C), 162.8 (Ph C), 174.4 (dd, CON) 175.9 (d, 
COH), 196.1(84%) 204.8(16%) (CO, enriched), 209.2(84%) 211.4(16%) (CO); 
v„Jneat) /cm' 2958, 2925, 2871, 1664, 1608, 1561, 1507, 1450, 1291, 1208, 1157, 
1035, 612, 490; m/z (CI) 151 (100%). 
6.5.24 5(DL)-[4-"C]-3-(E,E-4,6-Dimethylocta-2,4-dienoyl)-5-benzyl-
2,4-dioxopyrroIidine (3.54a) 
5(DL)-[4-'^C]-N-(2,4-Dimethoxybenzyl)-3-(E,E-4,6-dimethylocta-2,4-dienoyl)-5-
benzyl-2,4-dioxopyrrolidine (0.296g, 0.603mmol) was dissolved in trifluoroacetic acid 
(lOmL) and the bright red solution stirred under nitrogen for 5 minutes. The reaction 
mixture was quenched with ice, resulting in the formation of a pale yellow precipitate. 
This was exti^ acted into dichloromethane (2x 50mL), washed witii saturated aqueous 
NaCOj solution, dried (MgS04), and concentrated in vacuo. The residue was 
redissolved in metiianol (lOmL), and filtered to remove white solid impurities. The 
filtrate was reduced in vacuo to give the title compound as a waxy yellow soUd (0.161g, 
0.472nimol, 79%). Two tautomers in the ratio 85 : 15 were observable by NMR. 
5H(CDC13) (very broad) 0.78 (3H, t, J 7.2, CH3), 0.93 (3H, d, J 6.4, CH3), 1.27 (2H, 
m, CH,), 1.83 (3H, s, CH3), 2.43 ( IH, m, CH), 2.57 ( IH, m, CH,), 3.20 ( IH, m, 
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CH,), 3.93 ( I H , m, CH), 5.76 ( IH, d, J 8.4, CH), 6.32 ( IH, bs, NH), 7.16 (6H, m, 
CH & Ph) 7.43 ( IH , d, J 15.2); 5,(CDCl3) 11.9 (CH3), 12.4 (CH3), 20.0 (CH3), 29.9 
(CH,), 35.2 (CH), 38.3 (CH,), 62.7 (d, J 40.0, CH), 99.4 (d J 59.0 C), 116.2 (br, 
CH), 126.8 (Ph CH), 128.6 (Ph CH), 129.1 (Ph CH), 133.0 (Ph C), 136.8 (C), 149.4 
(br, CH), 151.6 (br, CH), 174.8 175.9 (br, CON & COH), 194.1(85%) 202.3(15%) 
(CO, enriched); v„,,(neat)/cm ' 3188 (br), 3064, 2959, 29259, 2871, 2345, 1678, 1645, 
1609, 1567, 1432, 1288, 981, 695; m/z (EI) 340 (M+, 33.03%). 
6.5.25 (L)-[CjDs]-Phenylalanine methyl ester (3.49b) 
Thionyl chloride (1.05g, 8.82mmol) was added dropwise to a solution of (L)-[C6D5]-
phenylalanine (l.Og, 5.88mmol) in methanol (lOmL) cooled to 0°C. The suspension 
was StUTed at room temperature until product fomiation was complete, as observed by 
t.l.c. (silica plates eluted with nPrOH/NHj (aq con'') 7 : 3, (developed with ninhydrin). 
Solvent was removed in vacuo, and the solid residue redissolved in saturated aqueous 
NaHC03 (20mL). The aqueous solution was extracted into diethyl ether (5x 30mL) and 
the organic exQ-acts were dried (MgS04), before removal of the solvent in vacuo to 
afford the title compound as a pale yellow oU (0.919g, 4.99mmol, 85%). 6H(CDC13) 
1.60 (2H, bs, NH,), 2.83 ( IH, dd, J^ .^  13.9, J^ ,^ 7.7, CH,), 3.05 ( IH, dd, Jg,„, 13.9, 
J,i, 5.1, CH,), 3.68 (3H, s, COOCH3), 3.68 ( IH, m, CH). 
6.5.26 (L)-[CjD5]-N-(2,4-Dimethoxybenzyl) phenylalanine methyl ester 
(3.51b) 
Methanolic HCl was added to a stured solution of (L)-[CgD5]-phenylalanine methyl ester 
(0.919g, 4.99mmol) in methanol (20mL) to adjust to pH 6. 2,4-Dimethoxybenzaldehyde 
(0.947g, 5.70mmol) was added and the solution stirred at room temperature for 30 
minutes. NaBHjCN (0.440g, 7.00mmol) was then added and the reaction stirred at 
room temperature for a further 16 hours. Methanol was removed in vacuo, distilled water 
(lOmL) added and the aqueous mixture extracted into diethyl ether (3x 30mL). The 
organic extracts were combined, washed with an aqueous solution of FeS04, dried 
(MgS04), filtered and reduced in vacuo, affording the crude product as a pale yellow oil. 
Impurities of 2,4-dimethoxybenzylalcohol were removed by distillation under reduced 
presure (furnace tempai-ature 110°C, O.lmmHg), The product could be further puiified 
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by silica gel flash chromatography (hexane: etiiylacetate, 50 : 50). Rf 0.60 (1.459g, 
4.36mmol, 87%) [«]^' =-69.23 (c 1.02, ethanol). 5H(CDC13) 2.12 ( IH , bs, NH), 2.89 
( I H , dd, J^,„ 13.5, J,i, 7.6, CH,), 2.97 ( IH, dd, J^ .^  13.5, 6.2, CH,), 3.49 ( I H , 
dd, J,i, 7.6, J,i, 6.26, CH), 3.59 (3H, s, COOCH3), 3.61 (3H, s, OCH3), 3.74 (3H, s, 
OCH3), 3.80 (2H, d, J 8.1 CH,), 6.37 (2H, m, Ph), 7.00 ( IH, d, J 8.1, Ph); 5,(CDCl3) 
39.4, (CH,), 47.2 (NCH,), 51.5 (COOCH3), 55.0 (OCH3), 55.2 (OCH3), 61.9 (CH), 
98.3 (Ph CH), 103.4 (Ph CH), 119.8 (Ph CH), 127.4-129.0 (m, Ph CD), 130.3 (Ph 
C), 137.1 (Ph C), 158.5 (Ph CO), 160.1 (Ph CO), 174.7 (CO); v^„(neat)/cm-' 3335 
(br), 2999, 2949, 2836, 2362 (w), 2274 (w), 1734, 1612, 1588, 1506, 1460, 1207, 
1156, 1036; m/z (EI) 333 (M-1, 1.98%). 
6.5.27 (L)-[C^D5]-N-(2,4-Dimethoxybenzyl)-N-(E,E-3-oxo-6,8-
dimethyldeca-4,6-dienoyl) phenylalanine methyl ester (3.52b) 
Pyiidiniumpa/a-toluene sulphonate (0.85 Ig, 3.40mmol) was added to a solution of 2,2-
dimethyl-6-(E,E-3,5-dimethylhepta-l,3-dienyl)-l,3-dioxin-4-one (0.851g, 3.40mmol) 
and (L)-[C6D5]-N-(2,4-dimethoxybenzyl)-phenylalanine methyl ester (1.34g, 4.00mmol) 
in toluene (15mL), and the mixture heated to reflux temperature for 3 hours witii stirring. 
After cooling the solvent was removed /// vacuo and the resultant red oil purified over 
silica (peti-oleum ether : etiiyl acetate, 6 : 4 R^  0.51) yielding the titie compound as a 
yellow oil (0.947g, 1.80mmol, 53%). The NMR was complicated by the presence of 
both the the enol and keto tautomers. 5H(CDC13) 0.83 (3H, 2x t, J 7.4, CH3), 0.96 (3H, 
2x d, J 6.4, CH3), 1.31 (2H, m, CH,), 1.72 1.80 (3H, 2x s, CH3), 2.42 ( IH , m, CH), 
3.11 3.37 (2H, m, CH,), 3.56 3.59 (3H, 2x s, COOCH3), 3.72 3.73 (3H, s, OCH3), 
3.76 3.77 (3H, s, OCH3), 3.80 (m, COCH2CO), 3.95 4.32 (2H, m, CH,), 4.10 4.51 
( I H , m, CH), 5.14 ( IH, s, COCH^COH), 5.54 5.77 ( IH, 2x d, J 9.6, CH), 5.73 6.21 
( I H , 2x d J 15.6, CH), 6.35 (2H, m, Ph), 6.91 6.97 ( IH, 2x d, J 8.6, Ph), 7.06 7.29 
( I H , 2x d, J 15.6, CH), 14.0 (0.5H, bs, OH); 5,(CDCl3) 11.9 (CH3) 12.4 (CH3), 20.0 
20.3 (CH3), 29.9 30.1 (CH,), 34.7 35.1 (CH), 35.1 35.4 (CH,), 46.5 47.7, (CH,), 
48.7 (CH,), 52.0 52.1 (COOCH3), 55.1 55.1 (OCH3), 55.2 55.3 (OCH3), 60.2 60.5 
(CH), 89.4 (COCH=COH), 98.2 (Ph CH), 98.5 (Ph CH), 103.6 (Ph CH), 116.0 116.6 
(Ph C), 120.4 123.5 (CH), 129.2 130.4 (Ph CH), 131.8 132.0 (Ph C), 137.8 138.1 
(C), 141.2 149.9 (CH), 145.6 150.6 (CH), 157.8 (Ph COCH3), 158.7 (Ph COCH3), 
160.3 160.9 (CON), 170.2 171.3 (COOCH3), 172.9 (C=COH), 193.8 (CO); 
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v„ax(neat)/cm-'2962, 2934, 2871, 2362, 1738, 1613, 1583, 1506, 1454, 1497, 1206, 
1156, 1118, 1032; m/z ( C I ) 527 (M+1, 6.85%), 335 (100%). 
6.5.28 5(L)-[CsDJ-N-(2,4-Dimethoxybenzyl)-3-(E,E-4,6-dimethylocta-
2,4-dienoyl)-5-benzyl-2,4-dioxopyrrolidine (3.53b) 
To a stiiTed solution of freshly subUmed potassium rm-butoxide (2.91mL of IM 
solution in rm-butanol, 2.92mmol) in fe/Y-butanol (30mL), was added a solution of (L)-
[C6D5]-N-(2,4-dimethoxybenzyl)-N-(E,E-3-oxo-6,8 dimethyldeca-4,6-dienoyl) 
phenylalanine methyl ester (0.792g, 1.46mmol) in tert-hntanol (20mL). After 15 minutes 
stirring the resultant red solution was quenched with dilute aqueous hydrochloric acid 
(lOmL). The organics were extracted into diethyl ether (Ix 60mL), washed with water 
( Ix 15mL), dried (MgS04) and evaporated in vacuo to afford the titie compound as a 
yellow oil (0.72g, 1.46mmol, 100%). Two tautomers in the ratio 84 : 16 were observed 
in the NMR. 5H(CDC13) 0.82 0.83 (3H, 2x t, J 7.3, CH3), 0.97 (3H, d, J 6.7, CH3), 
1.30 (2H, m, CH,), 1.84(16%) 1.86(84%) (3H, d, J 0.81, CH3), 2.44 ( IH , m, CH), 
3.14 (2H, d, J 4.9, CH,), 3.75 (3H, s, OCH3), 3.78 (3H, s, OCH3), 3.85(84%) 
3.99(16%) ( I H , t, J 4.7, CH), 4.14(84%) 4.22(16%) ( IH , d, J^ ,^  14.6, CH,), 
4.96(84%) 5.05(16%) ( IH , d, Jg,„ 14.9, CH,), 5.77 ( IH, d, J 9.7, CH), 6.41 (2H, m, 
Ph), 7.01 ( IH , d, J 9.7, Ph), 7.04 ( IH, d, J 15.4, CH), 7.42(84%) 7.43(16%) ( IH, d, 
J 15.4, CH); 5,(CDCl3) 11.9 (CH3), 12.4 (CH3), 20.0 (CH3), 29.9 (CH,), 35.1 (CH), 
35.2 (CH,), 38.4 (CH,), 55.3 (OCH3), 55.4 (OCH3), 62.6(16%) 64.9(84%) (CH), 
98.4 (Ph CH), 100.3 (C), 104.3 (Ph CH), 116.0 (CH), 116.1 (Ph C), 127.5-129.4 (m, 
3x Ph CD) 131.3 (Ph CH), 133.0 (Ph C), 135.5 (C), 149.5 (CH), 151.5 (CH), 158.5 
(Ph C), 160.8 (Ph C), 173.8 (CON) 174.7 (COH), 194.4(84%) 202.8(16%) (CO); 
v„,,(neat)/cm-' 2959, 2928, 2874, 2270, 1609, 1565, 1506, 1450, 1290, 1261, 1207, 
1156, 1100; m/z ( C I ) 495 (M+1, 8.34%), 151 (100%). 
6.5.29 5(L)-[CsD5]-3-(E,E-4,6-Dimethylocta-2,4-dienoyI)-5-benzyl.2,4-
dioxopyrrolidine (3.54b) 
5(L)-[C6D5]-N-(2,4-Dimethoxybenzyl)-3-(E,E-4,6-dimethylocta-2,4-dienoyl)-5-benzyl-
2,4-dioxopyrrolidine (0.67Ig, 1.36mmol) was dissolved in trifluoroacetic acid (25mL) 
and the bright red solution stuTed under nitrogen for 5 minutes. The reaction mixture was 
quenched with ice, resulting in the formation of a pale yellow precipitate. This was 
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extracted into dichloromethane (2x 75mL), washed with saturated aqueous NaC03 
solution, dried (MgS04), and concentrated in vacuo. The residue was redissolved in 
methanol (20mL), and filtered to remove white solid impurities. The filtrate was reduced 
in vacuo to give the titie compound as a waxy yellow sohd (0.457g, 1.33mmol, 98%). 
Two tautomers in the ratio 85 : 15 were obsei-vable by NMR. 5n(CDCl3) 0.86 (3H, t, J 
7.2, CH3), 1.01(85%) 1.11(15%) (3H, d, J 6.8, CH3), 1.34 (2H, m, CH,), 1.86(15%) 
1.92(85%) (3H, s, CH3), 2.50 ( IH, m, CH), 2.65 ( IH, m, CH,), 3.32 ( IH , m, CH,), 
4.01(85%) 4.18(15%) ( IH, m, CH), 5.70(15%) 5.87(85%) ( IH, d, J 10.0, CH), 6.28 
( I H , bs, NH), 7.14 ( IH , J 15.6, CH), 7.55(85%) 7.96(15%) ( IH , d, J 15.6, CH); 
5D(CDC13) 7.41 (bs, Ph); 6,(CDCl3) 11.9 (CH3), 12.4 (CH3), 20.0 (CH3), 29.9 (CH,), 
35.3 (CH), 38.3 (CH,), 61.5(15%) 63.4(85%) (CH), 99.4 (C), 115.7 (CH), 128.5 (m, 
Ph C D ) , 133.1 (Ph C), 136.6 (C), 150.7 (CH), 152.5 (CH), 175.5 175.6 (CON & 
COH), 194.1(85%) 202.7(15%) (CO); v^Jneat)/cm-' 3185 (br), 3063, 2967, 2954, 
2922, 2871, 1659, 1620, 1569, 1428, 1293, 979, 722; m/z (EI) 344 (M+, 18.25%). 
6.5.30 (DL)-Tyrosine methyl ester, hydrochloride (3.66) 
Thionyl chloride (8.33g, 70mmol) was added di-opwise to di-y distilled methanol (50mL) 
and stirred rapidly at -5°C. (DL)-Tyrosine (12.7g, 70mmol) was then added and the 
solution heated under reflux for 3 hours. After cooUng die solution was diluted with dry 
dietiiyl ether (200mL), resulting in precipitation of the product. The product was 
collected by filtration, washed with dietiiyl ether and dried in vacuo. Recrystallisation 
from ethanol afforded tiie product (15.1g, 65.18mmol, 93%) as shiny white crystals, 
m.p. 189.5-190°C (lit. 189-190°C)- 5H(CDC13) 2.74 (IH, dd, J .^^  13.1, J.^ , 7.9, CH,), 
2.98(1H, dd, Jg,„ 13.1, J„i, 5.3, CH,), 3.55 (3H, bs & m, N H , & CH), 3.67 (3H, s, 
COOCH3), 6.60 (2H, d, J 8.5, Ph), 6.91 (2H, d, J 8.3, Ph); 5,(CDCl3) 41.70 (CH,), 
54.22 (OCH3), 57.52 (CH), 117.80 (Ph CH), 129.73 (Ph C), 132,34 (Ph CH), 157.43 
(Ph COH); v„,, (neat)/cm-' 3301, 3256, 3044, 2884, 2858, 2608, 1742, 1607, 1588, 
1511, 1447, 1222. 
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6.5.31 (DL)-N-(2,4-Dimethoxybenzyl) tyrosine methyl ester, 
hydrochloride (3.67) 
2,4-Dimethoxybenzaldehyde (2.74, 16.50mmol) was added to a stirred solution of 
(DL)-tyrosine methyl ester, hydrochloride salt (3.48g, 15.0mmol) in methanol (70mL) 
and the reaction mixture stined at room temperatui-e for 30 minutes. NaBH3CN (1.13g, 
18.0mmol) was then added and the reaction stirred at room temperature for a further 16 
hours. 10% hydrochloric acid was carefully added via a pressure equaUsing dropping 
funnel until there was no further evolution of gas, and the solution remained at pH 1. 
The evolved gases were bubbled through KOH solution in a fume hood to neutraUse the 
HCN. The aqueous solution was extracted with ethyl acetate (3x 70mL), dried (MgS04) 
and reduced in vacuo to give a the title compound as a white amorphous solid, which 
could be recrystallised from acetonitrile (3.94g, 10.32mmol, 69%). 5H(CDC13) 3.18 
(2H, m, CH,), 3.57 (3H, s, COOMe), 3.69 ( IH, m, CH), 3.80 (3H, s, OCH3), 3.81 
(3H, s, OCH3), 4.10 (3H, bm, CH, & NH), 6.60 (2H, m, Ph), 6.74 (2H, d, J 8.5, 
Ph), 6.99 (2H, d, J 8.4, Ph), 7.44 ( IH, d, J 7.0, Ph); 5,(CDCl3) 34.6 (CH,), 43.9 
(NCH,), 52.5 (COOCH3), 55.4 (OCH3), 55.7 (OCH3), 59.6 (CH), 98.2 (Ph CH), 
105.0 (Ph CH), 110. 8 (Ph CH), 115.3 (Ph CH), 124.2 (PH C), 130.2 (Ph CH), 133.3 
(Ph C), 156.7 (Ph COH), 159.0 (Ph COCH3), 161.8 (Ph COCH3), 168.5 (CO); 
V™ax(neat)/cm-' 3224 (br), 3943, 2833, 2789, 2361, 1748, 1615, 1590, 1510, 1445, 
1422, 1211.59, 1159, 1133, 1034; m/z (CI), 346 (M+1, 15.72%), 196 (96.74%), 151 
(100%); Found 346.1654, C19H24NO5 (MH+) requkes 346.1654. 
6.5.32 (DL)-N-(2,4-Dimethoxybenzyl)-0-(4-methoxybenzyl) tyrosine 
methyl ester (3.69) 
(DL)-N-(2,4-Dimethoxybenzyl) tyrosine methyl ester, hydrochloride (1.75g, 
4.58mmol), K2C03(1.38g, lO.Ommol), 4-methoxybenzyl chloride (0.832g, 5.31mmol) 
and (Bu)4NI (1.85g, 5.01mmol) were dissolved in DMF (50mL) and stirred at 60° for 3 
days. After cooling to room temperatui'e, water (50mL) was added and the organics 
extracted into diethyl ether (3x 50mL). The ether extracts were washed with I N NaOH 
solution and brine, dried (MgS04), and reduced in vacuo to give a colourless oil. This 
was purified over silica (diethyl ether: hexane, 70 : 30 Rf 0.39) to give the titie compound 
as a viscous, colourless oil (1.96g, 4.21mmol, 92%). 6H(CDC13) 2.90 ( IH , dd, J^ .^  
13.6, J,i, 7.8, CH,), 3.04 ( IH , dd, J^ .^  13.6, J^ ,^ 7.6, CH,), 3.54 ( IH , m, CH), 3.75-
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3.90 (4H, m, 2x CH^), 3.71 (3H, s, OCH3), 3.73 (3H, s, OCH3), 3.78 (3H, s, OCH3), 
3.79 (3H, s, OCH3), 5.81 ( IH, bs, NH), 6.42 (2H, m, Ph), 6.68 (2H, d, J 7.2, Ph), 
6.79(2H, d, J 7.2, Ph), 6.87(2H, d, J 7.2, Ph), 7.12(2H, d, J 7.2, Ph), 7.15 ( IH, d, J 
8.0, Ph); 5,(CDCl3) 32.7 (CH^), 47.5 (CH^), 51.1 (COOCH3), 53.9 (CH^), 55.1 
(OCH3), 55.2, (OCH3), 55.3 (OCH3), 62.8 (CH), 98.1 (Ph CH), 103.9 (Ph CH), 
113.4 (Ph CH), 114.9 (Ph CH), 119.7 (Ph, C), 129.7 (Ph, CH), 130.3 (Ph C), 130.4 
(Ph CH), 131.6 (Ph C) 154.1 (Ph COCH^), 158.3 (Ph COCH3), 158.7 (Ph COCH3), 
159.5 (Ph C O C H 3 ) , 173.4 (CO); v„,,(neat)/cm ' 3389 (br), 2949, 2835, 1727, 1611, 
1586, 1507, 1454, 1438, 1240, 1206, 1154, 1105, 1032, 814; nVz (CI) 466 (M+1, 
6.87%), 151 (100%); Found 466.2230, C27H32NO6 (MH+) requires 466.2230. 
6.5.33 (DL)-N-(2,4-Diniethoxybenzyl)-0-benzyl tyrosine methyl ester 
(3.71) 
(DL)-N-(2,4-Dimethoxybenzyl) tyrosine methyl ester, hydrochloride (2.13g, 
5.59mmoI), K2C03(1.71g, 12.35mmol) and benzyl bromide (1.54g, 9.02mmol) were 
dissolved in DMF (50mL) and stined at 60° for 2 days. After cooUng to room 
temperature water (50mL) was added and the organics extracted into diethyl ether (3x 
50mL). The ether extracts were washed with I N NaOH solution and brine, dried 
(MgSOJ, and reduced in vacuo to give a colourless oil. This was purified over silica 
(diethyl ether: hexane, 70 : 30) Rj 0.42, to give the title compound as a viscous, 
colourless oil (1.87g, 4.29 mmol, 77%). 6H(CDC13) 2.92 ( IH , dd, J .^^  13.9, J,,, 7.8, 
CH2), 3.06 ( I H , dd, J^,„ 13.9, J,., 7.3, CH^), 3.65 ( IH, m, CH), 3.67-4.05 (4H, m, 
2x CH2), 3.72 (3H, s, OCH3), 3.74 (3H, s, OCH3), 3.79 (3H, s, OCH3), 3.80 (3H, s, 
OCH3), 5.45 ( IH , bs, NH), 6.42 (2H, m, Ph), 6.69 (2H, d, J 8.6, Ph), 6.89 (2H, d, J 
8.5, Ph) 7.22 (6H, m, Ph); 6,(CDCl3) 36.9 (CH^), 49.9 (CH^), 53.2 (CH^), 56.6 
(OCH3), 57.2, (OCH3), 57.4 (OCH3), 65.0 (CH), 100.2 (Ph CH), 106.0 (Ph CH), 
116.7 (Ph CH), 121.7 (Ph C), 128.7 (Ph CH), 130.0 (Ph CH), 130.7 (Ph CH), 132.4 
(Ph CH) 132.5 (Ph CH), 132.6 (Ph C), 141.7 (Ph C), 156.1 (Ph COCH^), 160.8 (Ph 
COCH3), 161.7 (Ph £0CH3), 175.4 (CO); v^,,(neat)/cm-' 3406 (br), 2948, 2834, 1715, 
1611, 1587, 1506, 1453, 1437, 1287, 1262, 1206, 1154, 1110, 1036, 823, 728, 697; 
m/z ( C I ) 436 (M+1, 9.92%), 151 (100%); Found 436.2124, C26H30NO5 (MH+) 
requires 436.2124. 
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6.5.34 (DL)-N-(2,4-Diinethoxybenzyl)-N-(E,E-3-oxo-6,8-dimethyldeca-
4,6-dienoyI)-0-benzyl tyrosine methyl ester (3.72) 
Pyridiniumpara-toluene sulphonate (0.25Ig, l.OOmmol) was added to a solution of 2,2-
dimethyl-6-(E,E-3,5-dimethylhepta-l,3-dienyl)-l,3-dioxin-4-one (0.250g, l.OOmmol) 
and (DL)-N-(2,4-dimethoxybenzyl)-0-benzyl tyrosine methyl ester (0.615g, 1.41mmol) 
in toluene (6mL), and the mixture heated to reflux temperature for 2 hours with stirring. 
After cooling the solvent was removed in vacuo and the resultant red oil purified over 
silica (peti-oleum ether : ethyl acetate, 6 : 4) yielding the title compound as a yellow oil 
(0.345g, 0.55mmol, 55%). The NMR spectra were complicated by keto and enol forms, 
and could not be fully assigned. 5H(CDC13) 0.92 0.99 (3H, 2x t, J 7.4, CH3) , 1.70 1.21 
(3H, 2x s, CH3), 1.40 (2H, m, CH2), 1.73 1.79 (3H, 2x s, CH3), 2.42 ( IH , m, CH), 
2,96-3.08 (2H, m, CHj), 3.10-3.39 (2H, m, CHj), 3.61 3.63 (3H, 2x s, OCH3), 3.70 
3.73 (3H, 2x s, OCH3), 3.79 (3H, s, COOCH3), 3.95 (COCH2CO), 3.60-4.60 (3H, m, 
CH & CH2), 5.13 (s, COCH=COH), 5.58 5.80 (IH, 2x d, J 9.6, CH), 5.67 6.20 ( I H , 
2x d J 15.6, CH), 6.15-7.20 (14H, m, Ph & CH); 5,(CDCl3) 11.9 (CH3) 12.4 (CH3), 
20.0 20.3 (CH3), 29.6 30.1 (CH^), 34.3 34.6 (CH), 34.8 35.1 (CH^), 47.6 51.1 
(CH2), 52.1 (COOCH3), 55.10 (OCH3), 55.3 (OCH3), 60.5 61.8 (CH), 61.6 63.0 
(CH2), 88.9 (COCH=COH), 98.1 (Ph CH), 103.9 (Ph CH), 114-140 (Ph) 120.2 123.3 
(CH), 141.7 151.0 (CH), 146.0 151.5 (CH), 145.4 150.5 (CH), 154.2 (Ph COCH3), 
154.8 (Ph COCH3), 158.7 159.6 (CON), 170.8 171.2 (COOCH3), 172.9 173.3 
(C=COH), 193.8 (CO); v„,,(neat)/cm ' 3371, 2959, 2932, 2358, 1738, 1614, 1578, 
1451, 1205; m/z (CI) 436 (36%) 151 (100%). 
6.5.35 5(DL)-N.(2,4-Dimethoxybenzyl)-3-(E,E-4,6-dimethylocta-2,4-
dienoyl)-5-(0-benzyl)-4-hydroxybenzyl-2,4-dioxopyrroIidine (3.73) 
To a stin-ed solution of freshly subUmed potassium tert-hutoxide (1 molar solution in tert-
butanol), (0.74mL, 0.739mmol) in toY-butanol (lOmL), was added a solution of (DL)-
N-(2,4-dimethoxybenzyl)-N-(E,E-3-oxo-6,8-dimethyldeca-4,6-dienoyl)-0-benzyl 
tyrosine methyl ester (0.238g, 0.379mmol) in rm-butanol (5mL). After 20 minutes 
stirring the resultant red solution was quenched with dilute aqueous hydrochloric acid 
(5mL). The organics were extracted into diethyl ether (Ix 30mL), washed with water (Ix 
5mL), dried (MgS04) and evaporated in vacuo to afford the title compound as an orange 
oil (0.182g, 0.306mmol, 81%). Two tautomers in the ratio 77 : 23 were observable by 
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NMR. 5H(CDC13) 0.85 (3H, t, J 7.3, CH3), 1.00 (3H, d, J 6.4, CH3), 1.29 (2H, m, 
CH,), 1.87 (3H, s, CH3), 2.43 ( IH, m, CH), 3.05 (2H, d, J 4.7, CH,), 3.6-4.0 (lOH, 
2XCH2 & 2xOMe), 5.22(77%) 5.40(23%) ( IH, m, CH), 5.82 ( IH, d, J 9.7, CH), 
6.30-7.40 (13H, Ph & CH), 7.43 ( IH, d, J 15.4, CH); 5,(CDCl3) 11.9 (CH3), 12.4 
(CH3), 20.0 (CH3), 29.7 (CH2) 29.9 (CH^), 34.6 (CH), 35.3 (CH^), 43.7 (CH^), 55.4 
(2x OMe). 64.5 (CH), 98.1 (C), 115.7 (CH), 135.4 (C), 150.4 (CH), 152.3 (CH), (8x 
Ph CH & 6xPh C), 173.90 & 174.15 (COH & CON), 194.1 (CO); v„„(neat)/cm-' 3332, 
2960, 2921, 2870, 2338 (w), 1610, 1565, 1506, 1448, 1205, 1154, 1035. 
6.5.36 5(DL)-3-(E,E-4,6-Dimethylocta-2,4-dienoyl)-5-(0-benzyl)-4-
hydroxybenzyl-2,4-dioxopyrroIidine (3.74) 
5(DL)-N-(2,4-Dimethoxybenzyl)-3-(E,E-4,6-dimethylocta-2,4-dienoyl)-5-(0-benzyl)-4-
hydroxybenzyl-2,4-dioxopyiTolidine (64.9mg, O.lOmmol) was dissolved in a solution 
of pentamethylbenzene (0.148g, l.Ommol) in trifluoroacetic acid (2mL) and the bright 
red solution stured under nitrogen, for lOminutes. The trifluoroacetic acid was removed 
in vacuo and the resulting solid dissolved in dichloromethane (lOmL) and washed with 
water (2x lOmL). After removal of the solvent in vacuo, the majority of the 
pentamethylbenzeme was precipitated out in methanol : water (85 : 15) and the filtrate 
containing the crude product, a red solid, was analysed by HPLC. MS and 'H NMR 
analysis of the crude product indicated only N-deprotection had occured even after four 
hours in trifluoroacetic acid, and therefore further purification was not attempted. 
5H(CDC13) 0.75 (3H, t, J 7.3, CH3) , 0.99 (3H, d, J 6.7, CH3) , 1.35 (2H, m, CH^), 
1.85 (3H, s, C H 3 ) , 2.43 ( IH , m, CH), 3.18 (2H, m, CH3) , 3.8-4.1 (3H, m, CH & 
CHj), 5.8 ( IH , d, J 9.6, CH), 6.5-7.5 ( I I H , Ph & 2x CH) m/z (ED 445 (M+, 28%), 
91 (100%). 
6.6 Feeding of Putative Tetramic acid Intermediates 
6.6.1 5(DL)-[4-"C]-3-(E,E-4,6-DimethyIocta-2,4-dienoyl)-5.benzyl-2,4-
dioxopyrrolidine 
5(DL)-[4-'^C]-3-(E,E-4,6-Dimethylocta-2,4-dienoyl)-5-benzyl-2,4-dioxopyrrolidine 
(0.136g, 0.40mmol) was dissolved in ethanol (8mL) and pulse fed to four production 
media cultures, through a micropore filter on days 4, 5, 6 and 7, to give a final 
217 
concentration 2.0 mmolar in each flask. Tenellin (70mg) was isolated and purified on 
day 1 l.'^C NMR showed no observable enrichment. 
6.6.2 5(L)-[CjDs]-3-(E,E-4,6-DimethyIocta-2,4-dienoyI)-5-benzyl-2,4-
dioxopyrroiidine 
5(DL)-[C6D5]-3-(E,E-4,6-Dimethylocta-2,4-dienoyl)-5-benzyl-2,4-dioxopyiToUdine 
(0.103g, 0.30mmol) was dissolved in ethanol (4mL) and pulse fed to four production 
media cultures, through a micropore filter on days 4, 5, 6 and 7, to give a final 
concentration 1.5 mmolar in each flask. TenelUn (80mg) was isolated and purified on 
day 1 l.^H NMR showed no obsei-vable enrichment. 
5(DL)-[C6D5]-3-(E,E-4,6-Dimethylocta-2,4-dienoyl)-5-benzyl-2,4-dioxopyrrohdine 
(0.103g, 0.30mmol) was dissolved in DMSO (2mL) and pulse fed as above. Tenellin 
(65mg) was isolated and purified on day 1 l."H NMR showed no observable enrichment. 
6.7 Attempted Isolation of Tetramic acid Intermediate 
6.7.1 L C M S analysis of Beauvaria bassiana cultures 
Ten production media flasks (50mL) were innoculated from 7 day old production media 
(5mL) and shaken at 200rpm, 32°C in the dark. One flask was removed on each of days 
1-9. The myceUa were obtained by centrifugation and exhaustively extracted into 
acetone. The acetone extracts were reduced in vacuo and redissolved in methanol to a 
concentration of Img/mL, and subjected to LCMS analysis, methanol : water, 85 : 15, 
0.1% tiifluoroacetic acid, over a Hypersil C-18 BDS-protected column (5|im, 250 x 
4.6mm). 
6.7.2 Growth Beauvaria bassiana with P450-inhibitors 
Two production media flasks (50mL) were incubated with metapyrone and two with 
miconazole at two concentrations of 2 mmolar and 4 mmolai- respectivley. After 10 days 
growth the mycelia were obtained by cenhifugation and exhaustively extracted into 
acetone. The acetone exttacts were reduced in vacuo and subjected to LCMS analysis. 
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methanol: water, 85 : 15,0.1% trifluoroacetic acid over a Hypersil C-18 BDS-protected 
column (5\xm, 250 x 4.6mm). 
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6.8 Synthesis of Phenylpropanoid Metabolites 
6.8.1 Methyl phenylacetate (4.22) 
Phenylacetic acid (2.5g, 18.36mmol) in diethyl ether (60mL) was quenched with a 
solution of diazomethane (25mmol) in ether (lOOmL) generated from Diazald (5.35g, 
25mmol) in ether (80mL) and potassium hydroxide (2g, 35.71mmol) in ethanol (20mL). 
Excess diazomethane was quenched by the dropwise addition of glacial acetic acid such 
that the yeUow colour disappeared. The solution was dried (MgSO^), filtered and 
evaporated under reduced pressure. The residue was purified over sihca 
(dichloromethane) to give methyl phenylacetate (2.70g, 17.99mmol, 98%) as a clear 
colourless oil. 5H(CDC13) 3.66 (2H, s, CH^), 3.71 (3H, s, OCH3), 7.32 (5H, m, Ar); 
5,(CDCl3) 41.7 (CH2), 52.5 (OCH3), 127.6 (CH), 129.1 (CH), 129.8 (CH), 134.5 (C), 
172.6 (CO); v„,, (neat)/cm-' 3031, 2953, 1738, 1258, 1161, 732; nVz (EI) 150 (M+, 
57.99%), 91 (100%). 
6.8.2 Phenylethanol (4.23) 
Methyl phenylacetate (l.OOg, 6.66mmol) was added dropwise to a stirred suspension of 
Uthium aluminium hydride (l.Olg, 26.64mmol) in diethyl ether (30mL). The mixture 
was heated under reflux for 2h under dry N2. After cooling to 20°C the reaction was 
quenched by the addition of wet diethyl ether (20mL), and poured into 5% H2SO4 
(30mL). The ether layer was separated and the aqueous layer extracted into diethyl ether 
(2x 30mL).The combined organic extracts were dried (MgSO^), filtered and evaporated 
under reduced pressure. The residue was over silica (CH2CI2) to give 2-phenylethanol 
(0.67g, 5.46mmol, 82%) as a clear colourless oil. 5H(CDC13) 1.73 ( IH , bs, OH), 2.87 
(2H, t, J 6.6, CH2), 3.86 (2H, t, J 6.6), 7.26 (5H, m, Ar); 5,(CDCl3) 39.7 (CH2), 64.2 
(CH2), 127.0 (CH), 129.1 (CH), 129.6 (CH), 139.0 (C); v„,,(neat)/cm-' 3355 (br), 
3027, 2942, 2877, 2246, 1603, 1496, 1453, 1046, 733, 699; m/z (EI) 122 (M+, 
40.56%), 91 (100%). 
220 
6.8.3 Phenylacetaldehyde (4.24) 
Pyridinium chlorochromate (2.16g, lOmmol), diied molecular sieves (35g) and freshly 
distilled dichloromethane were added to a diy flask under dry N^. 2-Phenylethanol 
(0.6Ig, 5mmol) was added dropwise and the mixture was stiixed vigorously for 2h. The 
dark brown reaction mixture was filtered through sihca (10cm depth) in a wide sintered 
glass funnel under reduced pressure. The column was washed with dichloromethane 
(400niL) and the filtrate reduced in vacuo to give phenylacetaldehyde as a pale yellow oil 
(0.47g, 3.91mmol, 78%). As the compound is unstable to storage it was routinely used 
without further purification. 5H(CDC13) 3.69 (2H, d, J 1.0, CH,) 7.30 (5H, m. Ar), 
9.75 ( I H , t, J 1.2); 5,(CDCl3) 51.1 (CH^), 127.9 (CH), 129.5 (CH), 130.1 (CH), 
130.2 (C), 199.9 (CO); (neat)/cm-' 3030, 2823, 2729, 1724, 1702, 911, 733, 700. 
6.8.4 (DL)-Phenylalanine hydrochloride (4.25) 
To a stiired solution of phenylacetaldehyde (0.415g, 3.45mmol) in methanol (15mL) 
cooled to -5°C, was slowly added a solution of NH^Cl (0.267g, 5mmol) in water 
(8mL). After 10 min stirring, KCN (0.326g, 5.00mmol) was added and stirring 
continued at 20°C for 24 hours. Methanol was removed in vacuo and the aqueous 
solution extracted into dichloromethane (3x 15mL), dried (MgS04) and evaporated in 
vacuo to afford a brown oil. This was heated under reflux with concentrated aqueous 
hydi'ochloric acid (lOmL) for 48 hours. Solvent was removed //; vacuo and the resulting 
solid washed with cold acetone (20mL) leaving a white amorphous solid, (DL)-
phenylalanine hydrochloride (0.335g, 1.66mmol, 49%). m.p 230-230.5°C (lit. 230°C)' 
5H(D20) 3.07 ( IH , dd, J,i, 7.6, J^,„ 14.6, CH), 3.23 ( IH, dd, J.^ , 5.9, 14.6, CH); 
4.24 ( I H , dd, J,i, 7.8, 5.6, CH), 7.27 (5H, m, Ar); 5,(D20) 40.0 (CH^), 58.6 
(CH), 132.5 (C), 133.7 (CH), 133.9 (CH), 138.4 (C), 175.9 (CO); v^„(neat)/cm-' 
2060 (br), 1732, 1600, 1486, 1412, 1226, 1194, 731.47, 699; m/z (CI-H) 166 (M+1, 
69.94%), 120 (100%); Found 166.0868, C^HpO^N (M+1) requires 166.0868; GCMS 
(0-, N-trimethylsilyl derivative) 218 (M-91,100%). 
6.8.5 [1-"C]-Methyl phenylacetate (4.22) 
[1-'^C]-Phenylacetic acid (l.Og, 7.29mmol) in diethyl ether (25mL) was quenched with 
a solution of diazomethane (15mmol) in diethyl ether (60mL) generated fi-om Diazald 
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(3.21g, 15mmol) in diethyl ether (50mL) and potassium hydroxide (1.2g, 21.4mmol) in 
ethanol (30mL). Excess diazomethane was quenched by the dropwise addition of glacial 
acetic acid such that the yellow colour disappeaied. The solution was dried (MgS04), 
filtered and evaporated under reduced pressure. The residue was purified over sihca 
(dichloromethane) to give [l-'^C]-methyl phenylacetate (0.99g, 6.55mmol, 89%) as a 
clear colourless oil. 5H(CDC13) 3.61 (2H, d, J^^CR 12.1, CHj), 3.71 (3H, d, J,3CH 3.9, 
OCH3), 7.31 (5H. m. Ph); 5,(CDCl3) 41.7 (d, J 57.7, CH,), 52.5 (d, J 2.6, OCH3), 
127.6 (C), 129.1 (CH), 129.8 (CH), 134.6 (C), 172.5 (CO, enriched); v„,, (neat)/cm-' 
3031, 2952, 1738, 1258, 1161, 732; m/z (EI) 151 (M+, 13.47%), 91 (100%). 
6.8.6 [l-^C'Hjl-Phenylethanol (4.23) 
[1-"C]-Methyl phenylacetate (0.93g, 6.19mmol) was added dropwise to a stirred 
suspension of lithium aluminium deuteride (l.OOg, 23.82mmol) in diethyl ether (30mL). 
The mixture was heated under reflux for 2h under diy N j . After cooling to 20°C the 
reaction was quenched by the addition of wet diethyl ether (20mL), and poured into 5% 
H2SO4 (30mL).The ether layer was separated and the aqueous layer extracted into diethyl 
ether (2x30mL).The combined organic extracts were dried (MgS04), filtered and 
evaporated under reduced pressure. The residue was purified over sihca 
(dichloromethane) to give [l-'^C^HjJ-phenylethanol (0.68g, 5.41mmol, 87%) as a clear 
colourless oil. 5H(CDC13) 2.59 ( IH, bs, OH), 2.86 (2H, d, J,3CH 5.5, CH2) 7.28 (5H, m 
Ph); 5,(CDCl3) 39.5 (d, CH^), 63.3 (enriched, p, CD2), 126.9 (C), 129.1 (CH), 129.6 
(CH), 139.2 (C); v„,Jneat)/cm-' 3346 (br), 3027, 2931, 2190, 2089, 1603, 1496, 
1453, 1103, 1081, 744, 699; m/z (ED, 125 (M+), (42.25%), 91 (100%). 
6.8.7 [l."C^H]-Phenylacetaldehyde (4.24) 
Pyridinium chlorochi-omate (2.16g, lOmol), diied moleculai- sieves (35g) and freshly 
distilled dichloromethane were added to a di-y flask under dry N2. [1-'^C-H2]-
Phenylethanol (0.54g, 4.32mmol) was added dropwise and the mixture was stured 
vigorously for 2h. The dark brown reaction mixture was filtered through silica (10cm 
depth) in a wide sintered glass funnel under reduced pressure. The column was washed 
with dichloromethane (400mL) and the filtiate reduced in vacuo to give 
phenylacetaldehyde as a pale yellow oil (0.44g, 3.60mmol, 83%). As the compound is 
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unstable to storage it was routinely used without further purification and analysis. 
5H(CDC13) 3.69 (2H, d, JI3CH 7.0, CH^) 7.30 (5H, m. Ar); 5,(CDCl3) 52.1 (d, J 31.7, 
CH2) , 129.4 (CH), 131.0 (CH), 131.6 (CH), 131.7 (C), 201.8 (enriched, t, CDO). 
6.8.8 [2-"C'H^'N]-(DL)-Phenylalanine hydrochloride (4.25) 
To a stirred solution of [l-'^C^H]-phenylacetaldehyde (0.478g, 3.91mmol) in methanol 
(15mL) cooled to -5°C was slowly added a solution of '^NH^Cl (0.427g, 7.83mmol) in 
water (6mL). After 10 min stirring, KCN (0.260g, 4.0mmol) was added and stirring 
continued at 20 °C for 24 hours. Methanol was removed in vacuo and the aqueous 
solution extracted into dichloromethane (3x 20mL), dried (MgS04) and evaporated in 
vacuo to afford a brown oil. This was heated under reflux with concentrated aqueous 
hydrochloric acid (lOmL) for 48 hours. Solvent was removed in vacuo and the resulting 
soUd washed with cold acetone (50mL) leaving a white amoiphous solid, [ 2 - ' ^ C ^ H ' ' N ] -
(DL)-phenylalanine hydrochloride (0.139g, 0.68mmol, 17%). SH(D20) 3.16 (2H, m, 
C H 2 ) , 7.30 (5H, m, Ph); 5,(D20) 40.02 (CH^), 60.14 (td, 1,3^^ 21.82, J , , ^ , , ^ 5.9, 
CD'^NH2), 132.41 (C), 133.54 (CH), 134.00 (CH), 138.48 (C), 175.96 (CO); GCMS 
( 0 - , N-trimethylsilyl derivative) 221 (M-91,100%). 
6.8.9 Para-hydroxycinnamic acid (4.35) 
Malonic acid (0.25g, 2.40mmol) and aniline (0.017mL) were dissolved in pyridine 
(ImL) and warmed gently until dissolved, /'ara-hydroxybenzaldehyde (0.342g, 
2.80mmol) was added and the mixture stirred at 65°C for 16 hours under N^. After 
cooling, the reaction mixture was added to a mixture of concentrated hydrochloric acid 
(2mL) and ice (4g). The brown precipitate was collected by filtration. The filti-ate was 
extracted into diethyl ether (2x 50mL), reduced in vacuo and combined with the 
precipitate. The precipitate was treated with 5% sodium hydrogen carbonate (lOOmL) to 
take up the acids, and washed with diethyl ether (2x 20mL). The alkaline aqueous 
solution was reduced in vacuo to 20 mL, and added dropwise to a mixture of 
concentrated hydrochloric acid (5mL) and ice (20g). The precipitate thus formed was 
collected by filtration, diied and reciystallised from ethanol / water to give pam-
hydroxycinnamic acid as a white solid (0.28g, 1.71mmol, 71%). m.p. 211-212°C (lit. 
210-211°C') 5H(DMSO-d6) 6.30 ( IH, d, J15.9 , CH), 6.80 (2H, d, J 8.4 ,Ph), 7.51 
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( I H , d, J 15.6, CH), 7.52 (2H, d, J 8.5, Ph), 10.00 ( IH, s, OH), 12.18 ( IH , bs, OH); 
5c(DMSO-d6) 117.1 (CH), 117.5 (Ph CH), 127.0 (Ph C), 131.9 (Ph CH), 146.0 
(CH), 161.4 (Ph C), 169.8 (COOH); v^,(neat)/cm-' 3357 (br), 3027, 2818, 1666, 
1626, 1600, 1589, 1510, 1447, 1311, 1241, 1211, 1171, 977, 828; m/z 164 (M+, 
100%), 147 (44.80%); Found 164.0473, C9Hg03 (M+) requkes 164.0473. 
6.8.10 [2-"C]-Pflra-hydroxycinnaniic acid (4.35) 
[2-'^C]-Malonic acid (0.25g, 2.38mmol) and aniline (0.017mL) were dissolved in 
pyridine (ImL) and warmed gently until dissolved, /'ara-hydroxybenzaldehyde (0.342g, 
2.80mmol) was added and the mixture stirred at 65°C for 16 hours under N , . After 
cooUng the reaction mixture was added to a mixture of concentrated hydrochloric acid 
(2mL) and ice (4g). The brown precipitate was collected by filtration. The filtrate was 
extracted into diethyl ether (2x 50mL), reduced in vacuo and combined with the 
precipitate. The precipitate was treated with 5% sodium hydrogen carbonate (lOOmL) to 
take up the acids, and washed with diethyl ether (2x 20mL). The alkaline aqueous 
solution was reduced in vacuo to 20 mL, and added dropwise to a mixture of 
concentrated hydrochloric acid (5mL) and ice (20g). The precipitate thus formed was 
collected by filtration, dried and recrystallised from ethanol / water to give [2-'^C]-para-
hydroxycirinamic acid as a white sohd (0.28g, 1.70mmol, 72%). m.p. 211-212°C 
5H(DMSO-d6) 6.27 ( IH, dd, JI3CH 136.7, J 15.6, CH), 6.77 (2H, d, J 8.0, Ph), 7.48 
( I H , d, J 16.8, CH),7.50 (2H, d, J 8.0, Ph), 9.97 ( IH, s, OH), 12.13 (bs, OH); 
5c(DMSO-d6) 115.3 (CH, enriched), 115.8 (Ph CH), 125.3 (Ph C), 130.1 (d, J 4.5, 
Ph CH), 144.2 (d, J 70.2, CH), 159.6 (Ph), 168.0 (d, J 73.2, COOH), m/z (EI) 165 
(M+, 100%), 148 (42.91%), 121 (36.07%). 
6.8.11 [/ne/a-^H2]-(DL)-Parfl-hydroxyphenyllactic acid (4.37) 
(DL)-fflra-hydroxyphenyllactic acid (lOOmg, 0.548mmol) was dissolved in 9% DQ in 
DjO (4mL) and heated at 80°C for 6 hours in a sealed tube. After coohng the solution 
was saturated with NaCl and exti'acted with ethyl acetate (4x lOmL). The combined 
extracts were dried over MgS04, filtered and evaporated. The product was purified by 
recrystaUsation from diethyl ether (78.7mg, 42.7mmol, 78%). m.p. 130-132.5°C (lit. 
133-135°C)^ 5H(CDC13) 2.76 ( IH, dd, J^ ^^  14.2, J,;, 7.4, CH2) , 2.91 ( IH , dd, J^,„ 
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14.2, J,.^  4.7, CH2), 4.32 ( IH, dd, J,., 7.3, J,., 4.9, CH), 7.01 (2H, s, Ph); 5,(CDCl3) 
41.1 (CHj), 73.7 (CH), 117.5 (t, J 24.2, Ph CD), 131.0 (Ph C), 133.1 (Ph CH), 156.6 
(Ph COH), 179.5 (CO); v„,,(neat)/cm ' 3464, 3290, 2950, 2927, 2568, 2463, 2274, 
2209, 1711, 1602, 1472, 1420, 1293, 1174, 1072; m/z (CI) 202 (M+18, 6.42%), 184 
(M+, 3.57%), 109 (100%). 
6.8.12 (DL)-Fara-hydroxyphenyllactic acid (4.39) 
fara-hydroxyphenyl pyruvic acid (0.72 Ig, 4.0mmol) as an emulsion in water (30mL) 
was added dropwise to sodium borohydride (0.227g, 6.0mmol) in water (15mL) stirred 
at 0°C. Stining was continued under N , for 1.5 hours at room temperature. Excess 
sodium borohydride was destroyed by addition of 10% aqueous hydi'ochloric acid. The 
aqueous solution was reduced in vacuo to lOmL and extracted into ethyl acetate (3x 
50mL). The organic extracts were dried (MgS04) and reduced in vacuo to give an off 
white solid. This was washed with diethyl ether to give pure (PL)-para-
hydroxyphenyllactic acid, as a white solid (0.471g, 2.74mmol, 65%). m.p. 129-130°C 
(lit. 133-135°C)^ 5H(D20) 2.73 ( IH, dd, J^ .^  14.1, J.^ , 7.2, CH2) , 2.88 ( IH , dd, J^ .^  
14.1, J^,^ 4.7, C H 2 ) , 4.30 ( IH, dd, J,i, 7.4, J,., 4.9, CH), 6.67 (2H, d, J 8.6, Ph), 
6.98 (2H, d, J 8.5, Ph); 5,(D20) 43.1 (CH2), 75.8 (CH), 119.8 (Ph CH), 133.0 (Ph 
C), 135.2 (Ph CH), 158.7 (Ph COH), 181.3 (CO); v^(neat)/cm-' 3468, 3173 (br), 
2363, 2261, 1714, 1616, 1599, 1447, 1194, 1173, 1104, 1173; m/z (CI) 182 (29.90%, 
M+), 165 (39.46%), 147 (100%), Found 182.0817, C9H12NO3 (M+NH^-H^O) 
requires 182.0817. 
6.8.13 [2-C'H]-(DL)-Para-hydroxyphenyllactic acid (4.39) 
f^/ra-hydroxyphenyl pyruvic acid (0.72Ig, 4.0mmol) as an emulsion in water (40mL) 
was added dropwise to sodium borodeuteride (0.293g, 7.0mmol) in water (20mL) 
stirred at 0°C. Sturing was continued under N2 for 1.5 hours at room temperature. 
Excess sodium borodeuteride was destroyed by addition of 10% aqueous hydrochloric 
acid. The aqueous solution was reduced in vacuo to lOmL and exQ-acted into ethyl acetate 
(3x 50mL). The organic exti'acts were dried (MgS04) and reduced in vacuo to give an off 
white solid. This was washed with diethyl ether to give pure [2-C^H]-(DL)-pG/a-
hydroxyphenyUactic acid, as a white solid (0.732 g, 4.0mmol, 100%). 5H(D20) 2.72 
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( I H , d, J^,„ 14.2, CH2) 2.88 ( IH, d, 1 ,^^  14.2, CH2), 6.67 (2H, d, J 8.4, Ph), 6.98 
(2H, d, J 8.4, Ph); S/CDCIj) 42.3 (CH2), 74.7 (t, CD), 119.0 (Ph CH), 132.2 (Ph C), 
134.4 (Ph CH), 157.9 (Ph COH), 180.8 (CO); 5D(D20) 4.25 (CD); v„,, (neat)/cm-' 
3473, 3197 (br), 2408, 2260, 1731, 1613, 1600, 1432, 1185, 1113; m/z (CI) 201 
(100%, M+18), 183 (0.71%). 
6.9 Feeding of Phenylpropanoid Metabolites 
6.9.1 [2.'H]-(DL)-Phenylalanine 
[2-^H]-(DL)-Phenylalanine (0.30g, 1.80mmol) was dissolved in distilled water (24mL) 
and pulse fed to six production media cultures, through a micropore filter on days 3,4, 5 
and 6, to give a final concentration 6.0 mmolar in each flask. TeneUin (50mg) was 
isolated and purified on day 10. ^H NMR showed no observable enrichment. 
6.9.2 [2-"C'H''N]-(DL)-Phenylalanine 
[2-'^C^H'^N]-(DL)-Phenylalanine (0.135g, 0.661mmol) was dissolved in distilled water 
(12mL) and pulse fed to three production media cultures, through a micropore filter on 
days 3, 4, 5 and 6, to give a final concentration 4.4 mmolar in each flask. TeneUin 
(50mg) was isolated and purified on day 10. 5,(DMS0) 140.3 ('^CH, enriched). No 
observable incorporation of ^H or '^N. 
6.9.3 [2-"C'H]-(DL)-Phenyllactic acid 
[2-'^C^H]-(DL)-Phenyllactic acid (0.532g, 0.320mmol) was dissolved in distilled water 
(12mL) and pulse fed to three production media cultures, through a micropore filter on 
days 3, 4, 5 and 6, to give a fmal concentration 6.0 mmolar in each flask. Tenellin 
(35mg) was isolated and purified on day 10. '^ C NMR showed no observable 
enrichment. 
6.9.4 [1-"C]-(DL)-Phenylalanine 
[1-"C]-(DL)-Phenylalanine (0.114g, 0.686mmol) was dissolved in distilled water 
(40mL) and pulse fed to four production media cultures, through a micropore filter on 
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days 3, 4, 5 and 6, to give a final concentration 3.5 mmolar in each flask. Tenellin 
(1 lOmg) was isolated and purified on day 10. 5,(DMS0) 173.1 ('^CO, enriched). 
6.9.5 [3-"C]-(DL)-Tyrosine 
[3-'^C]-(DL)-Tyrosine (0.125g, 0.686mmol) was dissolved in distilled water (40mL) 
and pulse fed to four production media cultures, through a micropore filter on days 3, 4, 
5 and 6, to give a final concentration 3.5 mmolar in each flask. Tenellin (106mg) was 
isolated and purified on day 10. 5,(DMS0) 110.9 ('^C, enriched). 
6.9.6 [2-"C]-/*ara-hydroxycinnamic acid 
[2-'^C]-/'«ra-hydroxycinnamic acid (0.165g, l.OOmmol) was dissolved in distilled water 
(ImL), neutralised with O.IM NaOH, and made up to 16mL with distilled water. This 
was pulse fed to four production media cultures, through a micropore filter on days 4, 5, 
6 and 6, to give a final concentration 5.0 mmolai" in each flask. Tenellin (70mg) was 
isolated and purified on day 10. '^ C NMR showed no obsei-vable enrichment. 
6.9.7 [M^/a-^H2]-(DL)-/>ara-hydroxyphenylJactic acid 
[Me/a-^H2]-(DL)-para-hydroxyphenyllactic acid (0.079g, 0.428mmol) was dissolved in 
distilled water (12mL) and pulse fed to four production media cultures, through a 
micropore filter on days 3, 4, 5 and 6, to give a final concentration 4.3 mmolar in each 
flask. Tenellin (50mg) was isolated and puiified on day 10. 5D(DMS0) 6.8 (Ph CD, 
enriched). 
6.9.8 [2-C^H]-(DL)-Para-hydroxyphenyllactic acid 
[2-C^H]-(DL)-/'ara-hydroxyphenyllactic acid (0.275g, 1.50mmol) was dissolved in 
distilled water (24mL) and pulse fed to six production media cultures, through a 
micropore filter on days 4, 5, 6 and 6, to give a final concentration 5.0 mmolai- in each 
flask. Tenellin (190mg) was isolated and purified on day lO.^H NMR showed no 
observable enrichment. 
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6.10 Production, Isolation and Analysis of Iso-fatty acids 
6.10.1 Growth of Streptomyces cinnamonensis 
Growth of 5. cinnamonensis was initiated by transfer of aliquots (3mL) of seven day old 
frozen production medium into two 500mL Erlenmeyer flasks each containing sterile 
seed medium (lOOmL). These flasks were shaken for ten days at 200 rpm, 32° C in the 
dark. The resultant cultures were used to initiate a batch of 500mL Erlenmeyer 
production medium flasks, each containing production medium (lOOmL), by the transfer 
of aUquots (3mL), and the cultures incubated under the same conditions for seven days. 
New production media flasks were routinely initiated from seven day old production 
medium flasks. 
6.10.2 Seed medium 
A solution of glucose (3.36g), soybean flour (2.1g), CaCOj (0.42g), FeS04.7H20 
(0.77g), MgCl (0.004g) in distilled water (140mL) was prepared. 70mL portions were 
sterilized in 500mL Erlenmeyer flasks plugged with cotton wool. 
6.10.3 Production medium 
A solution of glucose (45g), soybean flour (13.5g), CaC03 (2.7g), FeS04.7H20 
(0.94g), MgCl (0.027g) in distilled water (900mL) was prepared. lOOmL portions were 
sterilised in 500mL Erlenmeyer flasks plugged with cotton wool. 
6.10.4 Isolation of lipids 
Two flasks of seven day old production medium were centiifuged at 14 000 ipm for 30 
min. The pellets (cell mass) were washed in pH 7 buffer and re-centrifuged twice. The 
pellets were suspended in methanol (lOOmL), homogenised and filtered. The residue 
was resuspended in methanol (lOOmL), homogenised and filtered. The supernatant was 
reduced in volume to 150mL in vacuo. This was extracted into dichloromethane (2x 
150mL), dried (MgS04), and concentrated. The resultant brown coloured oil was 
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triturated with distilled hexane (15mL) to extract the lipids. Filtration and concentration 
of the filtrate afforded the Upid fraction (30mg) which was dried under vacuum to 
remove any hexane. This fraction was suitable for analysis by 'H and " C NMR (400 
MHz). 
6.10.5 Analysis of fatty acids by G C M S 
The lipid fraction (30mg) was refluxed in saturated KOH in methanol (15mL) for 16 
hours. The reaction mixture was added to H2O (85mL), acidified with concentrated HCl 
and extracted into ether, the ether extracts were washed (H2O), dried (MgS04) and the 
ether removed in vacuo to yield the glycerol-free fatty acids. 
The fatty acids were methylated by heating under reflux for 16 hours in methanol 
(lOmL), acidified with para-toluene sulphonic acid (200mg, 1.43mmol). Metiianol was 
removed in vacuo and the residue redissolved in diethyl ether (lOOmL) and washed with 
H2O (3x lOmL). The ether was removed in vacuo leaving a pale yellow oil. This was 
dissolved diethyl ether (ImL) and was analysed by GCMS, under E I and C I mode. 
6.11 Synthesis of 3-Aminolsobutyrate 
6.11.1 a-Cyanopropanoic acid (5.20) 
Sodium carbonate (2.12g, 20mmol) was added to a solution of a-bromopropionic acid 
(6.12g, 40mmol) in acetonitrile (40mL), and the reaction stirred at room temperature for 
3 hours. Precipitated sodium a-bromopropionate was filtered, washed witii ether and 
dried under reduced pressure. A solution of this salt (6.52g, 37.3mmol), NaOH (O.lOg, 
2.50mmol), and excess NaCN (2.74g, 55.9mmol) was heated in H2O (20mL) between 
65°-80°C for 4 hours. After cooling, the reaction mixture was carefully acidified in a 
well ventilated fume hood, with dilute HCl^ ^ ,^. The HCN gas evolved was bubbled into 
KOH solution. iiC\^^^ was added dropwise until there was no further evolution of HCN. 
The organics were extracted into ethyl acetate, dried (MgS04), and concentrated to give 
a-cyanopropanoic acid as a yellow oil, (1.74g, 47%). 5H(CDC13) 3.64 ( I H , q, J 7.4, 
CH), 1.55 (3H, d, J 7.4, CH3); 5c (CDCI3) 170.60 (CO), 117.91 (CN), 32.04 (CH), 
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15.51 (CHj); v„„ (neat) / cm ' 3103.9 (b), 2952, 2615, 2259, 1739, 1459.7, 1266, 
1202, n i l , 811; m/z ( E I ) 100 (M+1,35.54%), 54, (100%). 
6.11.2 (DL)-|3-Aminoisobutyric acid (5.22) 
Adam's catalyst, Pt02 (200mg) was added to a solution of a-cyanopropionic acid 
(0.50g, 5.05mmol) in a mixture of dried and distilled etiianol : chloroform (10 : 1 ) 
(33mL), and stirred vigorously under hydrogen at room temperature and atmospheric 
pressure for 18 hours. Filtration of tiie reaction mixture through a Celite pad followed by 
concentration of tiie filtrate afforded an oil. This was purified by Dowex (H* form), 
eluted with NH4OH, concentrated and recrystalhsed witii ethanol affording (3-
aminoisobutyric acid (0.34g, 65%). m.p. 177.5-178°C (lit 176.5-177.5°C)' 5^ (D2O) 
2.90 (2H, m, CH2), 2.48 ( IH, m, CH), 1.03 (3H, d, J 7.2, CH3); 5c(D20) 183.41 
(CO), 44.90 (CH2), 41.48 (CH), 17.05 (CH3); v„,, (KBr disc)/cm ' 3363.2, 3401.1, 
2968.3, 1676.7, 1627.7, 1569.66, 1572.2, 1418.9; m/z (CI) 104 (M+1, 100%), 61 
(22.27%). 
6.11.3 [2-"CN]-a-Cyanopropanoic acid (5.20) 
Sodium carbonate (4.24g, 40mmol) was added to a solution of a-bromopropionic acid 
(12.2g, SOmmol) in acetonitrile (80mL), and the reaction stirred at room temperature for 
3 hours. Precipitated sodium a-bromopropionate was filtered, washed with ether and 
dried under reduced pressure. A solution of this salt (4.72g, 27mmol), KOH (0.14g, 
2.50mmol), and K'^CN (2.00g, 30.3mmol) was heated in HjO (20mL) between 75° C 
for 4 hours. After cooling, the reaction mixture was carefully acidified in a weU 
ventilated fume hood, with dilute HCl until there was no further evolution of H'^CN. 
The organics were extracted into ethyl acetate, diied (MgS04), and concentrated to give 
[l-'^C]-a-cyanopropanoic acid as a yellow oil, (1.69g, 56%). 6H(CDC13) 10.05 ( I H , 
bs, OH), 3.71 ( IH , dq, J^H 10.6 and J 7.4, CH), 1.64 (3H, dd, 6.1 and J 7.4, 
CH3); 5c (CDCI3) 171.40 (CO), 117.51 CCN), 32.62 (CH), 15.57 (CH3); 
v„„(neat)/cm-' 3001 (b), 2951, 2607, 2207, 1939, 1459, 1267, 1209, 1110, 811; m/z 
( E I ) 101 (M+1, 100%), 55 (75.22%). 
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6.11.4 (DL)-|3-[3-"C'HJ-Aminoisobutyric acid (5.21) 
Adam's catalyst, PiOj (200mg) was added to a solution of a-cyanopropanoic acid 
(0.60g, 6.00mmol) in a mixtuie of dried and distilled MeOD : CDCI3 (10 : 1 v/v) 
(33mL), and stirred vigorously under deuterium gas at room temperature and 
atmospheric pressure for 18 hours. Filti'ation of the reaction mixture through a ceUte pad 
followed by concentration of the filtrate afforded an oil. This was purified by Dowex (H* 
form), eluted with NH40H,concentrated and recrystallised with ethanol affording (DL)-
[p-'^C^HJ-P-aminoisobutyric acid (0.32g, 50%). 5H (D,0) 2.48 ( I H , m, CH), 1.03 
(3H, dd, % H 4.9 andJ 7.3, CH3); 5c(D20) 183.41 (CO), 44.90 (m, ''CD^), 41.48 
(CH), 17.05 (CH3); m/z (CI) 107 (M+1, 100%). 
6.12 Feeding Experiments to Streptomyces cinnamonensis 
6.12.1 Sodium [3-"C]-(DL)-isobutyrate 
[3-'^C]-(R,S)-isobutyrate (221mg, 2.0mmol) was dissolved in sterilised water (6mL). 
This was pulse fed to 2x 5. cinnamonensis production medium cultures on days 0, l,and 
2 to give final concentration lOmmolar in each flask. The fatty acids (13mg) were 
isolated on day 7. 5c(CDCl3) 22.67 ('^CH3 enriched). The fatty acid methyl ester were 
fornied (as above). GCMS analysis confimied 50% labelling of M+1 peak of 
isopalmitate. 
6.12.2 (DL)-p-[3-"C'HJ-Aminoisobutyric acid 
(DL)-(P-'^C"H2)-(3-aminoisobutyric (0.22g, 2.06mmol) was dissolved in distilled water 
(16mL) and pulse fed to 4x 5. cinnamonensis production medium cultures on days 0, 1, 
2, 3 of growth to give a final concentration 5.15mmolar in each flask. The fatty acids 
were isolated on day 7. 5c(CDCl3) No incorporation of '^C or observed. 
6.12.3 (DL)-P-[3-"C^H2]-Aminoisobutyric acid (increased concentration) 
(DL)-(P-'^C-H2)-p-aminoisobutyric (0.21g, 2.00mmol) was dissolved in distilled water 
(16mL) and pulse fed to 4x 5. cinnamonensis production medium cultures on days 0, 1, 
2, 3 of growth to give a final concenti-ation 10.0 mmolar in each flask. The fatty acids 
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were isolated on day 7. 5^ (CDCI3) No incorporation of '^C or observed. The fatty 
acid methyl ester were formed (as above). GCMS analysis showed a tentative 4.5% 
labelling of M+1 peak of isopalmitate. 
6.12.4 Sodium [l-"C]-methacrylate 
[l-'^C]-Sodium methacrylate (0.21g, 1.94mmol) was dissolved in distilled water 
(12mL) and pulse fed to 3x S. cinnamonensis production medium cultures on days 0, 1, 
2, 3 of growth to give a final concentration of 6.46 mmolar in each flask. The fatty acids 
were isolated on day 7. ScCCDClj) 38.03 ('^CH enriched). 
6.13 Feeding Experiments to bkd- Streptomyces avermitilis 
6.13.1 (DD-p-p.^C'H^l-Aminoisobutyric acid 
The following feeding experiments were performed by R. W. Fedechko, Central 
Research Division, Bioprocess Research, Pfizer Inc., Eastern Point Road, Groton, CT 
06340, USA. 
Cells were grown for 3 days, 29°C, 200rpm, in seed medium (8mL) in a Ix 6" glass 
tube. These tubes were inoculated by transfer of 0.5mL from a 20% glycerol stock. After 
3 days, 2x 300mL Erlenmeyer flasks, one containing 25mL of production medium, and 
one containing 25mL of 'particulate free' production medium were inoculated with 
preform growth (2mL) and grown for 15 days at 29°C, 200ipm, after which the 
metabolites were isolated and sent for analysis. The flasks were examined for avermectin 
production and it appeared to be occuring. 
(DL)-P-[3-'^C^H2]-Aminoisobutyrate (22.5mg, 0.21mmol) was added to each flask at 
the beginning of tiie production phase of avermectin, to give a final concentration of 
8.5mmolar. At tiie end of the fermentation, these flasks were tested for sterility (BHI 
sti'eak), and confirmed to be sterile. In preparation for FAME derivitisation , the ceUs 
were collected by centiifugation (10,000 rpm/ Soi-vall SS34/15 minutes) and then frozen 
at -20°C. 
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6.13.2 F A M E derivitisation and GCMS analysis of fatty acids 
Cells were removed from -20°C, and allowed to waim to room temperature. An aUquot 
(Ig) was removed and Reagent 1 (45g NaOH, 150 mL HPLC-grade MeOH, 150 mL 
distilled water) (2.5 mL) was added to each. The tubes were vortexed, incubated for 5 
minutes at 100°C, voitexed again, and mcubated for an additional 25 minutes followed 
by cooling to room temperature. Methylation reagent (325mL 6N HCl , 5mL hplc-grade 
MeOH) (5mL) was added, followed by heating for 10 minutes at 80°C. After the tubes 
had cooled, extraction reagent (200mL hexane, 200mL MTBE) (3.25mL) was added. 
These tubes were gendy mixed by inversion for 10 minutes, followed by removal of 
most of tiie lower aqueous layer using a Pasteur pipette. Base wash (10.8g NaOH in 
900mL distilled water) (7.5 mL) was added, and the tubes mixed gently by inversion for 
5 minutes. The upper, organic layer was then removed and evaporated to dryness. 
G C M S analysis was performed by K. E . Reynolds, Department of Pharmaceutical 
Sciences, 20 North Pine Street, University of Maryland, Maryland 21202-1180, 
Baltimore, USA. 
The above samples were analysed by GCMS with the mass spectrometer sweepmg 240-
280 A M U , and again with the mass specti-ometer sweeping 50-350 AMU. In botii 
samples labelling of isopalmitate and isomyristate with an M-i-2 species was observed. 
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APPENDIX 
Research Conferences Attended 
21st Century Heterocyclic Chemistry, University of Sunderland, 7th May 1997. 
Royal Society of Chemistry Bio-organic Group Postgraduate Symposium, University of 
Liverpool, 16th December 1996, (oral presentation). 
Royal Society of Chemistry Intemational Interdisciplinary Conference. Polyketides: 
Chemistry, Biology and Molecular Genetics, University of Bristol, lst-3rd April 1996, 
(poster presentation). 
Royal Society of Chemistry Bio-organic Group Postgraduate Symposium, University of 
Southampton, 18th December 1995. 
Royal Society of Chemistry Perkin Regional Meeting, University of Durham, 8th December 
1995. 
Biological Challenges for Organic Chemistry, University of St Andrews, 9th-13th July 
1995. 
Symposium on Recent Progress in Polyketide Biosynthesis, University of Cambridge, 4th 
April 1995. 
SCI Novel Organic Chemistry: 6th Graduate Symposium, University of York, 1st March 
1995. 
Recent Developments in Stereochemistry, University of Sheffield, December 20th 1994. 
Royal Society of Chemistry Bio-organic Group Postgraduate Symposium, University of 
Durham, 12th December 1994. 
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Departmental Colloquia 
1994 
October 5 Prof. N. L. Owen, Brigham Young University, Utah, USA 
Determining Molecular Structure - the INADEQUATE NMR way 
October 19 Prof. N. Bartlett, University of California 
Some Aspects of Ag(II) and Ag(III) Chemistry 
November 2 Dr P. G. Edwards, University of Wales, Cardiff 
The Manipulation of Electronic and Structural Diversity in Metal 
Complexes-New Ligands 
November 10 Dr M. Block, Zeneca Phamiaceuticals, Macclesfield 
Large-scale Manufacture of ZD 1542, a Thromboxane Antagonist 
Synthase Inhibitor 
November 16 Prof. M. Page, University of Huddersfield 
Four-membered Rings and ^-Lactamase 
November 17 Dr Caims-Smith, Unversity of Glasgow 
Clay Minerals and the Origin of Life 
November 23 Dr J. M. L. WiUiams, University of Loughborough 
New Approaches to Assymetric Catalysis 
1995 
January 25 Dr D. A. Roberts, Zeneca Phamiaceudcals 
The Design and Synthesis of Inhibitors of the Renin-angiotensin System 
January 1 Mrs S.Owen, Northumberiand Water 
Trace Organics in the Environment 
February 1 Dr T. Cosgrove, Bristol University 
Polymers do it at Interfaces 
February 16 Prof. H. Kroto, Sussex University 
Ceo-The Cellestial Sphere that Fell to Earth 
February 22 Prof. E. Schaumann, University of Claustal 
Silicon- and Sulphur-mediated Ring-opening Reactions of Epoxides 
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March 23 Prof. Riess, Nice University 
Highly Fluorinated Compounds and Systems for Biomedical Uses 
May 4 Prof. A. J. Kresge, University of Toronto 
The Ingold Lecture Reactive Intemiediates: Garboxylic-acid Enols and 
Other Unstable Species 
May 9 Prof. Townsend, Unilever 
lOM Lecture Polymers for the Year 2000: The Challenges Ahead. 
July 7 Dr Kevin Reynolds, University of Maryland at Baltimore 
The Molecular Biology and Biochemisty of Fatty Acids from 
Streptomyces 
October 18 Prof. A. Alexakis, Univ. Pierre et Marie Gurie, Paris 
Synthetic and Analytical Uses of Ghiral Diamines 
October 25 Dr D. Martin Davies, University of Northumbria 
Chemical Reactions in Organised Systems 
November 1 Prof W. Motherwell, UCL London 
New Reactions for Organic Synthesis 
November 3 Dr B. Langlois, University Qaude Bernard-Lyon 
Radical Anionic and Pseudo Cationic Trifluoromethylation 
November 8 Dr D. Craig, Imperial College, London 
New Strategies for the Assembly of Heterocyclic Systems 
1996 
January 10 Dr BiU Henderson, Waikato University, NZ 
Electrospray Mass Spectroscopy - A New Sporting Technique 
February 14 Dr J. Rohr, Univ. Gottingen, FRG 
Goals and Aspects of Biosynthetic Studies on Low Molecular Weight 
Natural Products 
February 28 Prof. E. W. Randall, Queen Mary & Westfield College 
New Perspectives in NMR Imaging 
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March 6 Dr Richard Whitby, University of Southhampton 
New Approaches to Chiral Catalysts: Induction of Planar and Metal 
Centred Asymmetry 
March 13 
1997 
January 15 
Prof. Dave Gamer, Manchester University 
Mushrooming in Chemistry 
Dr V. K. Aggarwal, University of Sheffield 
Suphur Mediated Assymetric Synthesis 
January 16 Dr Sally Brooker, University of Otago, NZ 
Macrocycles: Exciting yet Controlled Thiolate Coordination Chemistry 
January 22 Dr Neil Cooley, BP Chemicals, Sunbury 
Synthesis and Properties of Altemating Polyketones 
January 29 Dr Julian Clarke, UMIST 
What can we leam about polymers and biopolymers from 
computer-generated nanosecond movie clips? 
February 5 Dr A. Haynes, University of Sheffield 
Mechanism in Homogenous Catalytic Carbonylation 
February 6 Prof. P. Bardett, University of Southampton 
Integrated Chemical Systems 
February 12 Dr Geert-Jan Boons, University of Birmingham 
New Developments in Carbohydrate Chemistry 
February 25 Professor A. G. Sykes, University of Newcasde 
The Synthesis, Structure and Properties of Blue Copper Proteins 
February 26 Dr Tony Ryan, UMIST 
Making Hairpins from Rings and Chains 
March 5 Dr J. Staunton FRS, Cambridge University 
Tinkering with Biosynthesis: Towards a New Generation of Antibiotics 
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